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Clathrin-mediated endocytosis is a selective pathway for the entry of transmembrane proteins 
into the cell through the generation of a short-lived vesicular intermediate. Cells and tissues 
depend on this process for obtaining nutrients, modulation of signaling and cell migration. The 
clathrin-coated structure intermediate is assembled on the plasma membrane from a cohort of 20-
30 distinct proteins that aid in cargo selection, scaffolding, membrane bending and scission of 
the vesicle. Exactly how these complex assemblies are nucleated at the plasma membrane 
remains unclear although the lipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) plays 
an important role by anchoring many of the endocytic components. The work in this thesis helps 
to clarify the nucleation phase by describing the molecular details of the interaction between a 
PtdIns(4,5)P2-generating lipid kinase PIPKIγ and the heterotetrameric clathrin adaptor AP-2. By 
engaging a subdomain on the AP-2 β2 subunit appendage, the kinase is strategically positioned 
at assembly sites to generate PtdIns(4,5)P2 and drive coat assembly forward. Clathrin binds to the 
same subdomain on the β2 appendage but with a higher apparent affinity. I therefore invoke a 
model in which PtdIns(4,5)P2 production for nucleation is negatively regulated by PIPKIγ 
displacement from AP-2 by clathrin at later stages of assembly. I also demonstrate that a cargo-
sorting alternate adaptor that binds to the other subsite on the AP-2 β2 appendage is not subject 
to displacement by clathrin during clathrin-coated vesicle budding, ensuring non-competitive 
cargo incorporation into the vesicle. Finally, the PtdIns(4,5)P2-binding EFC domain proteins 
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 v 
FCHO1 and FCHO2 have been proposed to act as dedicated nucleators of clathrin-coated 
structures on the plasma membrane. I demonstrate in multiple cell lines that these proteins are 
not invariantly required for placement of clathrin-coated assemblies on the plasma membrane 
despite being early arriving components themselves. FCHO1/2 are involved in the regulation of 
the size and number of these assemblies in some cellular contexts. My data support the model of 
PtdIns(4,5)P2 regulated, not protein regulated, nucleation of clathrin-coated structures; however 
multiple parallel pathways may contribute to initiation of endocytic buds. 
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1.0  INTRODUCTION 
1.1 INTRACELLULAR TRANSPORT 
1.1.1 Vesicular transport 
Central to the classification and diversification of life on earth are the inherent differences 
between eukaryotic and prokaryotic cells. Eukaryotic cells have evolved a cohort of membrane-
bound organelles that facilitate numerous biochemical reactions and serve to separate these 
reactions in space and time, while prokaryotes have not (Alberts et al., 2002). These organelles 
contain three-dimensional aqueous reaction vessel lumens of varying molarities and pH and an 
encompassing two-dimensional lipid membrane scaffold. This type of static representation of 
eukaryotic cell structure fails to convey the immense effort cells make in order to maintain 
homeostasis. Continual energy expenditure must be made to target proteins and lipids to the 
correct sub-cellular location and to prevent passive transport of inappropriate molecules, as well 
as to retrieve membrane that prevents organelle contraction and expansion. Not surprisingly, 
complex and conserved mechanisms have evolved to control intracellular traffic. 
The existence of sub-cellular organelles has been known since the 19th century, however 
our understanding of communication between these organelles only began to take shape in the 
1960s through the work of George Palade. Working with pancreatic exocrine cells, Palade 
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showed that newly synthesized proteins destined for secretion are first translocated into the 
endoplasmic reticulum (ER) and then sequentially transit through the Golgi complex, secretory 
granules and finally the extracellular space (Palade, 1975). Non-secreted proteins that reside at 
the plasma membrane, endosomes and lysosome also pass through some of these common 
compartments. Palade noted that the compartments maintain their identity over time and 
postulated that secretory proteins shuttle between them in transport vesicles. In time, Palade’s 
work gave rise to the generalized vesicle transport hypothesis (Bonifacino and Glick, 2004): A 
donor membrane generates a small (~50-100 nm) vesicle into which proteins (soluble and 
membrane-bound) are packaged, the vesicle travels to a target membrane and fusion of the two 
lipid bilayers releases the contents into the target. 
Further substantiating the vesicle transport model and initiating the molecular 
characterization of this process was work by the Schekman and Rothman laboratories. A screen 
for Saccharomyces cerevisiae secretion or sec mutants by Schekman’s group revealed 23 
complementation groups that displayed morphologic phenotypes associated with altered 
vesicular transport: 1. accumulation of small vesicles, 2. an enlarged ER network and 3. an 
abnormal Golgi complex (Novick et al., 1980). Over the following two decades the sec proteins 
were identified and characterized as components of the vesicle generation and fusion machinery 
(Schekman and Novick, 2004). In a different in vitro approach by Rothman’s laboratory, donor 
membrane Golgi fractions lacking an enzyme necessary for the synthesis of complex 
oligosaccharides generation on the viral glycoprotein (G protein) from Vesicular Stomatitis 
Virus (VSV-G) infected cells were mixed with a wild-type acceptor membrane Golgi fraction. 
The further processing of viral glycoprotein N-linked sugars was monitored to follow transport 
between Golgi cisternae (Balch et al., 1984a; Balch et al., 1984b; Braell et al., 1984). VSV-G, 
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starting in the donor Golgi became fully processed despite the seemingly maintained integrity of 
the Golgi fractions. These experiments strongly suggested that cellular proteins are shuttled by 
vesicles to their destination. 
1.1.2 Coated vesicles 
Working in the same years as Palade, Thomas Roth and Keith Porter discovered a common 
theme in vesicular transport: generation of trafficking vesicles occurs through a coated vesicle 
intermediate. As will become apparent in later sections, protein coats fulfill three main functions 
during vesicle formation: 1. assistance in deforming the membrane, 2. uniformity in size of 
generated vesicles and 3. selection of integral membrane proteins destined for transport, hereafter 
referred to as ‘cargo’. 
1.1.2.1 Clathrin-coated vesicles 
Roth and Porter were interested in how circulating proteins within female mosquito hemolymph 
were deposited as yolk inside developing oocytes (Roth and Porter, 1964). They noticed that 
shortly following a blood meal, a proliferation of “bristle-coated pits and vesicles” on the 
cytoplasmic surface of the mosquito oocyte plasma membrane occurs. These pits and vesicles 
contained three distinguishable layers by electron microscopy: an inner, extracellular/luminal 
layer corresponding to massed yolk protein, a middle layer of ~75-Å corresponding to the bilayer 
membrane, and an outer layer ~200-Å thick that resembled a coat of fibrous bristles in the thin 
sections. Most remarkably, they correctly predicted from static images that these coated pits 
likely operated as a shuttle by concentrating yolk, budding from the surface, uncoating and 
fusing to form the large mature yolk bodies seen in mosquito oocytes. Coated vesicles are not 
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restricted to the endocytic pathway and were subsequently observed on the Golgi complex 
(Friend and Farquhar, 1967) where they are involved in anterograde biosynthetic traffic. 
The ensuing decade was dedicated to isolating coated vesicles and biochemically 
characterizing them. Fractionation of guinea pig brain and electron microscopic observation 
revealed that coated vesicles were ~50 nm diameter vesicles surrounded by a ~100 nm diameter 
cage of pentagonal and hexagonal facets (Kanaseki and Kadota, 1969). By purifying these 
vesicles biochemically, Barbara Pearse identified the main proteinaceous component of coated 
vesicles as a ~180 kDa protein that she named clathrin (Pearse, 1975, 1976). Trimerization of 
clathrin heavy chain molecules into a three-legged triskelion that also contains three 25-29 kDa 
associated clathrin light chain polypeptides was found to be the basic structural unit of these 
coated vesicle cages (Ungewickell and Branton, 1981). Less abundant, and initially overlooked, 
associated proteins (APs) of ~110, 50 and 16 kDa isolated with coated vesicles were 
subsequently shown to promote clathrin triskelion polymerization in vitro (Keen et al., 1979) and 
were re-dubbed ‘assembly polypeptides’ for APs (Keen, 1987). Clathrin-coated vesicles (CCVs) 
are now known to coordinate trafficking of cargo both from the plasma membrane during 
endocytosis and in biosynthetic traffic out of the trans-Golgi network (TGN) and on endosomes 
in endocytic trafficking. The molecular details of coat-directed vesicle assembly will be 
discussed below. 
1.1.2.2 COPI coated vesicles 
The generality of the use of protein coats for vesicle formation was extended when ultrastructural 
examination of the Golgi revealed coated buds that were not immunoreactive for clathrin 
(Griffiths et al., 1985; Orci et al., 1985). Closer analysis demonstrated these coats were 
morphologically different from clathrin and appeared as ‘obtuse spikes’ (Orci et al., 1986). 
 5 
Biochemical purification of protein components of this coat gave rise to the name Golgi coat 
promoter or Coatomer (Waters et al., 1991) and later COPI coats. COPI coats are now known to 
be important in the early secretory pathway where they mediate retrograde transport between 
Golgi cisternae, from the Golgi to the ER and also, possibly, in anterograde transport from the 
ER-Golgi Intermediate Complex to the Golgi (Beck et al., 2009). It was likely the transport of 
oligosaccharide-processing enzymes between Golgi fractions in COPI vesicles that allowed 
VSV-G to mature in the Rothman experiments (Balch et al., 1984a; Balch et al., 1984b). The 
COPI coat recognizes specific amino-acid tracts or sorting signals within cargo, in this case 
typically ER resident proteins, for inclusion into budding vesicles. This process is termed cargo 
selection and is another common theme of vesicular transport as discussed below. 
1.1.2.3 COPII coated vesicles 
In contrast to the purely morphological initial discovery of clathrin and COPI coats, a third, ER-
derived coated vesicle was discovered as a result of its in vitro reconstitution (Barlowe et al., 
1994). COPII coated vesicles are formed at distinct ER exit sites from the progressive assembly 
of the Sar1 Guanosine triphosphate (GTP)ase, the Sec23/24 inner coat, and Sec13/31 outer coat 
(Miller and Barlowe, 2010) that culminates in the release of small (~60 nm) vesicles (Barlowe et 
al., 1994). Many of the sec mutants possess mutations in genes for the COPII coat or its 
regulatory factors (Schekman and Novick, 2004). Assembling COPII buds segregate cargo for 
export from resident ER proteins through the recognition of diacidic and dihydrophobic sorting 
signals in the cytosolic portion of transmembrane cargo or soluble cargo receptors (Aridor et al., 
1998; Barlowe, 2003). 
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1.2 THE ENDOCYTIC PATHWAY 
Cells, both in multicellular organisms and free-living unicellular organisms, do not operate in 
complete isolation but must interact with their environment. The plasma membrane represents a 
barrier between the potentially harsh surroundings and the cell’s controlled cytosol. The cell 
must continually respond to its environment and can accomplish this in part by actively adjusting 
the protein and lipid composition of the plasma membrane. This is often handled by endocytosis, 
the invagination and vesiculation/tubulation of a region of plasma membrane entrapping a 
volume of extracellular fluid and integral membrane proteins in the immediate region. Delivery 
of the vesicle/tubule to internal membranes then allows degradation or recycling of the 
internalized contents. Because of the complexity of cell-cell, cell-tissue and cell-organism 
communication, mammalian cells have evolved a multitude of endocytic pathways each with 
different functions to effectively interact with and respond to their environment. 
1.2.1 Clathrin-independent endocytosis 
Endocytic pathways are first characterized by their dependence on or independence of a clathrin 
coat. Within the clathrin-independent endocytosis (CIE) branch, internalization is further 
classified by size (Mayor and Pagano, 2007). Macropinocytosis is the internalization of large 
volumes of extracellular fluid through membrane extensions that fuse with each other or back 
onto the plasma membrane producing vesicles on the order of >1 µm (Kerr and Teasdale, 2009). 
Macropinocytosis is tied to the formation of circular dorsal ruffles, can be stimulated by various 
growth factors, and requires the actin cytoskeleton and the Rho family GTPase Rac1 (Doherty 
and McMahon, 2009). One natural function of macropinocytosis is fluid-phase sampling of the 
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environment for antigen presentation by immune cells, though a variety of pathogens can induce 
macropinosome formation for their host entry (Kerr and Teasdale, 2009). 
Phagocytosis is an endocytic pathway for the internalization of large (>1 µm) solid 
particles into cells. Professional phagocytic cells, including macrophages, monocytes and 
neutrophils in mammals, engulf opsonized pathogens or apoptotic cell bodies through actin-
enriched membrane protrusions (Doherty and McMahon, 2009). There appears to be at least two 
distinct phagocytic pathways: internalization of IgG opsonized particles ligated to its receptor 
FcγR in a mainly Rac1 and Cdc42 GTPase dependent pathway and uptake of C3bi-coated 
particles by the complement receptor CR3 in a mainly RhoA GTPase dependent manner (Groves 
et al., 2008). 
There also exist multiple clathrin-independent pathways for generating trafficking 
vesicles on a smaller order (< 1µm) and pinocytic (fluid-phase) in nature (Mayor and Pagano, 
2007). The best characterized of these is caveolar endocytosis. Caveolae are 50-80 nm flask-
shaped plasma membrane invaginations that are enriched in cholesterol and sphingolipids 
(Hansen and Nichols, 2010). One of the primary functions of caveolae is in transcytosis of serum 
factors in endothelial cells (Oh et al., 2007) such as albumin (Schubert et al., 2001). Caveolae 
are also subverted for simian virus 40 entry (Anderson et al., 1996). Caveolae have a striated 
coat by electron microscopy formed by the proteins caveolins and cavins, but how these 
structures contribute to function or endocytosis is not clear (Hansen and Nichols, 2010). New 
data suggest caveolae are membrane reservoirs to regulate surface tension (Sinha et al., 2011). 
Finally, there are a number of other clathrin and caveolin-independent endocytic 
pathways that appear to operate in the absence of a morphologically discernable coat and require 
Rho/ADP ribosylation factor (Arf) family GTPases. For example, tubular and ring-like plasma 
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membrane invaginations called Clathrin- and Dynamin-independent Carriers (CLICs) 
endocytose glycosylphosphatidylinositol-anchored proteins and Cholera toxin B in a process 
dependent on Cdc42 GTPase (Kirkham et al., 2005; Mayor and Pagano, 2007). The variability in 
mechanisms to generate non-clathrin endocytic vesicles/phagosomes/macropinosomes may 
reflect the unique challenges or range of cargo encountered at the interface between various cell 
types and their environment. Many questions pertaining to the mechanics and cargo selection of 
CIE pathways remain. 
1.2.2 Clathrin-mediated endocytosis 
By far the best-characterized endocytic pathway at the morphological, biochemical, structural 
and mechanistic levels is that generating CCVs. Clathrin-mediated endocytosis (CME) plays 
critical roles in nutrient absorption such as for the transferrin (Tf) receptor (TfR) and low density 
lipoprotein receptor (LDLR) (Orci et al., 1978; Booth and Wilson, 1981), modulation of signal 
transduction through downregulation of surface receptors (Le Roy and Wrana, 2005), cell 
migration (Nishimura and Kaibuchi, 2007) and neurotransmission (Smith et al., 2008). In the 
standard textbook model, clathrin-coated pits (CCPs), or more appropriately clathrin-coated 
structures (CCSs), are generated anew from the progressive accumulation of adaptors and 
clathrin from a soluble pool on a region of the plasma membrane (Alberts et al., 2002). A layered 
assembly is created with the cargo-laden plasma membrane on the inside, a middle adaptor layer 
bound to cargo and an outer clathrin coat layer attached to the adaptor layer. Increasing curvature 
of the nascent bud is accompanied by concentration of cargo molecules (Figure 1.1). Finally the 
GTPase dynamin oligomerizes at the neck and promotes scission of the vesicle followed shortly 
by uncoating and recycling of the endocytic components.  
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Figure 1.1: Clathrin-coated pit and vesicle formation. 
Clathrin-coated pits form through successive steps. On a patch of the plasma membrane, AP-2 adaptors 
and clathrin-associated sorting proteins (CLASPs) are recruited during the nucleation phase. If the 
assembly fails to stabilize the components are released and dissolution occurs. If the components are 
stabilized through binding transmembrane cargo receptors, the assembly continues through a growth 
phase during which more cargo is concentrated and clathrin trimers are polymerized into a coat. When the 
assembly is deeply invaginated, Dynamin GTPase assembles at the neck to promote scission with the help 
of actin-mediated tension. After budding the coat is disassembled and coat components are recycled for 
further rounds of endocytosis. Image modified from (Traub, 2009). 
 
 
1.3 COMPONENTS AND ASSEMBLY OF CLATHRIN-COATED STRUCTURES 
1.3.1 Clathrin 
As described above, clathrin is a trimer of three heavy chains with three associated light chains 
forming a triskelion. The triskelion contains three-fold rotational symmetry about the heavy 
chain C-terminal trimerization domain (Ungewickell and Branton, 1981). Each heavy chain leg 
is kinked and contains a straight, helical proximal segment, a flexible knee, a straight, helical 
distal segment, a straight, helical ankle segment and an N-terminal, β-propeller fold terminal 
domain (Figure 1.2A) (Edeling et al., 2006b).  
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In an assembled clathrin lattice, a single triskelion vertex is present at each corner 
between adjacent hexagon–hexagon or hexagon–pentagon facets. Triskelion self-assembly is 
accomplished through anti-parallel binding of proximal and distal leg segments (Fotin et al., 
2004). In this configuration many terminal domains are clustered beneath the polygonal lattice 
specifically below vertices (see Figure 1.6) (Edeling et al., 2006b). This architecture is important 
as clathrin has no inherent affinity for the plasma membrane and binds via interactions with the 
adaptor layer through its terminal domains (Unanue et al., 1981). 
 
 
 
 
Figure 1.2: Organization of clathrin and AP-2. 
(A) Clathrin heavy chains (red) trimerize at their C-termini to form a triskelion. A straight segment 
adjacent to the trimerization domain is the proximal leg, followed by the knee, distal leg, ankle and the 
terminal domain. One clathrin light chain (green) binds to one heavy chain along the proximal leg. The 
triskelion is curved, projecting the terminal domains down. (B) AP-2 is a heterotetramer composed of two 
large subunits, α (blue) and β2 (green), a medium subunit µ2 (magenta) and a small subunit σ2 (orange). 
All four subunits fold compactly into a brick-like core. The large subunits have an unstructured C-
terminus (hinge) that ends in an independently folded appendage domain. Regions on the β2 subunit that 
bind clathrin are denoted by gold circles. 
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1.3.2 The heterotetrameric adaptor AP-2 
In order to act as a mechanical scaffold for vesicle formation, clathrin binds to adaptors that 
themselves bind to the membrane as well as cargo molecules. For this reason, the originally 
named ‘assembly polypeptides’ (Keen, 1987) have more commonly assumed the name ‘adaptor 
proteins’ as they can link clathrin assembly to cargo selection. The AP family is composed of 
four heterotetrameric protein complexes (AP-1–4) that are ubiquitously expressed (Boehm and 
Bonifacino, 2001). The APs each contain two large (~100-140 kDa) subunits: γ, α, δ, ε and β1-4, 
one medium (~50 kDa) subunit: µ1-4 and one small (~20 kDa) subunit: σ1-4 for AP-1 through 
AP-4, respectively. These adaptors regulate CCV formation (AP-1 and AP-2) or vesicle 
formation (AP-3 and AP-4) at different subcellular domains: AP-2 at the plasma membrane and 
AP-1, AP-3 and AP-4 at the TGN and endosomes (Nakatsu and Ohno, 2003). Further discussion 
will focus on how AP-2 coordinates endocytosis at the plasma membrane. 
Biochemical and structural studies have greatly advanced our knowledge of how AP-2 
functions in CCV assembly. AP-2 (as well as AP-1, -3 and -4) consists of a brick-like core 
domain with two independently folded appendages connected by flexible, unstructured chains 
called the hinge domains (Figure 1.2B) (Heuser and Keen, 1988). The AP-2 core is assembled 
from all four subunits: the α and β2 N-termini, the µ2 and the σ2. The α and β2 subunit N-
termini each have an alpha-solenoid fold with a sharp ~90° turn that creates a curved rectangle 
(Collins et al., 2002). Tucked into the large subunit turns are the structurally analogous σ2 for α 
and the µ2 N-terminus for β2. The µ2 subunit has a middle unstructured domain and C-terminal 
curved β-sheet domain. This µ2 C-terminus fits neatly into the remaining space of the α/β2 
‘bowl’ (Collins et al., 2002). 
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Projecting off at the C-termini of α and β2 are the unstructured hinge domains that end in 
the folded ‘appendage’ domains. Despite a low primary sequence conservation between the α 
and β2 appendages, they share a similar tertiary structure (Traub et al., 1999; Owen et al., 2000), 
Both appendages can be further divided into an amino terminal sandwich subdomain, comprised 
of a β-sandwich fold, and a carboxyl terminal platform subdomain, formed by a combination of 
β-sheet and α helices. The AP-2 appendage domains are critical to proper CME as they 
coordinate interactions with ~20-30 endocytic proteins including clathrin (Mishra et al., 2004; 
Edeling et al., 2006a) and antibodies that bind the α appendage (AP.6) interfere with Tf uptake 
when microinjected into cells (Chin et al., 1989). The appendages will be discussed in greater 
detail below. 
Cargo molecules contain linear amino-acid sequences in their cytosolic aspects, known as 
sorting signals, for their positive-selection and incorporation into forming CCVs. As the most 
prominent component of CCVs after clathrin, AP-2 is the prototypical adaptor for cargo 
selection. The µ2 subunit of AP-2 specifically recognizes tyrosine-based sorting signals of the 
consensus YXXØ (where X is any amino acid and Ø is a bulky hydrophobic residue) (Ohno et 
al., 1995; Owen and Evans, 1998). AP-2 can coordinate the simultaneous internalization of 
multiple sorting signal type containing cargo (Table 1.1). It also recognizes the consensus 
[DE]XXXL[LI] (brackets indicate one of the contained residues) through the σ2 and α 
hemicomplex (Doray et al., 2007; Kelly et al., 2008). These different signals allow the non-
competitive (Warren et al., 1997) constitutive endocytosis of a variety of receptors. Interestingly 
in the ‘closed’ conformation the µ2 C-terminal domain and σ2/α hemicomplex cargo sites are 
blocked by the β2 subunit (Collins et al., 2002) and must undergo rearrangement to 
accommodate cargo. This suggests recognition of sorting signals is not what recruits AP-2 to the 
 13 
plasma membrane and agrees with failure of AP-2 to bind to endosomes that are rich in TfR and 
LDLR. 
1.3.3 Monomeric adaptors 
1.3.3.1 Clathrin-associated sorting proteins 
The AP-2 centric model of cargo sorting has been expanded in recent years with the observations 
that distinct cargo with different sorting signals do not compete with each other for entry through 
CCPs (Warren et al., 1998) and that short interfering RNA (siRNA) depletion of AP-2 in cell 
culture only minimally affects internalizaton of some cargo such as LDLR (Hinrichsen et al., 
2003; Motley et al., 2003). An array of alternate adaptors or clathrin-associated sorting proteins 
(CLASPs), that increase the sorting repertoire of CCSs beyond AP-2-bound cargo, and their 
recognized sorting signals have been identified (Traub, 2009). 
β-arrestin 1 and 2 were the first recognized CLASPs. Following stimulation of G protein-
coupled receptors (GPCRs) with an appropriate ligand, multiple serine and threonine residues 
within the cytosolic loops of these receptors are phosphorylated by the G protein-coupled 
receptor kinase (GRK) family members (Ritter and Hall, 2009). β-arrestins contain an N-
terminal bilobed arrestin fold that simultaneously recognizes this three dimensional array of 
receptor-attached phosphates and receptor loops (Marchese et al., 2003) and phosphoinositides 
(Gaidarov et al., 1999). This interaction rapidly desensitizes signal propagation by uncoupling 
heterotrimeric G proteins from the receptor. β-arrestin is usually soluble in the basal state as the 
largely unstructured C-terminus is bound back on the arrestin fold as an inhibitory clamp. Upon 
receptor engagement, electrostatic associations with the receptor-attached phosphates discharge 
the C-terminus revealing AP-2 appendage and clathrin binding motifs (Edeling et al., 2006a; 
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Burtey et al., 2007). The revealed clathrin coat interaction motifs target β-arrestin and the 
associated desensitized receptor to pre-existing clathrin-coated pits for endocytosis and 
downregulation (Scott et al., 2002). In contrast to the YXXØ and [DE]XXXL[LI] sorting signals 
constitutively recognized by AP-2, β-arrestin recognition of phosphate signals and coupling to 
the endocytic machinery constitutes a regulated form of endocytosis. As there are roughly 1000 
GPCRs encoded in the human genome (Takeda et al., 2002) making them the largest receptor 
family, and many but not all utilize β-arrestins and clathrin, this endocytic regulation is critical to 
homeostasis and adaptation. 
 
Table 1.1: Sorting signals for clathrin-mediated endocytosis 
Sorting Signal/Type Recognition Protein or 
Domain 
Example of Cargo 
YXXØ* AP-2 µ2 Transferrin receptor 
[DE]XXXL[LI] AP-2 σ2/α CD4 
[FY]XNPX[YF] Dab2 and ARH PTB domain LDL receptor 
phospho-Ser/Thr β-arrestin 1 and 2 GPCRs 
Ubiquitin epsin and eps15 UIM EGF receptor 
* ∅ indicates a bulky hydrophobic residue: Leu, Met, Ile, Phe 
 
The CLASPs autosomal recessive hypercholesterolemia (ARH) and Disabled-2 (Dab2) 
recognize sorting signals of the consensus sequence [FY]XNPX[YF] (Traub, 2009). 
Coincidentally, this tyrosine-based sorting signal was discovered by Joseph Goldstein and 
Michael Brown (Anderson et al., 1977; Chen et al., 1990) prior to the characterization of AP-2 
or knowledge of alternative adaptors. Mutations in this sequence prevent endocytosis of low 
density lipoprotein particles by LDLR giving rise to familial hypercholesterolemia. In these 
proteins, the N-terminal phosphotyrosine binding (PTB) domain (a misnomer because it binds 
unphosphorylated tyrosine) simultaneously binds the [FY]XNPX[YF] signal and the inositol 
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headgroup of the lipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) (Figure 1.3), 
coordinating cargo sorting and membrane localization (Stolt and Bock, 2006). The ARH and 
Dab2 C-termini are unstructured and bind to AP-2 and clathrin, similar to β-arrestin. 
In mammals, many cell surface molecules destined for CME contain primary sequence 
encoded sorting signals, however in the yeast S. cerevisiae the primary endocytic signal is 
appended ubiquitin molecules (Lauwers et al., 2010). Three ubiquitin binding proteins, Ent1p, 
Ent2p, and Ede1p function redundantly in yeast to sort ubiquitinated cargo (Shih et al., 2002). 
The mammalian orthologues epsin 1, epsin 2, and epidermal growth factor receptor substrate 15 
(eps15), respectively function in a similar manner (Wendland, 2002; Sorkina et al., 2006). To 
target to the plasma membrane, epsin 1 contains an epsin N-terminal homology (ENTH) domain 
and eps15 contains three N-terminal eps15 homology (EH) domains that both bind to 
PtdIns(4,5)P2 (Figure 1.3) (Traub, 2009). The C-terminal regions of both epsin 1 and eps15 are 
unstructured. Immediately downstream of the ENTH domain in epsin 1 are three ubiquitin-
interacting motifs (UIM) while eps15 contains two UIMs at its extreme C-terminus that bind 
polyubiquitin (Hawryluk et al., 2006) by conforming to α-helices (Sims and Cohen, 2009). Epsin 
contains multiple NPF motifs (Asp-Pro-Phe) that allow it to bind the eps15 EH domains, and in 
fact the name epsin comes from its identification as an eps15 in
 
teracting protein (Chen et al., 
1998). The remaining regions of unstructured polypeptide contain motifs for binding AP-2 and 
clathrin (epsin 1) or solely AP-2 (eps15) and will be described in detail below. Similar to post-
translational phosphorylation for β-arrestins, ubiquitination of cargo following activation such as 
for the epidermal growth factor receptor (EGFR) promotes regulated endocytosis through 
epsin/eps15 (Traub, 2009). A common theme begins to emerge that many, but not all, CLASPs  
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Figure 1.3. Endocytic protein domains for plasma membrane association. 
Crystal structures of domains of significant tertiary structure of adaptors involved in CME. The AP180 N-
terminal homology (ANTH) domain from AP180 (PDB# 1HG5), epsin N-terminal homology (ENTH) 
domain from epsin (PDB# 1H0A), a phosphotyrosine binding (PTB) domain from Dab2 (PDB# 1M7E) 
and the open conformation of the AP-2 core (PDB# 2XA7) are depicted. These domains display affinity 
for the lipid PtdIns(4,5)P2. The plasma membrane is represented by the yellow line and individual 
PtdIns(4,5)P2 molecules are represented by six-member rings with red dots at the 1, 4 and 5 positions 
embedded in the plasma membrane. PtdIns(4,5)P2 coordinates with specific residues in these domains. 
AP-2 binds four molecules of PtdIns(4,5)P2: two through the µ2 subunit, one through the β2 and one 
through the α subunit. By rotating the structures 90° the PtdIns(4,5)P2 contact sites are more clearly seen 
(red spots, bottom). The unstructured C-termini of AP180, epsin and Dab2 are depicted as black lines. 
The AP-2 appendages (PDB# 1E42 and 1QTS) are shown connected by unstructured hinge domains. 
Structures were rendered in PyMOL. 
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sort cargo and recognize the plasma membrane through folded N-terminal domains and interact 
with the endocytic machinery through interaction motifs within unstructured C-terminal regions. 
1.3.3.2 Endocytic Accessory factors 
CCPs are highly regulated protein assemblies both in time and space. As such they contain a 
multitude of additional structural and enzymatic factors, termed accessory factors, that control 
assembly. For example, the neuronal specific protein AP180 and its ubiquitously expressed 
homolog clathrin assembly lymphoid myeloid leukemia protein (CALM) may act as CLASPs for 
soluble NSF attachment protein receptors (SNAREs) (Harel et al., 2008), they also function to 
promote AP-2 and clathrin assembly at the plasma membrane (Ahle and Ungewickell, 1986). 
AP180 and CALM accomplish these functions through the typical modular architecture: a 
PtdIns(4,5)P2 binding AP180 N-terminal homology (ANTH) domain (Figure 1.3), structurally 
related to the epsin ENTH domain, and an unstructured C-terminus with multiple AP-2 and 
clathrin binding motifs (Kalthoff et al., 2002). Intersectin is a CCP structural protein that does 
not bind cargo. It appears to scaffold assembly/CLASP proteins such as the epsins and eps15 to 
later acting scission (dynamins), actin-related (neural Wiskott-Aldrich Syndrome Protein, N-
WASP), and lipid phosphatase (synaptojanin, SHIP2) proteins (Pechstein et al., 2010b). 
The energetic cost of generating a spherical vesicle from a flat membrane of typical 
biological composition is a membrane-bending free energy of ~250-600 kBT and reactions of 
thermal energy >100 kBT do not occur spontaneously (Hurley et al., 2010). Clathrin 
polymerization is absolutely required for generating membrane curvature (Hinrichsen et al., 
2006) and could potentially supply some of this energy. Further membrane bending and/or 
stabilization may come from members of the Bin/Amphiphysin/Rvs167 (BAR) domain family 
(Suetsugu et al., 2010). BAR domains are α-helical obligate anti-parallel homodimers that have 
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a crescent shape. Through numerous Lys/Arg residues on the concave domain surface that 
interact with negative phospholipids and the propensity of these domains to oligomerize, BAR 
domain proteins influence membrane curvature in various locations throughout the endocytic and 
biosynthetic pathways. The BAR domain proteins endophilin and amphiphysin bind indirectly 
(endophilin) or directly (amphiphysin) to AP-2 and clathrin (Slepnev et al., 2000) and both bind 
directly to dynamin through their C-terminal SH3 domains (Simpson et al., 1999). By 
preferentially binding curved membranes with a circular diameter of ~22 nm, endophilin and 
amphiphysin couple constriction of the neck of deeply invaginated CCPs to dynamin recruitment 
for scission (Brett and Traub, 2006). 
The terminal stages of CCV formation are characterized by vesicle scission, propulsion 
and uncoating. The dynamin GTPase plays a critical role in liberating the forming vesicle from 
the plasma membrane. Though the mechanistic details are still being worked out, dynamin self-
assembly at the neck of deeply invaginated CCPs and its GTP hydrolysis induce conformational 
changes that promote membrane scission (Mettlen et al., 2009). Actin nucleation may provide 
tensile force for scission (Ferguson et al., 2009) and transport for movement of the vesicle away 
from the membrane (Galletta et al., 2010). In 3T3 cells, actin is apparently used at all buds 
(Taylor et al., 2011). Finally, CCVs must uncoat to allow fusion of the vesicle with endosomes. 
This is accomplished by targeting the chaperone Hsc70 to clathrin triskelions on the vesicle after 
budding through an interaction with the co-chaperone auxilin (neuron specific) or cyclin G-
associated kinase (GAK, ubiquitous), two adaptors that directly engage the clathrin trimerization 
domain (Eisenberg and Greene, 2007). ATP hydrolysis by Hsc70 promotes triskelion 
disengagement and this step in conjunction with dynamin-mediated GTP hydrolysis are the only 
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direct energy inputs into the system. This raises the issue of how a complex assembly process 
proceeds forward favorably without frequent failure. 
1.4 NUCLEATION OF CLATHRIN-COATED STRUCTURES 
The formation of CCPs at the plasma membrane is a constitutive process. The biochemical and 
biophysical reactions that govern the earliest phase of CCP construction, i.e. the process of going 
from a naked patch of plasma membrane to a nascent assembly of AP-2, clathrin and cargo, is 
termed nucleation. Despite active research in the CME field for the past four and a half decades, 
it is only within the last 10 years that a clearer molecular understanding of this dynamic process 
has begun to take shape. 
Purified AP-1 and AP-2 promote clathrin cage assembly in vitro at physiological pH 
(Keen, 1987) and early on were expected to precede clathrin deposition on membranes. At the 
TGN, recruitment of AP-1 is dictated by the Arf1 GTPase (Stamnes and Rothman, 1993; Traub 
et al., 1993) working in concert with cargo (Le Borgne et al., 1996; Salamero et al., 1996). 
Nucleation of AP-1-positive CCVs is initiated when a guanine nucleotide exchange factor (GEF) 
for Arf1 stimulates GTP binding by Arf1. The GTP bound active form of Arf1 extends a 
myristol group to anchor itself to the membrane. Through coincidence detection, AP-1 
recognizes Arf1-GTP and cargo on the TGN for its correct placement. Coatomer utilizes Arf1 in 
a mechanistically similar manner to nucleate COPI coats and Sar1 GTPase stimulates COPII coat 
production. Thus coat nucleation in these instances is directly dependent on an energy input 
(GTP). 
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To date, no evidence implicates an obligatory GTPase in the nucleation of AP-2-positive 
CCVs at the plasma membrane. Some in vitro experiments have shown that recombinant GTP-
loaded Arf6 can increase the recruitment of purified AP-2 to liposome membranes (Paleotti et 
al., 2005). A second study showed that Arf6 may be important in the specific internalization of 
the angiotensin receptor through CCPs (Poupart et al., 2007). However neither study 
demonstrated a strict dependence of CCSs distribution on Arf6, though a regulatory role for this 
protein is within reason. Recently, it was demonstrated that Arf6 is loaded into CCVs in 
preparation for its function in recycling from endosomes (Montagnac et al., 2011). Therefore 
unlike other coated-vesicle pathways, CME is not dependent on an Arf GTPase. 
1.4.1 An AP-2 docking complex and synaptotagmins 
The earliest models for CCP initiation at the plasma membrane posited that receptor tails 
promoted AP-2 recruitment to the membrane with subsequent clathrin assembly (Pearse and 
Crowther, 1987). The attractiveness of this model aside from its simplicity is that CCVs would 
only be generated when cargo was available. This model was further supported by reconstitution 
experiments in which purified AP-2 and clathrin were used to generate CCPs on isolated 
fibroblast ventral membranes. Treatment of AP-2/clathrin stripped membranes with elastase 
prior to addition of purified components abolished AP-2 binding (Mahaffey et al., 1990). Also 
the elastase-cleaved membrane-derived fragments purified over an AP affinity column were 
dominated by a 45 kDa fragment that could inhibit AP-2 binding to membranes (Peeler et al., 
1993). This gave rise to the idea that there was a specific AP-2 receptor or “docking complex” 
responsible for nucleating CCPs that would then be available for cargo concentration 
(Kirchhausen et al., 1997).  
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The process of CME is perhaps most robust in neurons and in particular at presynaptic 
boutons where it serves the function of compensatory endocytosis for replenishment of synaptic 
vesicles (SV) (Rizzoli and Jahn, 2007). The hypothesis that a SV protein could act as an AP-2 
docking factor, because many proteins found in SVs are directly retrieved by CCVs without an 
endosomal intermediate, lead to the finding that Synaptotagmin I (Syt I) could bind AP-2 (Zhang 
et al., 1994). Syts are integral membrane and Ca2+ binding proteins that act as a molecular trigger 
for Ca2+ induced exocytosis (Pang and Sudhof, 2010). As Syt I is a neuronal protein, this finding 
could not explain how AP-2 was recruited in somatic cells. This was followed by a second study 
by the same group that showed a variety of Syts with wider tissue expression profiles also bound 
AP-2 (Li et al., 1995). 
Further research into this model for CCV nucleation showed that tyrosine sorting signal-
containing peptides increased AP-2 binding to Syt I, suggesting cargo enhances recruitment of 
AP-2 (Haucke and De Camilli, 1999). AP-2 binding of the Syt Ca2+-binding C2 domain, C2B, 
occurs through the µ2 subunit at a region distinct from YXXØ-recognition (Haucke et al., 2000), 
so perhaps the excess peptide biased the AP-2 core toward the open conformation so that it can 
recognize Syt. Finally, in a cell culture model, a truncated version of the more ubiquitous Syt VII 
oligomerizes with endogenous Syt of HeLa cells and inhibits LDL uptake as a dominant negative 
(von Poser et al., 2000). These lines of evidence were interpreted as to label Syt a nucleating 
protein for CME. 
However the function of Syt as a dedicated docking protein for AP-2 has been called into 
question for the following reasons: 1. Neurotransmission phenotypes of Syt-null Drosophila 
have provided contradictory results, either being modest (DiAntonio et al., 1993) or severe 
(Littleton et al., 1993), whereas AP-2α mutant alleles are lethal (Gonzalez-Gaitan and Jackle, 
 22 
1997), 2. Proteomics of liver-derived CCVs failed to detect a Syt isoform (Girard et al., 2005), 
and 3. Research along these lines have not been followed up on in more recent years. For these 
reasons, Syts may be cargoes for CCPs but are not likely to be the nucleating complex in all 
budding reactions; Syts have a well established biochemical role in regulating membrane fusion 
(Pang and Sudhof, 2010). 
1.4.2 Phosphatidylinositol lipids and associated lipid kinases 
How then is AP-2 selectively deposited at the plasma membrane to promote CCS assembly? 
Phosphatidylinositol is a relatively minor lipid present in the cytosolic leaflets of eukaryotic cell 
membrane, constituting just ~15% of total phospholipids (Di Paolo and De Camilli, 2006). 
Reversible phosphorylation of three hydroxyl groups (C-3, C-4 and C-5) on the 6-member 
inositol ring gives rise to seven different phosphatidylinositol phosphate (PIP) moieties or 
phosphoinositides (Figure 1.4A,B). A subset of these phosphoinositides has specific cellular 
distributions on various organelles. Phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) is 
concentrated almost exclusively at the plasma membrane. Therefore PtdIns(4,5)P2 could act as a 
compartmental cue to regulate AP-2 and clathrin assembly (Figure 1.4C). 
Purified AP-2 binds to protein-extracted vesicles and membranes (Virshup and Bennett, 
1988) (though integral membrane receptors are likely present and may have contributed), which 
initially implicated AP-2-membrane interactions as important for CCP formation. In fact, 
clathrin has no affinity for membranes (Unanue et al., 1981) and so AP-2 is required to link 
clathrin to the budding vesicle and the cargo. This is accomplished through four PtdIns(4,5)P2-
recognizing basic side chain residue patches within the AP-2 core that coordinate with the lipid 
phosphate groups: one each upon the α subunit (Gaidarov and Keen, 1999; Collins et al., 2002)  
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Figure 1.4: Phosphoinositide species generation and subcellular distribution. 
(A) The inositol ring of phosphatidylinositol (PtdIns) can be reversibly phosphorylated at the C-3, C-4 
and C-5 positions. Phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) is shown. (B) Reversible 
phosphorylation of PtdIns yields seven different phosphoinositides. These reactions are carried out by 
many unique and some overlapping lipid kinases (red) and phosphatases (black). Only relevant lipid 
enzymes are labeled for simplicity. (C) Subcellular distribution of phosphoinositides. MVB/LE, 
multivesicular body/late endosome; TGN, trans-Golgi network. (B) and (C) are modified from (Vicinanza 
et al., 2008). 
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and β2 subunit (Jackson et al., 2010) and two at the distal C-terminus of the µ2 subunit (Collins 
et al., 2002; Rohde et al., 2002; Jackson et al., 2010). Mutation of these critical residues in the 
AP-2 α subunit prevent recruitment of the AP-2 complex to the plasma membrane in cells 
(Gaidarov and Keen, 1999) and inhibits Tf endocytosis (Motley et al., 2006) while the β2 site is 
also important for binding to membranes (Jackson et al., 2010). The importance of PtdIns(4,5)P2 
in CCP assembly extends to nearly all adaptors as their modular domains, including the ENTH 
(Itoh et al., 2001), ANTH (Ford et al., 2001), EH (Naslavsky et al., 2007) and PTB (Mishra et 
al., 2002a) domains, bind this lipid (Figure 1.3). 
Cell culture assays have allowed careful perturbation of lipids to assess the effects on 
CCP nucleation. The earliest demonstration for a direct role of PtdIns(4,5)P2 in nucleation 
involved the inhibition of TfR sequestration in perforated cells by the addition of the 
PtdIns(4,5)P2-binding pleckstrin homology domain from phospholipase C δ (Jost et al., 1998). 
More recently, an expression system consisting of rapamycin-inducible protein domain 
heterodimerization leading to membrane recruitment of a phosphatidylinositol 5-phosphatase, 
convincingly shows that acute PtdIns(4,5)P2 depletion causes a dramatic loss of fluorescently-
tagged AP-2 from the plasma membrane (Zoncu et al., 2007) and disruption of Tf uptake (Varnai 
et al., 2006). The reproducibility of this experiment has strengthened this model of nucleation 
(Abe et al., 2008). Furthermore, pharmacological inhibition of phospholipase D, an enzyme that 
produces phosphatidic acid (PtdOH) that can stimulate PtdIns(4,5)P2-producing lipid kinases, 
causes reversible loss of endocytic structures on the plasma membrane (Boucrot et al., 2006), 
though the specificity of PtdOH inhibition by this method has been called into question 
(Antonescu et al., 2010). That currently no similar observations of complete loss of AP-2 
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structures upon Arf6 or Syt depletion have been reported indicates that, currently, PtdIns(4,5)P2 
is the most likely candidate for facilitating CCP nucleation. 
PtdIns(4,5)P2 in mammals is produced by the type I and type II PIP kinases (PIPKI and 
PIPKII) (Heck et al., 2007). Though originally thought to both use phosphatidylinositol-4-
phosphate (PtdIns(4)P) as a substrate, it is now known that PIPKIs utilize PtdIns(4)P and 
phosphorylate the C-5 position while PIPKIIs utilize phosphatidylinositol-5-phosphate 
(PtdIns(5)P) and phosphorylate the C-4 position to generate the same product. PIPKIs produce 
the majority of PtdIns(4,5)P2 in cells and this family is further divided into three isoforms: 
PIPKIα, PIPKIβ (Ishihara et al., 1996; Loijens and Anderson, 1996), and PIPKIγ (Ishihara et al., 
1998). In addition PIPKIγ is alternatively spliced at its C-terminus producing PIPKIγ661 
(PIPKIγa), PIPKIγ635 (PIPKIγb) and PIPKIγ688 (PIPKIγc) (mouse terminal residues 661 and 
635, rat terminal residue 688) (Giudici et al., 2004). 
Direct modulation of PtdIns(4,5)P2 generating and consuming enzymes have also 
highlighted the importance of lipid metabolism in CCP nucleation and regulation of endocytosis. 
Knockout of PIPKIγ in mice is postnatally lethal by 24 hours. However in isolated neurons from 
these animals, a defect in compensatory endocytosis and reduction in generation of clathrin-
coated bud profiles following depolarization is observed (Di Paolo et al., 2004). The pups 
appeared anatomically normal after birth and are thought to have died from synaptic defects, 
underscoring the importance of PtdIns(4,5)P2 for CME in neurotransmission. In Drosophila, 
hypomorphic alleles of the type I PIPK Skittles greatly reduces yolk protein endocytosis in 
oocytes (Compagnon et al., 2009). By contrast, knockout of synaptojanin 1 in mice, a 
polyphosphoinositide phosphatase, results in the accumulation of clathrin-coated vesicle profiles 
(~6x greater than wildtype) in nerve terminals of neurons in culture (Cremona et al., 1999). 
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These results and others have given rise to a phosphoinositide phosphorylation-
dephosphorylation cycle model in which a wave of PtdIns(4,5)P2 production promotes CME and 
its hydrolysis promotes uncoating (Cremona and De Camilli, 2001). This model gained support 
recently when live-cell imaging studies of fluorescent PtdIns(4,5)P2-binding domains expressed 
at low-levels in yeast, where CME shares many mechanistic parallels with vertebrate CME, 
indicated that PtdIns(4,5)P2 levels rise and fall during endocytic actin patch progression (Sun et 
al., 2007a). 
An important question for the regulation of CCP nucleation and turnover is whether the 
steady-state levels of PtdIns(4,5)P2 at the plasma membrane are sufficient for CCP generation or 
whether local generation of PtdIns(4,5)P2 is needed in addition? Three lines of evidence suggest 
that direct binding of PIPKIs to the endocytic machinery could prime nascent assembly zones for 
PtdIns(4,5)P2 production and drive the budding reaction forward. In one, a putative YXXØ 
sorting signal (YSPL) in the C-terminus of PIPKIγ engages the AP-2 µ2 subunit via the YXXØ 
recognition region (Bairstow et al., 2006). Forced expression of PIPKIγ in MDCK cells 
increased Tf endocytosis without detectably altering global PtdIns(4,5)P2 levels, while PIPKIγ 
knockdown in HeLa cells reduced Tf uptake. Similarly, another group found that the AP-2 µ2 
subunit can bind the core of PIPKIα, β or γ but at a region distinct from the YXXØ sorting signal 
recognition domain (Krauss et al., 2006). Simultaneous binding of YXXØ sorting signal-
containing cargo stimulates PIPKI enzymatic activity. In a completely different study, the C-
terminus of PIPKIγ was found to interact with the AP-2 β2 subunit appendage domain (Nakano-
Kobayashi et al., 2007). In neurons, depolarization results in dephosphorylation of the PIPKIγ C-
terminus, allowing its interaction with AP-2 and in turn stimulates kinase activity. At least for 
 27 
CME in the brain, where PIPKIγ is highly concentrated, one or a combination of these modes of 
interaction may be important for rapidly nucleating CCPs. 
 These summarized findings on PtdIns(4,5)P2 can be combined with a role for cargo in 
synthesizing a general mechanism of CCP nucleation. The presence of cargo, and the cytosolic 
sorting signals contained within, by itself does not drive recruitment of AP-2 to membranes to 
nucleate CCPs as determined by overexpression studies (Santini et al., 1998; Loerke et al., 
2009). In fact there is a cooperativity between PtdIns(4,5)P2 binding by the α/β2/µ2 subunits and 
sorting signal recognition by the AP-2 core (Höning et al., 2005). Structural studies reveal that 
the AP-2 core is likely in a ‘closed’ conformation in the cytosol and a conformational change 
stabilized by PtdIns(4,5)P2 binding to α/β2/µ2 allows cargo access to the sorting subunits 
(Collins et al., 2002; Jackson et al., 2010). This conformational change is catalyzed by µ2 
Thr156 phosphorylation by adaptor-associated kinase 1 (AAK1) (Ricotta et al., 2002) biasing the 
µ2 subunit to extend and expose the PtdIns(4,5)P2 and YXXØ-binding regions (Jackson et al., 
2010). Therefore cargo likely stabilizes nucleating clathrin structures and is incorporated into 
budding vesicles during assembly (Ehrlich et al., 2004; Loerke et al., 2009). Coincidence 
detection of PtdIns(4,5)P2 and cargo restrict AP-2 deposition to the plasma membrane. 
1.4.3 The EFC domain proteins FCHO1 and FCHO2 
The BAR domain proteins are intimately tied to membrane curvature generation/sensing 
throughout the endocytic and biosynthetic pathways (Suetsugu et al., 2010). BAR domains 
themselves are obligate anti-parallel homodimers that form a crescent shape. The N-BAR 
subfamily consists of members such as amphiphysin with an N-terminal BAR domain containing 
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an amphipathic helix that may insert into the membrane during protein assembly. The extended 
FER/CIP4 homology (EFC) domain (also known as F-BAR) subfamily has sequence similarity 
to N-BAR proteins as well as overall conservation of tertiary structure (Roberts-Galbraith and 
Gould, 2010). The majority of EFC domain proteins have the EFC domain at the N-terminus and 
one or more SH3 domains at the C-terminus, similar to N-BAR proteins. The main difference 
between EFC and N-BAR proteins is that EFC domain proteins typically have a larger radius of 
curvature associated with the crescent-shaped EFC domain and some EFC domain proteins form 
end-to-end oligomers, a property not yet demonstrated for N-BAR proteins (Roberts-Galbraith 
and Gould, 2010). 
A recently discovered subfamily within the EFC domain proteins is the muniscin proteins 
(mu homology domain and menisc
In mammals, FCHO1 and FCHO2 have been proposed to act as nucleators of CCPs 
(Henne et al., 2010). FCHO1/2 like Syp1p bind to PtdIns(4,5)P2-enriched membranes and can 
us shaped) that include FCHO1, FCHO2 and Syp1p (Reider et 
al., 2009). The Fes/CIP4 homology only (FCHO) proteins were discovered as lacking a C-
terminal SH3 domain unlike other EFC domain proteins but now, in addition to the S. cerevisiae 
protein Syp1p, are known to have a C-terminal µ homology domain (µHD). The µHD has 
sequence and structural homology to the cargo sorting AP-2 µ2 subunit (Reider et al., 2009). 
This property makes the muniscins a unique group of proteins within the EFC subfamily whose 
cellular functions are largely unknown. In yeast, Syp1p (FCHO homolog) and Ede1p (eps15 
homolog) are early arriving proteins at cortical actin patches (endocytic sites in yeast) where they 
regulate patch turnover and polarized endocytic placement at the bud neck (Stimpson et al., 
2009). Syp1 binds Ede1p through its µHD and may also act as a cargo-specific adaptor for the 
endocytosis of the yeast transmembrane protein Mid2p (Reider et al., 2009). 
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promote tubulation in vitro (Reider et al., 2009; Henne et al., 2010). FCHO1/2 and eps15 are 
early components of mammalian CCPs, preceding clathrin and other endocytic proteins. This is a 
property that would be expected for a nucleating factor. Most striking is that the levels of FCHO 
proteins are reported to control the rate of AP-2 appearance/disappearance at the plasma 
membrane: FCHO1 + 2 knockdown completely eliminates fluorescently labeled AP-2 
appearance at spots on the membrane while overexpression of FCHO2 increased the number and 
fluctuations of AP-2 spots (Henne et al., 2010). This property of FCHO1/2 is attributed to the 
binding of the adaptors eps15 and intersectin to the µHD which could then bind AP-2 for 
tethering and recruiting it to the plasma membrane. Early recruitment of FCHO1/2 could then 
begin an assembly chain to construct CCPs. In this model, nucleation and assembly are therefore 
tied to initiation of membrane curvature. These findings and conjectures remain to be 
independently validated. 
1.5 PROGRESSION OF CLATHRIN-COATED STRUCTURES 
1.5.1 Clathrin-assembly interaction motifs 
Following the nucleation phase, or the placement of a few molecules of AP-2 and clathrin on the 
plasma membrane, a growth or assembly phase must occur as the nascent bud grows to the 
appropriate size to incorporate cargo and promote membrane invagination. CCPs are complex 
protein assemblies built from a large number of protein-protein interactions (see web diagram in 
(Traub, 2011)). On the order of 30 proteins are implicated in or are present at some time in  
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Figure 1.5: General architecture of endocytic adaptors and accessory factors. 
The modular structure of many endocytic proteins comprised of one or more folded domains (colored 
boxes) and regions for which secondary structure cannot be predicted (zigzags, Jpred2) containing motifs 
for AP-2 and/or clathrin. Regions not corresponding to known domains are represented by straight lines. 
ANTH, AP180 N-terminal homology; BAR, BIN-amphiphysin-RVS; CC, coiled coil; EH, eps15 
homology; ENTH, epsin-N-terminal homology; IPP5c, inositol 5-phosphatase catalytic domain; J, DNA J 
domain; MHD, µ subunit homology domain; PTB, phosphotyrosine-binding domain; PX, Phox domain; 
Sac1, suppressor of actin 1; SH3, Src homology 3, SHD, stonin homology domain; TEN, tensin 
homology; THATCH, talin-HIP1/1R actin-tethering C-terminal homology. Figure modified from (Mishra 
et al., 2004). 
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assembling clathrin lattices. Work over the past two decades has attempted to characterize the 
molecular details of these interactions and how they are organized in space and time (Traub, 
2005; Schmid and McMahon, 2007; Reider and Wendland, 2011). A common theme has 
emerged that unstructured primary sequence motifs in adaptors, accessory factors and regulatory 
enzymes bind to folded hub domains in AP-2 and clathrin (Figure 1.5). 
As introduced earlier, the core of AP-2 is primarily responsible for binding to 
PtdIns(4,5)P2- enriched membranes via the α and β2 (Jackson et al., 2010) and µ2 (Rohde et al., 
2002) subunits and to YXXØ and [DE]XXXL[LI] sorting signals through the µ2 and σ2/α, 
respectively. The α and β2 appendage domains in contrast act as hubs and coordinate 
interactions with a majority of proteins involved in CME (Traub et al., 1999; Owen et al., 2000).  
Typically hydrophobic residue side chains with specific spacing between residues in the 
unstructured region of the appendage binding partner bury themselves in the binding pocket of  
 
Table 1.2: Clathrin assembly interaction motifs 
Consensus Sequence Example Proteins Binding Site 
DP[FW] eps15, epsin, Dab2 AP-2 α appendage platform 
FXDXF amphiphysin, AP180 AP-2 α appendage platform 
WXX[FW]X[DE] Synaptojanin 1, AAK1, NECAP AP-2 α appendage sandwich 
[DE]nX1-2FXX[FL]XXXR β-arrestin 1/2, ARH, epsin 1 AP-2 β2 appendage platform 
F rich eps15, AP180, amphiphysin AP-2 β2 appendage sandwich 
L∅[DEN] ∅[DEN] AP-2, epsin, Dab2, ARH, β-
arrestin 
clathrin HC terminal domain 
PWXXW amphiphysin clathrin HC terminal domain 
NPF epsin 1, Dab2 eps15 EH domain 
* X denotes any amino acid; ∅ indicates a bulky hydrophobic residue: Leu, Met, Ile, Phe 
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either the α or β2 appendage platform (C-terminal) subdomain or sandwich (N-terminal) 
subdomain (Table 1.2). The interaction of a single motif is relatively weak, kD 10-100 mM, 
however low affinity is often compensated for by high avidity with the presence of multiple 
motifs (Edeling et al., 2006b). 
The α appendage binding sites were fully characterized first by structural and 
biochemical studies and accommodate three different interaction motifs. The α appendage 
platform binds DP[FW] and FXDXF motifs in partially overlapping sites (Benmerah et al., 1996; 
Owen et al., 1999; Brett et al., 2002). These motifs are present in a large number of endocytic 
proteins including eps15, epsin, Dab2, synaptojanin and AP180 (Mishra et al., 2004). The 
binding site upon the α appendage sandwich subdomain binds the motif of consensus 
WXX[FW]X[DE] (Mishra et al., 2004; Praefcke et al., 2004; Ritter et al., 2004; Walther et al., 
2004). The presence of this motif is more restricted than DP[FW] and FXDXF and is found in 
proteins such as synaptojanin 1, AAK1 and GAK. Also, proteins that have both platform and 
sandwich binding motifs such as synaptojanin 1 can engage both simultaneously (Mishra et al., 
2004). The presence of multiple and varied motifs likely allows these proteins to cross-link AP-2 
molecules and stabilize the assembly. 
While the α appendage binds endocytic motifs in extended, unstructured conformations, 
the AP-2 β2 appendage platform subdomain induces unstructured motifs to adopt an α-helical 
secondary structure (Mishra et al., 2005; Edeling et al., 2006a; Schmid et al., 2006). Sequences 
of the consensus [DE]nX1-2FXX[FL]XXXR in the CLASPs ARH, β-arrestin and epsin facilitate 
binding to this domain (Edeling et al., 2006a; Schmid et al., 2006). The key anchoring Phe and 
Arg residues are spaced as to align on one side of the induced α-helix. The β2 appendage also 
harbors a sandwich site for binding endocytic proteins. Though not as fully characterized as 
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other sites, it appears that Phe side chains of a sequence in eps15, AP180 and amphiphysin are 
important for burrowing in this binding pocket during engagement (Edeling et al., 2006a; 
Schmid et al., 2006). 
 The clathrin heavy chain terminal domain is also a hub during assembly. The terminal 
domain is a seven-bladed β-propellar fold that projects down into the adaptor layer of CCPs and 
CCVs. Many adaptors including AP-2, epsin, Dab2, ARH and β-arrestins contain a clathrin box 
motif of the consensus LØ[DEN]Ø[DEN] that binds in a linear conformation between blades 1 
and 2 of the terminal domain (ter Haar et al., 2000; Traub, 2005). Often a clathrin box motif will 
accompany one or more AP-2 interaction motifs. A less common W box motif (PWXXW) found 
in amphiphysins may also contribute to assembly and binds to the center of the terminal domain 
(Miele et al., 2004). Clathrin and W box motifs allow adaptors and AP-2 to capture soluble  
 
 
Figure 1.6: Molecular assembly of clathrin-coated structures. 
This figure illustrates the initial placement of adaptors and clathrin on the plasma membrane prior to 
membrane invagination. AP-2 molecules are transiently recruited by binding PtdIns(4,5)P2 through the α 
subunit (far left) and are stabilized by µ2 rearrangement (far right). This promotes receptor binding 
(center). Clustering of AP-2 and CLASPs promotes clathrin binding through AP-2 appendages and 
clathrin box motifs in the AP-2 hinge (yellow ellipse) and monomeric adaptors. FCHO1/2 and eps15 and 
intersectin are not depicted. Sorting signals or tags within cargo molecules are labeled below the figure, as 
are the adaptors that recognize these signals. Adaptors and cargo are color-coded. This flat clathrin 
assembly will proceed to a spherical coat such as that seen in Figure 1.1. 
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clathrin triskelions and promote their polymerization. Clearly the multiplicity of binding partners 
and four spatially separate interaction surfaces of the AP-2 appendages permit many binding 
possibilities. How these are managed during assembly is not clear but seems crucial to the 
successful budding of a CCV. 
1.5.2 Chronology of assembly 
Combining the information from adaptor-AP-2-clathrin binding and recent data from time-
resolved imaging of transiently expressed accessory factor lifetimes at productive CCPs (Taylor 
et al., 2011), we can begin to construct a clearer picture of how CCPs assemble. An ‘early 
adaptor module’ (based on peak time and recruitment profile) consists of FCHO1, FCHO2, 
eps15 and AP-2 and peaks early (Taylor et al., 2011). Binding of FCHO1/2 to PtdIns(4,5)P2 may 
allow the simultaneous binding of eps15 and intersectin to the FCHO µHD and PtdIns(4,5)P2 or 
vise versa (Henne et al., 2010). A nascent bud site so constructed may then be set for the 
recruitment of AP-2 (which appears after FCHO and eps15), through binding to a DPF array 
(Mishra et al., 2004) and Phe rich β2 appendage sandwich binding site (Schmid et al., 2006) at 
the eps15 C-terminus and/or α/β2 sandwich binding motifs in intersectin (Pechstein et al., 
2010a). Co-recognition of AP-2 appendage interaction motifs and PtdIns(4,5)P2-enriched 
membranes through the α/β2 subunits would transiently dock ‘closed’ AP-2 molecules. AAK1 
recruited by the AP-2 α appendage then would mediate phosphorylation of Thr156 on AP-2 µ2 
(Ricotta et al., 2002) and PtdIns(4,5)P2 and cargo sorting would stabilize the open AP-2 
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conformation. AAK1 activity is increased by assembled clathrin, ensuring sorting competent AP-
2 in CCSs while simultaneously regulating AAK1 kinase activity (Conner et al., 2003). 
A ‘later adaptor module’ that slowly builds and peaks at the time of vesicle scission but 
may start appearing during the ‘early adaptor module’ is composed of epsin, CALM (the 
ubiquitous AP180 homolog), and clathrin (Taylor et al., 2011). Epsin, by virtue of its 
PtdIns(4,5)P2-binding ENTH domain, C-terminal DPW motifs, and NPF motifs that bind the 
eps15 EH domain (de Beer et al., 2000) would be recruited. AP180/CALM would bind 
PtdIns(4,5)P2 through the ANTH domain, AP-2 α and β2 appendages through an array of motifs 
(Ford et al., 2001) and eps15 through NPF motifs. This point of assembly would be critical for 
clathrin recruitment and polymerization. Epsin, AP180/CALM and AP-2 contain clathrin box 
motifs (Morris et al., 1993; Shih et al., 1995; Drake et al., 2000). It has been proposed that the 
unstructured C-termini of the monomeric adaptors/accessory factors could extend with a radius 
of 150-180 Å into the cytosol and create a clathrin ‘capture zone’ through the exposed clathrin 
box motifs (Ungewickell and Hinrichsen, 2007; Zhuo et al., 2011). Membrane bound AP-2 
molecules could potentially extend the appendage domains up to 60 Å to capture and stabilize 
clathrin triskelions closer to the membrane where they would begin to polymerize. AP-2 strongly 
binds clathrin in an anti-parallel bivalent manner through a clathrin box squence contained in the 
β2 hinge (Shih et al., 1995) and a second binding region on the β2 appendage that recognizes the 
clathrin distal leg (Edeling et al., 2006a; Schmid et al., 2006). At this point the assembly may 
resemble the schematic shown in Figure 1.6. 
Bud invagination requires clathrin polymerization (Hinrichsen et al., 2006) but alone may 
be insufficient and require other factors. An amphipathic helix inserted into the membrane by the 
epsin ENTH domain may contribute by expanding the cytosolic membrane leaflet relative to the 
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extracellular leaflet (Ford et al., 2002), although this remains to be shown in vivo. The N-BAR 
and EFC domain proteins likely contribute as well. Syndapin2, an EFC protein, is recruited and 
exits during the assembly phase and may stabilize or induce curvature along FCHO1/2 and 
clathrin (Taylor et al., 2011). The N-BAR protein module of endophilin 2, amphiphysin 1, and 
BIN1 sharply peak and regress just prior to scission suggesting they function at the highly curved 
CCP neck where they can recruit dynamin through their SH3 domains. In accordance with this, 
dynamin 1 and 2 peak almost precisely at the moment of scission (Taylor et al., 2011). 
Amphiphysin in particular is at least partially recruited through interaction with the AP-2 α and 
β2 appendages and clathrin terminal domains (Miele et al., 2004; Edeling et al., 2006a). 
1.5.3 Accessory factor displacement and directionality of assembly 
A currently unresolved and global question in the field is, given the number of components and 
complexity of their interactions, what ensures the forward progression of CCP assembly? Clearly 
the residency of an endocytic protein at an assembling bud is determined by the number of 
contacts it makes with the coat proteins, the affinity and avidity of these interactions, and 
availability of binding sites over time. If phases of assembly are determined by the protein 
content in CCPs at that time, directionality could be imparted by the addition of new protein 
components or removal of others. 
Biochemical experiments have confirmed that some accessory factors can be displaced 
from AP-2 during clathrin assembly. Initial structural and functional characterization of the AP-2 
β2 appendage revealed that while the α appendage has no affinity for clathrin, the β2 appendage 
can bind clathrin weakly (Owen et al., 2000). When supplied with the β2 appendage and the 
 37 
adjacent hinge domain, which contains a clathrin box motif, clathrin bound more robustly and 
the binding of adaptors/accessory factors including AP180, eps15 and epsin was compromised. 
Site-directed mutagenesis of potential binding surfaces concentrated on the platform domain as 
that was the only site known on the α appendage at the time. Mutation of a few residues 
including Tyr888, Arg879 and Trp841 on the platform of the isolated β2 appendage alone 
reduced or eliminated binding of clathrin as well as the adaptors/accessory factors with the 
exception of eps15 and suggested that adaptor and clathrin binding to the platform site was 
mutually exclusive (Owen et al., 2000). These findings were confirmed in a later study by the 
same group that showed that with increased binding of clathrin to the β2 appendage and hinge, 
AP180 and amphiphysin binding decreased relative to binding to the appendage alone (Schmid 
et al., 2006). However this study was fraught with inconsistencies to the first. Binding of eps15 
and epsin to the β2 appendage and hinge were unaffected by the presence of clathrin. 
Furthermore, mutation of the β2 platform residue Tyr888 that eliminated binding of accessory 
factors and clathrin in pull down assays previously (Owen et al., 2000), had only a minor effect 
on the accessory factors (Schmid et al., 2006). 
In contrast to these studies, two lines of evidence suggest that the distal leg of clathrin 
binds not to the β2 appendage platform but to the sandwich site. In pull down experiments with 
the β2 appendage and hinge domain, mutation of the β2 sandwich site (tyrosine-815) and the 
terminal domain-binding clathrin box within the hinge had a synergistic effect in the reduction of 
clathrin binding (Edeling et al., 2006a). This site is bound by eps15, AP180 and amphiphysin. 
Secondly, computational modeling suggests the clathrin leg ankle domain binds to the Golgi-
localized gamma-adaptin ear homology protein (GGA), an adaptor for CCV formation at the 
Golgi, at a site that has structural homology to the AP-2 β2 appendage sandwich subdomain 
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(Knuehl et al., 2006). GGAs do not have a platform subdomain. Though the precise details are in 
conflict, the idea that clathrin binds to AP-2 in an anti-parallel manner by the clathrin terminal 
domain binding a clathrin box motif in the hinge and the clathrin ankle domain binding to the 
appendage is supported. Competition of proteins from AP-2 could remove them from the bud 
site unless the proteins make additional contacts such as with clathrin itself. 
A variation on this idea is the “changing hubs” model (Schmid et al., 2006; Schmid and 
McMahon, 2007). In this model, the early assembly phase is governed by the AP-2 appendage 
hubs. The numerous appendage binding partners are recruited and assist in recruiting and 
assembling clathrin. As clathrin polymerizes into the lattice around AP-2 and occupies the β2 
appendage (in this model the platform site), the displaced binding partners are retained within the 
assembling CCP through a switch in binding to the clathrin terminal domain hub. It is proposed 
that this change in binding site importance can drive the process forward although the precise 
mechanistic details are unknown. 
1.6 GOALS OF THIS DISSERTATION 
Clathrin-mediated endocytosis is a complex cellular phenomenon that utilizes ~20-30 proteins to 
build a scaffold that efficiently selects cargo from other resident surface proteins while 
simultaneously invaginating the plasma membrane. Work over the past few decades has 
identified many of these participating components and uncovered how they interact with the 
coat, however a clear understanding of the initial nucleation phase of clathrin-coated pit 
assembly is lacking. My dissertation research seeks to define how early regulatory proteins 
interface with the endocytic machinery and test the function of newly identified nucleator 
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proteins in vivo. In Chapter 2, I show that the PtdIns(4,5)P2-generating enzyme PIPKIγ, present 
at nerve terminals, prefers to bind to AP-2 via the β2 appendage. I also show that it specifically 
binds to the β2 appendage sandwich subdomain in an interaction that is mutually exclusive with 
clathrin. Because PIPKIγ associates with the sandwich subdomain and my model is that 
PtdIns(4,5)P2 production could be finely controlled by evicting the PIPKIγ when clathrin 
assembly overwhelms the β2 hub, clathrin would need to engage the sandwich site to regulate 
protein dynamics. Therefore, in Chapter 3 I test the “changing hubs” model of clathrin-coated pit 
assembly and show that in vivo the β2 appendage platform partner β-arrestin 1 is not displaced 
by clathrin during endocytosis. In Chapter 4 I test the function of the recently discovered 
endocytic proteins FCHO1 and FCHO2 in clathrin-mediated endocytosis in vivo. While 
FCHO1/2 have been proposed to act as obligate nucleators of clathrin-coated pits, I show that 
they are not absolutely required for endocytic site placement in cells or for cargo internalization. 
Instead they appear to regulate clathrin-coated structure size and number. This thesis helps to 
clarify mechanistic models on how the site of clathrin assembly is initially selected and formed. 
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2.0  CLATHRIN REGULATES THE ASSOCIATION OF PIPKIγ661 WITH THE AP-2 
ADAPTOR β2 APPENDAGE* 
*Reprinted from Journal of Biological Chemistry, (2009, volume 284, issue 20, pp. 13924-
13939), with permission from The American Society for Biochemistry and Molecular Biology 
2.1 ABSTRACT 
The AP-2 clathrin adaptor differs fundamentally from the related AP-1, AP-3 and AP-4 sorting 
complexes because membrane deposition does not depend directly on an Arf-family GTPase. 
Instead, phosphatidylinositiol 4,5-bisphosphate (PtdIns(4,5)P2) appears to act as the principal 
compartmental cue for AP-2 placement at the plasma membrane, as well as for the docking of 
numerous other important clathrin-coat components at the nascent bud site. This PtdIns(4,5)P2 
dependence makes type I phosphatidylinositol 4-phosphate 5-kinases (PIPKI) lynchpin enzymes 
in the assembly of clathrin-coated structures at the cell surface. PIPKIγ is the chief 5-kinase at 
nerve terminals and here we show that the 26 amino acid, alternatively-spliced C-terminus of 
PIPKIγ661 is an intrinsically unstructured polypeptide that binds directly to the sandwich 
subdomain of the AP-2 β2 subunit appendage. An aromatic side chain-based, extended 
interaction motif that also includes the two bulky C-terminal residues of the short PIPKIγ635 
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variant is necessary for β2 appendage engagement. The clathrin heavy chain accesses the same 
contact surface on the AP-2 β2 appendage but, because of additional clathrin binding sites 
located within the unstructured hinge segment of the β2 subunit, clathrin binds the β2 chain with 
a higher apparent affinity than PIPKIγ661. A clathrin-regulated interaction with AP-2 could 
allow PIPKIγ661 to be strategically positioned for regional PtdIns(4,5)P2 generation during 
clathrin-coated vesicle assembly at the synapse.  
2.2 INTRODUCTION 
The key regulatory activity of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) during 
clathrin-mediated endocytosis is firmly established (Di Paolo and De Camilli, 2006; Krauss and 
Haucke, 2007). The heterotetrameric AP-2 adaptor complex and numerous clathrin-associated 
sorting proteins (CLASPs) display dedicated surfaces or domains that engage PtdIns(4,5)P2  with 
good selectively (Maldonado-Baez and Wendland, 2006; Schmid and McMahon, 2007; 
Ungewickell and Hinrichsen, 2007). PtdIns(4,5)P2, which is localized to the cell surface, thus 
biases the deposition and assembly of these coat components at the plasma membrane by 
synergizing with other low affinity interactions in a phenomenon termed coincidence detection 
(Di Paolo and De Camilli, 2006; Schmid and McMahon, 2007). Later acting endocytic 
regulatory proteins also bind to PtdIns(4,5)P2. The large GTPase dynamin contains a pleckstrin 
homology (PH) domain, which engages PtdIns(4,5)P2 and is required for vesicle scission (Vallis 
et al., 1999). Similarly, the clathrin uncoating cofactor, auxilin, has a PTEN-homology domain 
that also binds to phosphoinositides and is necessary for targeting of this J-domain protein to 
clathrin-coated membranes (Lee et al., 2006). The lipid binding features of all these endocytic 
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components is in full accord with PtdIns(4,5)P2 being necessary for both early and late stages of 
coated vesicle production (Jost et al., 1998). 
PtdIns(4,5)P2 is a general, apparently ubiquitous marker of the plasma membrane and the 
concept of functionally autonomous, stable PtdIns(4,5)P2-enriched microdomains within the 
cytosolic leaflet of the membrane has been challenged (Brough et al., 2005; van Rheenen et al., 
2005; Yaradanakul and Hilgemann, 2007). This raises the question of whether the prevailing 
PtdIns(4,5)P2 concentration at the cell surface is simply permissive and sufficient for nucleation 
and sustained clathrin-coated vesicle assembly and budding, or whether, in addition to basal 
PtdIns(4,5)P2 that might act as an initial compartmental cue, regional synthesis of this lipid is 
also necessary for clathrin-coat assembly and progression. Supporting the first possibility is the 
general decrease in PtdIns(4,5)P2 levels in the brains of phosphatidylinositol phosphate kinase 
type Iγ (PIPKIγ) nullizygous mice that parallels major synaptic vesicle recycling aberrations in 
neurons of these animals, which die before (Narkis et al., 2007; Wang et al., 2007) or shortly 
after (Di Paolo et al., 2004) birth. Also, activated P2Y purinergic receptors, which trigger 
phospholipase C-mediated cleavage of PtdIns(4,5)P2, diminish clathrin-mediated uptake of 
insulin (Carvou et al., 2006), suggesting that signaling and endocytic processes can utilize a 
common phosphoinositide pool. PtdIns(4,5)P2 is rather uniformly dispersed over the plasma 
membrane of the budding yeast Saccharomyces cerevisiae (Stefan et al., 2002; Yu et al., 2004) 
and Mss4p, the only phosphatidylinositol 4-phosphate 5-kinase in this organism, is not localized 
to cortical, clathrin-containing endocytic structures (Sun et al., 2007a). In mammalian cells, the 
subcellular positioning of PIPKI enzymes is, at least in part, dictated by substrate 
availability/concentration as switching the activation loop residues of a type II PIPK, which 
usually acts on PtdIns5P, to that of a PIPKI, induces the chimeric kinase to localize to the cell 
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surface (Kunz et al., 2000). In addition, ectopically expressed, tailored proteins that drive 
rapamycin-induced consumption of bulk PtdIns(4,5)P2 lead to a rapid and dramatic loss of the 
majority of surface-associated clathrin-coated structures and halt clathrin-dependent 
internalization (Varnai et al., 2006; Zoncu et al., 2007; Abe et al., 2008). In fact, excess PH 
domain can block clathrin-mediated endocytosis in an in vitro reconstitution assay (Jost et al., 
1998).  
Yet the second idea of localized PtdIns(4,5)P2 synthesis is in accord with the subcellular 
localization of PIPKI isozymes depending upon more than just the location of PtdIns4P (Brough 
et al., 2005), and with the PIPKI enzymes associating physically with the AP-2 adaptor complex 
(Bairstow et al., 2006; Krauss et al., 2006; Nakano-Kobayashi et al., 2007) and with β-arrestin 
(Nelson et al., 2008). That the interaction with AP-2 stimulates catalysis (Krauss et al., 2006; 
Nakano-Kobayashi et al., 2007) lends additional support for a feed-forward model for staged 
PtdIns(4,5)P2 generation at nascent clathrin assembly zones at the cell surface. The fact that 
ectopic expression of PIPKI enzymes in cultured cells increases both the number of surface 
clathrin-coated structures and the rate of internalization (Padron et al., 2003) also indicates that 
PtdIns(4,5)P2 on the cell surface can be limiting. Local production of PtdIns(4,5)P2 might 
counteract general competition of endocytic factors with other cell surface proteins for a limited 
phosphoinositide pool, and thus may be important to sustain the rapid kinetics of clathrin-
mediated endocytosis. This may be particularly relevant in vivo during signal transmission when 
PtdIns(4,5)P2 is consumed to generate diacylglycerol (DAG), Ins(1,4,5)P3 or PtdIns(3,4,5)P3 
(Carvou et al., 2006; Di Paolo and De Camilli, 2006; Krauss and Haucke, 2007). 
Irrespective of precisely how PIPKI enzymes translocate to the plasma membrane, what 
is also clear is that temporal remodeling of PtdIns(4,5)P2 apparently accompanies coated vesicle 
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biogenesis (Perera et al., 2006; Sun et al., 2007a). After targeted gene disruption of the 
phosphoinositide polyphosphatase synaptojanin 1, neurons exhibit excessive and prolonged 
clathrin coat associations with the membrane (Cremona et al., 1999; Harris et al., 2000). 
Somewhat analogously, S. cerevisiae synaptojanin null mutants display mislocalized 
PtdIns(4,5)P2, the phospholipid now appearing in endosomal structures (Stefan et al., 2002; Sun 
et al., 2007a). These results show clearly that under normal conditions, PtdIns(4,5)P2 within 
forming transport vesicles is dephosphorylated prior to, or rapidly following, scission from the 
cell surface. Recent time-resolved live-cell imaging of the two splice isoforms of synaptojanin 1, 
termed SJ145 and SJ170 (Ramjaun and McPherson, 1996), reveals that while SJ145 masses at 
the bud site around the time of the fission event, SJ170 populates the coat throughout the 
assembly process (Perera et al., 2006). Thus molecular mechanisms appear to exist to align 
cycles of PtdIns(4,5)P2 formation and hydrolysis with progression of the coated assemblage 
toward the final fission step. In this study, we confirm that PIPKIγ, a vital lipid kinase (Di Paolo 
et al., 2004; Narkis et al., 2007; Wang et al., 2007) and the major PtdIns4P kinase at the synapse 
(Wenk et al., 2001), binds to AP-2 chiefly through the functionally autonomous appendage 
domain of the large β2 chain. We show that this depends on an interaction surface positioned 
upon the sandwich subdomain of the β2 appendage, a site also engaged by clathrin and eps15. 
Binding of these proteins to the β2 appendage is mutually exclusive, leading to a model for 
spatial and temporal phosphoinositide remodeling managed by AP-2 appendages.  
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2.3 RESULTS 
2.3.1 PIPKIγ661 membrane translocation and AP-2 recruitment 
Synaptic plasma membranes (Figure 2.1A), purified from rat brain synaptosome preparations 
(Figure 2.1B) by hypotonic lysis, contain trace levels of all three PIPKI isoforms, α, β and γ 
(Figure 2.1C). After extracting the membranes with 1 M KCl, predominantly the ~90-kDa 
PIPKIγ isoforms and PIPKIα are removed, but the treatment has no effect on the membrane-
associated proteins Syt 1 and SNAP-25 (Figure 2.1C). Cell-free kinase assays show that the salt-
washing procedure diminishes the temperature-dependent synthesis of PtdIns(4,5)P2 to ~67% (n 
= 3; Figure 2.1D, compare lane b and d), presumably due to the removal of PIPKI. By contrast, 
PtdIns4P synthesis changes <10% on the extracted membranes. Using the salt-washed synaptic 
plasma membranes as a template for in vitro clathrin-coat assembly assays, we find that the 
translocation of cytosolic clathrin, the AP-2 adaptor complex and AP180 correlates with the 
accumulation of PIPKIγ661on the synaptic membranes (Figure 2.1E, lane c), and an increase in 
PtdIns(4,5)P2 synthesis (Figure 2.1D, compare lane d and f). The recruitment of PIPKIγ661 
under these conditions suggests there may be linkage between PIPKIγ and AP-2/clathrin 
membrane translocation. In fact, there is evidence for PIPKI enzymes associating directly with 
AP-2 in three molecularly distinct manners. The long-splice isoform of PIPKIγ contains a C-
terminal 644YSPL sequence that can interact with the cargo-selective µ2 subunit of AP-2, akin to 
YXXØ-type receptor sorting signals (Bairstow et al., 2006). The same general region of the 26 
amino-acid C-terminal insert of PIPKIγ661 can bind to the independently folded  
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Figure 2.1: PIPKIγ661 and AP-2 are coordinately recruited to the synaptic plasma membrane. 
 (A) and (B), aliquots of synaptic plasma membrane (A) or synaptosomes from which they were derived 
(B) were fixed with 2% glutaraldehyde and processed for EM. Thin section micrographs typical of the 
many fields examined are shown. (C) Samples of 50 µg synaptic plasma membrane (SPM) were 
suspended in assay buffer alone or supplemented with  1 M KCl were sedimented after incubation on ice 
for 30 min. Aliquots of each resuspended membrane pellet were prepared for SDS-PAGE and 
immunoblotting. Portions of the blots were probed with an affinity-purified polyclonal anti-PIPKI 
antibody or mAbs directed against Syt 1 or SNAP-25. (D) Reactions containing 0.5 mg/ml untreated or 
salt-washed synaptic plasma membranes, 5 mg/ml cytosol and 500 µM [γ-32P] ATP were prepared as 
indicated. After incubation at 37°C for 10 min the lipids were extracted and analyzed by TLC and 
autoradiography. A representative experiment of 3 is shown and the migration positions of authentic 
phospholipid standards are indicated. (E) reactions containing 50 µg/ml salt-washed synaptic plasma 
membranes, 5 mg/ml rat brain cytosol and an ATP regenerations system were prepared as indicated. After 
incubation at 37°C for 15 min, membranes were sedimented and prepared for SDS-PAGE and 
immunoblotting. Portions of the blots were probed with anti-clathrin-subunit heavy chain (HC) mAb 
TD.1, rabbit R11-29 anti-µ2 serum, or an anti-AP180, anti-PIPKIγ or anti-SNAP-25 mAb, and only 
relevant portions of the blots are shown. 
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β2 appendage of AP-2 (Nakano-Kobayashi et al., 2007). In addition, the central kinase domain 
of all three PIPKI isoforms is proposed to associate with the µ2 subunit of AP-2, but in a manner 
that does not overlap with cargo binding; rather, concomitant PIPKI and YXXØ-sequence 
engagement by µ2 appears to stimulate the catalytic activity of the lipid kinase (Krauss et al., 
2006). 
2.3.2 The PIPKIγ661 binding surface upon AP-2 
To attempt to resolve whether the β2 or µ2 subunit of AP-2 represents a dominant interaction 
partner for the C-terminal 26 amino acid extension of PIPKIγ661, we used baculovirus-encoded 
AP-2 hemicomplexes (Figure 2.2C) (Doray et al., 2007). First, we verified that the individual 
chains expressed in Sf9 cells associate into a macromolecular complex. Anti-FLAG 
immunoprecipitation shows that removal of the FLAG-tagged β2 subunit also depletes the µ2 
subunit from the lysate (Figure 2.2A, compare lane a and b). The relative stoichiometry of the 
assembled β2⋅µ2 hemicomplex is seen on the Coomassie blue-stained gel (lane c). Likewise, a 
FLAG-tagged β2-subunit trunk, lacking the C-terminal 359 residues encoding the unstructured 
hinge as well as the appendage domain, immunoprecipitates along with the co-expressed µ2 
(lane f). This is expected, as µ2 binds to the α-helical solenoid portion of the β2 subunit trunk 
(Collins et al., 2002). These experiments confirm the assembly of the β2⋅µ2 and β2 trunk⋅µ2 
hemicomplexes. Notably, the putative insect β subunit, recognized by the anti-β mAb, was not 
depleted from the lysates with the anti-FLAG mAb (lanes b and e).  
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Figure 2.2: An AP-2 hemicomplex can bind YXX∅ sorting signals. 
(A) Equivalent volumes of Sf9 cell lysate overexpressing either the β2·µ2 or the β2 trunk·µ2 
hemicomplex before (lanes a and d) or after (lanes b and e) immunoprecipitation with agarose-coupled 
anti-FLAG mAb M2, and aliquots from the washed and FLAG-peptide eluted immunprecipitate pellet 
(lane c and f) were resolved by SDS-PAGE and either stained with Coomassie blue or transferred to 
nitrocellulose. Portions of the blots were probed with anti-β1/β1-subunit mAb 100/1 or anti-µ2 serum, 
and only the relevant portions shown. The migration position of the molecular mass standards is indicated 
on the left, and the location of the immuoprecipitated β2 subunit (black arrowhead), β2 trunk (open 
arrowhead) and µ2 subunit (white arrowheads) are shown. (B) Approximately 250 µg of GST (lanes a,b,e 
and f) or GST-CI-MPR (YSKV; lanes c,d,g and h) immobilized on glutathione-Sepharose was incubated 
with Sf9-cell lysates overexpressing either the β2·µ2 (lanes a-d) or β2 trunk·µ2 (lanes e-h) 
hemicomplexes as indicated. After centrifugation, aliquots of ~1.5% of each supernatant (S) and ~12.5% 
of each washed pellet (P) were resolved by SDS-PAGE and either stained with Coomassie blue or 
transferred to nitrocellulose. Portions of the blots were probed with anti-β1/β1-subunit mAb 100/1 or 
anti-µ2 serum, and only the relevant portions shown. (C) Schematic representation of the AP-2 β2⋅µ2 
hemicomplex used in (A) and (B). 
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The capability of the two hemicomplexes to bind comparably to YXXØ-type sorting signals, 
which are recognized by the µ2 subunit (Ohno et al., 1995; Owen and Evans, 1998), is seen with 
a portion of the CI-MPR cytoplasmic domain (residues 2337-2372) fused to glutathione-S-
transferase (GST) (Figure 2.2B) (Doray et al., 2007). While there is no association of either the 
FLAG-β2 subunit or µ2 with GST (lanes b and f), some of both the β2 and µ2 protein are 
recovered in the pellet fraction from GST-CI-MPR affinity isolations (lanes d and h). Still, none 
of the presumptive Sf9 AP-2 (β subunit) binds to the GST-CI-MPR (lanes f and h), and the 
relative stoichiometry of the bound µ2 compared with the soluble fraction is greater than either 
the β2 full-length or β2 trunk (lanes d and h). We interpret this to indicate that µ2 alone 
(uncomplexed) has the highest apparent affinity for YXXØ signals, although the strength of this 
interaction is still rather weak. Some of the binary β2⋅µ2 or β2 trunk⋅µ2 complexes also clearly 
associate with GST-CI-MPR but the failure of heterotetrameric AP-2 to bind appreciably is fully 
consistent with the cytosolic pool of AP-2 assuming a basal, closed conformation that blocks the 
YXXØ binding site on µ2 (Collins et al., 2002).  
Similar experiments using the C-terminal region of the PIPKIγ635 or PIPKIγ661 kinase 
variants (Ishihara et al., 1998) show that only the long-splice isoform associates with theβ2⋅µ2 
hemicomplex (Figure 2.3, lane j). In fact, the presence of the full-length β2 subunit bound to 
GST-PIPKIγ(460-661) can be seen by Coomassie blue staining. By contrast, if incubated with 
either GST or GST-PIPKIγ46635), there is complete recovery of the full-length or the β2 trunk 
in the supernatant fraction (lanes a, c, e and g). This shows that necessary AP-2 binding 
information is indeed located within the terminal 26 residues of PIPKIγ661. Nevertheless, the β2 
trunk⋅µ2 hemicomplex does not associate with the GST-PIPKIγ (460-661) like the intact β2⋅µ2 
hemicomplex (compare lane l and j).  
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Figure 2.3: The C terminus of PIPKIγ661 but not PIPKIγ635 binds selectively to the AP-2 β2 
appendage. 
Approximately 200 µg of GST (lanes a-d), GST-PIPKIγ (460-635) (lanes e-h) or GST-PIPKIγ (460-661) 
immobilized on glutathione beads was incubated with incubated with Sf9-cell lysates overexpressing 
either the β2·µ2 (lanes a,b,e,f,i and j) or β2 trunk·µ2 (lanes c,d,g,h,k and l) hemicomplexes. After 
centrifugation, aliquots of ~1.5% of each supernatant (S) and ~15% of each washed pellet (P) were 
resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose. Portions 
of the blots were probed with anti-β1/β1-subunit mAb 100/1, anti-FLAG mAb M1 or anti-µ2 serum, and 
only the relevant portions shown. The migration positions of the FLAG-tagged β2 (arrowheads) and the 
presumptive Sf9 cell β subunit (open arrowheads) are indicated. 
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There is a full-length β subunit recovered in the pull-down pellet after incubation with the β2-
trunk lysate, but this chain does not contain a FLAG epitope (lane l), and the bound µ2 migrates 
slightly slower than the expressed mammalian µ2 subunit (lane l). We thus conclude that 
although the β2 trunk⋅µ2 fails to bind to the immobilized GST-PIPKIγ (460-661), the 
endogenous Sf9 AP-2 heterotetramer specifically engages the 26 amino-acid extension of 
PIPKIγ661 since no binding is seen with the PIPKIγ (460-635) (lane h). This is in sharp contrast 
to the lack of association of the endogenous invertebrate AP-2 complex (Sf9 AP-2) with a GST-
presented YXXØ sorting signal (Figure 2.2B).  
In other experiments to assure that the FLAG-epitope-negative, ~100-kDa β-
immunoreactive band and the slower mobility µ2 subunit are indeed constituents of the Sf9 cell 
AP-2, we used affinity isolation with a C-terminal segment of ARH. ARH contains a single 
[DE]nX1-2FXX[FL]XXXR AP-2-binding motif that binds exclusively to the β2 subunit 
appendage (He et al., 2002; Mishra et al., 2002b; Edeling et al., 2006a; Schmid et al., 2006). The 
GST-ARHM2 fusion contains a 20 amino acid tract that fully contains this interaction motif 
(Mishra et al., 2005) that quantitatively removes the presumptive Sf9 cell β subunit from the 
supernatant and is recovered in the pellet fraction (data not shown). Furthermore, when bound to 
the immobilized ARH β-subunit interaction motif, the slower mobility µ2 form is detected (data 
not shown). These studies reveal that the β and µ2 bands observed indeed represent the 
endogenous invertebrate AP-2 present in the Sf9 cell lysates.  
The 26 amino acid extension of PIPKIγ661 also binds physically to the FERM domain of 
the integrin-associated protein talin, allowing regulated PtdIns(4,5)P2 formation at focal 
adhesions (Di Paolo et al., 2002; Ling et al., 2002). Accordingly, the ~230-kDa insect talin in 
lysates of either β2⋅µ2 (Figure 2.3, lane j) or β2 trunk⋅µ2 (lane l) binds to the GST-PIPKIγ (460-
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661) but not (460-635) (lanes f and h), as expected. Overall, we conclude from this series of 
experiments that the β2 appendage of the AP-2 complex, and not the µ2 subunit, is the major site 
for PIPKIγ661 interaction under these conditions. This interpretation is in full accord with a 
recent independent study (Nakano-Kobayashi et al., 2007). 
2.3.3 PIPKIγ661 appendage selectivity 
The AP-2 complex has two independently folded appendages that project away from the central 
heterotetrameric core (see Figure 1.2). Despite only ~11% sequence identity, the α- and β2-
subunit appendages have an analogous overall fold (Owen et al., 2000) and share many binding 
partners (Edeling et al., 2006a; Schmid et al., 2006); therefore, the appendages could either be 
indiscriminately or selectively accessed by PIPKIγ661. In fact, PIPKIγ661 shows a striking 
selectivity for the β2 appendage over the α. Pull-down assays show that the GST-α and GST-β2 
appendages bind to similar and different subsets of CLASPs and accessory factors (Figure 2.4, 
lanes d and f). While both bind to AP180, epsin 1, and eps15 roughly equally, only GST-β2 
binds to PIPKIγ661 (Figure 2.4, lane d, right). This is reminiscent of the strict preference of 
ARH and β-arrestin for the β2 appendage (He et al., 2002; Laporte et al., 2002; Mishra et al., 
2002b; Edeling et al., 2006a; Schmid et al., 2006). Significantly, the α appendage also has 
distinctive interaction partners; the endocytic protein NECAP 1 binds only to GST-α, for 
example (Figure 2.4, lane f) (Ritter et al., 2004). Cdk5 is known to phosphorylate PIPKIγ661 at 
Ser645 and dephosphorylation of this residue by calcineurin following calcium-induced synaptic 
vesicle exocytosis allows an interaction with AP-2 to promote compensatory endocytosis 
(Nakano-Kobayashi et al., 2007). Of the two bands detected by the anti-PIPKIγ mAb, 
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Figure 2.4: PIPKIγ661 discriminates between the AP-2 α and β2 appendages. 
Approximately 100 µg of GST (lanes a and b), GST-β2 appendage (lanes c and d) or GST-αC appendage 
(lanes e and f) immobilized on gluthathione-Sepharose was incubated with rat brain cytosol as indicated. 
After centrifugation, aliquots of ~1.5% of each supernatant (S) and ~10% of each washed pellet (P) were 
resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose. Portions 
of the blots were probed with anti-PIPKIγ mAb clone 12, anti-AP180 mAb clone 34, or affinity-purified 
anti-eps15, epsin 1 or NECAP 1 antibodies, and only the relevant portions shown. The different migration 
of the non-phosphorylated (arrowhead) and phosphorylated (pPIPKIγ) forms of PIPKIγ is indicated. 
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Figure 2.5: PIPKIγ661 directly engages the β2 appendage. 
Approximately 5 µg of His6-tagged β2 hinge + appendage (H +A; lanes c-) immobilized on Ni-NTA-
agarose was incubated with ~25 µg GST (lanes c and d), GST-PIPKIγ (460-635) (lanes e and f), GST-
PIPKIγ (460-661) (lanes g and h) or GST-PIPKIγ (460-661 with a phosphomimetic S645E mutation) 
(lanes i and j) as indicated in the presence of carrier BSA. GST-PIPKIγ (460-661) was also incubated 
with Ni-NTA-agarose alone (lanes a and b). After centrifugation, aliquots of ~2.5% of each supernatant 
(S) and ~25% of each washed pellet (P) were resolved by SDS-PAGE and stained with Coomassie blue. 
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only the lower band, which corresponds to the unphosphorylated protein, binds to β2, consistent 
with previous findings (Nakano-Kobayashi et al., 2007).  
2.3.4 PIPKIγ661 directly engages the β2 appendage 
In binary interaction assays, when immobilized His6-tagged AP-2 β2 hinge + appendage is 
incubated with soluble GST-PIPKIγ (460-661), the two proteins interact and PIPKIγ is recovered 
in the pellet with the β2 hinge + appendage (Figure 2.5, lane h). Conversely, the C-terminal 
segment of the PIPKIγ short-splice isoform (GST-PIPKIγ(460-635)) does not bind the β2 hinge 
+ appendage and remains in the supernatant (Figure 2.5, lane e), as does GST (lane c). This 
corroborates a direct interaction between PIPKIγ661 and the β2 appendage mediated by the 26 
amino acid extension of the long splice isoform. Furthermore, a phosphomimetic S645E mutant 
in a GST-PIPKIγ (460-661) background has a sharply reduced ability to bind β2 (Figure 2.5, lane 
j) in the direct interaction assay.  
2.3.5 PIPKIγ661 binds the β2 appendage sandwich domain 
Like the AP-2 α appendage, the β2 appendage plays an integral role in recruiting CLASPs and 
accessory factors to sites of endocytosis by acting as an organizational hub (Owen et al., 2000; 
Edeling et al., 2006a; Schmid et al., 2006; Keyel et al., 2008). The β2 appendage contains two 
rigidly apposed functional surfaces: an N-terminal, β-sheet-containing sandwich subdomain and 
a C-terminal, α-helix- and β-sheet-containing platform subdomain (Owen et al., 2000). Mutation 
and co-crystallization studies reveal the two sites bind to discrete sets of endocytic  
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Figure 2.6: PIPKIγ661 physically contacts the sandwich subdomain of the AP-2 β2 appendage. 
(A) Approximately 100 µg of GST (lanes a and b), GST-β2 appendage (lanes c and d) or GST-β2 Y888V 
(lanes e and f) or Y815A (lanes g and h) mutant appendage immobilized on gluthathione-Sepharose was 
incubated with rat brain cytosol as indicated. After centrifugation, aliquots of ~1.5% of each supernatant 
(S) and ~10% of each washed pellet (P) were resolved by SDS-PAGE and either stained with Coomassie 
blue or transferred to nitrocellulose. Portions of the blots were probed with anti-PIPKIγ mAb clone 12, 
anti-AP180 mAb clone 34, or affinity-purified anti-eps15 antibodies, and only the relevant portions 
shown. The slowed migration of the phosphorylated from of PIPKIγ (pPIPKIγ) is indicated, as is the 
location of the Coomassie-blue stained epsin 1 band. (B) Approximately 100 µg of GST (lane a and b) or 
GST-β2 appendage (lanes c-f) immobilized on glutathione-Sepharose was incubated with rat brain 
cytosol in the absence or presence of 2 µM eps15 (622-736) competitor polypeptide (lanes e and f) as 
indicated. After centrifugation, aliquots of ~1.5% of each supernatant (S) and ~10% of each washed pellet 
(P) were resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose. 
Portions of the blots were probed with anti-PIPKIγ mAb clone 12, anti-amphiphysin mAb clone 15, anti-
AP180 mAb clone 34, or anti-eps15 antibodies, and only the relevant portions shown. The slowed 
migration of the phosphorylated from of PIPKIγ (pPIPKIγ) is indicated, as is the location of the 
Coomassie-blue stained epsin 1 band.  
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proteins (Edeling et al., 2006a; Schmid et al., 2006). To determine whether PIPKIγ661 interacts 
with either of these sites, we mutated select residues critical for binding at each surface. A 
Y888V mutation in the β2 platform subdomain has no effect on the binding of PIPKIγ or the 
established sandwich-binding partners AP180 and eps15 (Figure 2.6A, lane d and f). This 
alteration does reduce epsin 1 binding (49,50). By contrast, a Y815A sandwich subdomain 
mutation completely eliminates the binding of PIPKIγ661, AP180, and eps15, while epsin 1 
binding is essentially unaffected (Figure 2.6A, lane h). These results indicate that PIPKIγ661 
associates directly with the sandwich subdomain of the β2 appendage. 
Competition experiments in which the immobilized GST-β2 is incubated with cytosol 
and an eps15 polypeptide encompassing the region co-crystallized with β2 appendage at the 
sandwich site (50) confirm the contact site. Alone, the GST-β2 recovers the typical cohort of 
soluble endocytic proteins (Figure 2.6B, lane d). Addition of the eps15 polypeptide to the 
mixture substantially reduces PIPKIγ661 and amphiphysin I and -II binding (Figure 2.6B, lane 
f). AP180 binding is clearly reduced, although not to the same extent as the kinase (lane f). 
2.3.6 Delineation of the PIPKIγ661 AP-2 interaction motif 
Since the PIPKIγ (460-661) but not the -(460-635) binds to the AP-2 β2 appendage, we 
evaluated whether just the terminal 28 amino acids of the human PIPKIγ668 variant (also termed 
PIP5K Iγ90 (Di Paolo et al., 2002)) are sufficient for this interaction. AP-2 binds to only the 28-
residue extension considerably weaker than in the context of the 460-661 fragment in a GST 
pull-down assay (Figure 2.6, compare lane f and h). Yet, in the same assay, the extent of the 
association with talin is similar for both GST fusions (Figure 2.6). This could indicate 
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Figure 2.7: The alternatively spliced C terminus of PIPKIγ alone does not contain all the AP-2 
binding information. 
Approximately 200 µg of GST (lanes a and b), GST-PIPKIγ (460-635) (lanes c and d), GST-Hs PIPKIγ 
(641-668) (lanes e and f), GST-PIPKIγ (460-661) (lanes g and h), GST-PIPKIγ (460-661/S645E) (lanes i 
and j) or GST-ARH (180-308) (lanes k and l) immobilized on glutathione-Sepharose was incubated with 
rat brain cytosol as indicated. After centrifugation, aliquots of ~1.5% of each supernatant (S) and ~10% of 
each washed pellet (P) were resolved by SDS-PAGE and either stained with Coomassie blue or 
transferred to nitrocellulose. Portions of the blots were probed with anti-clathrin heavy chain (HC) mAb 
TD.1 and anti-β1/β2 subunit mAb 100/1, anti-AP-2 α subunit mAb C4, or anti-talin mAb 8d4, and only 
the relevant portions shown. The position of talin (red arrowhead) and the AP-2 β2 and α subunits (black 
arrowhead) on the stained gel is shown. Note that PIPKIγ661 clearly binds to the β2 appendage of AP-2 
more weakly than ARH, which has a KD for AP-2 of ~2 µM (Edeling et al., 2006a; Schmid et al., 2006). 
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that while talin binds only the 26/28 amino acid extension in PIPKIγ661/668, AP-2 may bind 
primarily to this same region but depend on a distinct secondary structural element or be 
stabilized by an adjacent region(s) within residues 460-635.  
Using controlled tryptic proteolysis of bacterially expressed 460-635 and 460-661 
polypeptides derived from PIPKIγ, a hierarchical sequence of degradation fragments is observed 
(Figure 2.8A). Immunoblots with either a mAb that detects both PIPKIγ635 and -661 or affinity-
purified antibodies that detect the 26 amino-acid extension of PIPKIγ661 reveal that both 
epitopes are efficiently removed by low concentrations of trypsin. This is in contrast to the stably 
folded bacterial chaperone DnaK, co-purified with the PIPKIγ peptides, that is unaffected by 
lower trypsin concentrations (Figure 2.8A). Neither antibody reacts with the more stable PIPKIγ 
fragments. Additionally, circular dichroism analysis of the 460-635 and 460-661 protein 
segments indicate that both are essentially unstructured (Figure 2.8B). Indeed, the 460-661 
polypeptide is resistant to denaturation at 100°C, as are the C-terminal portions of the natively 
unstructured endocytic proteins epsin 1 and AP180 (Kalthoff et al., 2002). We believe the 
intrinsic disorder of the C-terminal region of PIPKIγ makes it unlikely that the difference in AP-
2 binding between the GST-PIPKIγ (460-661) and GST-Hs PIPK1γ (641-668) (equivalent to the 
mouse 636-661) is due to secondary structural elements. Instead, residues at the junction of the 
635 and 661 splice isoforms may contribute to AP-2 β2-appendage binding. To examine this 
further, we used a third rodent PIPKIγ splice variant, PIPKIγ687 (also termed PIPkin IγC 
(Giudici et al., 2004) or PIPkin Ig93 (Giudici et al., 2006)), which contains a distinct 26 amino-
acid insert positioned between the C-terminus of PIPKIγ635 and the N-terminus of PIPKIγ661 
26 amino-acid insert (Figure 2.9). Interestingly, separating the C-terminal end of the 635 splice 
isoform from the 661 insert in this configuration diminishes AP-2 binding to roughly that seen  
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Figure 2.8: The PIPKIγ661 C terminus lacks secondary structure. 
(A) Aliquots (20 µg) of PIPKIγ (460-635) (lanes a-f) or PIPKIγ (460-661) (lanes g-l) were incubated 
alone or with 1:5 serial fivefold dilutions of trypsin (0.6-375 ng) in 50 mM Tris pH 8.0, 150 mM NaCl, 5 
mM CaCl2, 1 mM DTT at 37°C for 1 hour. Proteolysis was stopped by the addition of 95°C SDS sample 
buffer and aliquots of 10% of each reaction resolved by SDS-PAGE either stained with Coomassie blue 
or transferred to nitrocellulose. The PIPKIγ (460-661) portion of the blot was probed with anti-PIPKIγ 
mAb clone 12 that recognizes both isoforms or with an affinity purified antibody that recognizes only the 
PIPKIγ661 isoform. (B) Circular dichroism spectra of PIPKIγ (460-635) (open circles), PIPKIγ (460-661) 
(triangles), and epsin 1 ENTH domain (squares) polypeptides were measured in 25 mM potassium 
phosphate + 1 mM DTT. Measurements were made from 280 nm to 185 nm at 1 nm increments and the 
spectra were baseline corrected and represent the average of five (PIPKIγ) or three (ENTH) runs. Note the 
signature α-helical features of the globular ENTH domain compared with the unstructured PIPKIγ 
polypeptides. 
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Figure 2.9: Schematic of the three PIPKIγ splice variants. 
Primary sequence alignment of the C-terminal segment of PIPKIγ isoforms from various species; murine 
(Mm; accession number: NP_032870.1), rat (Rn; NP_001009967.2), human (Hs; NP_036530.1), bovine 
(Bt; XP_585653.4), feline (Cf; XP_542172.2), opossum (Md; XP_001363745.1), platypus (Oa; 
XP_001511349.1) and zebrafish (Dr; XP_683392.3). Identical residues colored pink and conservatively 
substituted residues yellow. The location of the talin-binding motif is indicated above, and the GST-
fusion proteins spanning the junction between the PIPKIγ635 and -661 isoforms tested below. 
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Figure 2.10: Differing partner binding properties of the three PIPKIγ splice variants. 
(A) Approximately 200 µg of GST (lanes a and b), GST-PIPKIγ (460-635) (lanes c and d), GST-PIPKIγ 
(460-661) (lanes e and f), or GST-PIPKIγ (460-687) (lanes g and h) immobilized on glutathione-
Sepharose was incubated with rat brain cytosol as indicated. After centrifugation, aliquots of 1.5% of each 
supernatant (S) and 10% of each washed pellet (P) were resolved by SDS-PAGE and either stained with 
Coomassie blue or transferred to nitrocellulose. Portions of the blots were probed with anti-clathrin heavy 
chain (HC) mAb TD.1 and anti-β1/β2 subunit mAb 100/1, or with anti-talin mAb 8d4 and only the 
relevant portions shown. (B) Approximately 200 µg of GST (lanes a and b), GST-PIPKIγ (460-635) 
(lanes c and d), GST-PIPKIγ (460-661) (lanes e and f), GST-PIPKIγ (636-661) (lanes g and h), GST-
PIPKIγ (630-661) (lanes i and j) , or GST-PIPKIγ (624-661) (lanes k and l) immobilized on glutathione-
Sepharose was incubated with rat brain cytosol as indicated. After centrifugation, aliquots of 1.5% of each 
supernatant (S) and 10% of each washed pellet (P) were resolved by SDS-PAGE and either stained with 
Coomassie blue or transferred to nitrocellulose. Portions of the blots were probed with anti-clathrin heavy 
chain (HC) mAb TD.1 and anti-β1/β2 subunit mAb 100/1, or anti-talin mAb 8d4, and only the relevant 
portions shown. The position of talin (open arrowhead) and the AP-2 β2 and αC subunits (black 
arrowhead) on the stained gel is shown. 
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with the GST-PIPKIγ (460-635) alone (Figure 2.10A). This indicates that residues proximal to 
the 26 amino-acid insert may contribute to the engagement of the β2 appendage of the AP-2 
adaptor. Indeed, a pair of constructs that include the last six (GST-PIPKIγ (630-661)) or twelve 
(GST-PIPKIγ (624-661)) residues of PIPKIγ635 have dramatically increased AP-2 binding 
capability compared with the mouse PIPKIγ661 C-terminus alone fused to GST (GST-
PIPKIγ636-661)) (Figure 2.10B). There is little change in the interaction with talin for these 
fusion proteins however. These results confirm then that the extreme C-terminal region of the 
PIPKIγ635 splice isoform contributes to binding to the AP-2 β2 appendage but, alone, is 
insufficient for associating with AP-2.  
2.3.7 The β2 sandwich subdomain contact surface 
A yeast two-hybrid interaction screen with the PIPKIγ 630-661 peptide fused to the DNA 
binding domain of Gal4p corroborates that this sequence engages the sandwich subdomain of the 
β2 appendage. Transformed AH109 yeast grow on quadruple dropout selection plates only when 
expressing both the PIPKIγ (630-661) and β2 appendage but not either protein alone (Figure 
2.11A). Site-directed mutagenesis of selected residues on the β2 appendage shows a Y888V 
mutation, which disrupts the platform interaction site (Owen et al., 2000), has no effect on 
PIPKIγ interaction. By contrast the Y815A substitution, as well as alteration of several other side 
chains that contribute to the sandwich site interaction surface (Gln756, Gln804, Ala806 and 
Lys808; Figure 2.11B) (Edeling et al., 2006a; Schmid et al., 2006) strongly impede the binding 
to the PIPKIγ C-terminal 630-661 polypeptide (Figure 2.11A). 
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Figure 2.11: AP-2-PIPKIγ interaction in a yeast two-hybrid assay. 
(A) Saccharomyces cerevisiae strain AH109 transformed with the indicated Gal4 pGBKT7 binding 
domain (BD) pGADT7 activation domain (AD) plasmid combinations were spotted onto SD minimal 
medium plates lacking either Leu and Trp, or Ade, His, Leu, and Trp and grown at 30°C. (B) Ribbon 
representation (PDB accession: 2G30) of the AP-2 β2 appendage sandwich subdomain indicating the 
location of important side chains (blue, nitrogen; red, oxygen) involved in accommodating the PIPKIγ661 
C-terminal interaction motif. Shown in stick representation (gold) is the location of co-crystallizing AAF 
peptide that demarcates a portion of the binding surface upon the β2 appendage sandwich subdomain.  
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2.3.8 Pinpointing key anchor residues in PIPKIγ necessary for β2 appendage engagement 
Having delineated the AP-2 β2 interaction motif in PIPKIγ661 to a tract of ~20 residues, we next 
tested the importance of selected hydrophobic side chains within this region. This is because for 
all characterized adaptors and accessory factors that associate with the α and β2 appendages, 
aromatic residue-containing motifs are critically important binding determinants, such as the 
DP[FW] motif in eps15 and epsin (Maldonado-Baez and Wendland, 2006), the 
WXX[FW]X[DE]n motif in SJ170 (Jha et al., 2004), NECAP (Ritter et al., 2004) and stonin 2 
(Mishra et al., 2004; Walther et al., 2004), and the [DE]nX1-2FXX[FL]XXXR motif in ARH and 
β-arrestin (Edeling et al., 2006a; Schmid et al., 2006). There are five phylogenetically conserved 
aromatic residues in the mapped PIPKIγ AP-2 binding region (Figure 2.9 and 2.12A). Two, 
Trp642 and Tyr644, are vicinal to Ser645, which inhibits AP-2 binding when phosphorylated 
(Figure 2.5) (Nakano-Kobayashi et al., 2007). Both a W642A mutation and a more conservative 
phenylalanine substitution (W642F) eliminate β2 binding (Figure 2.12B and 2.13A, lanes f and 
h) in either binary GST pull-down assays (Figure 2.12B) or with rat brain cytosol (Figure 
2.13A). Likewise, a Y644A change eliminates β2-appendage binding (Figure 2.12B and 2.13A, 
lane j) but the conservative Y644F mutation reduces, but does not abolish, β2 engagement 
(Figure 2.12B and 2.13A, lane l). This finding is significant because alignment of the sequences 
that follow the C-terminal IYF of the Iγ635 isoform in either the Iγ661 or Iγ687 variants shows 
some obvious similarities (Figure 2.12A). The longest Iγ687 insert has a Trp positioned 
analogously to Trp642 in Iγ661 and a Phe at the position equivalent to Tyr644. In fact, five of the 
eleven N-terminal residues are identical between the two alternatively spliced proteins and two 
conservatively substituted (Figure 2.12A). Nevertheless, the Iγ687 protein does not bind to AP-2
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Figure 2.12: Delineation of key anchor residues that mediate PIPKIγ661 binding to the β2 
appendage. 
(A) Primary sequence alignment of the two PIPKIγ 26 amino acid inserts and comparison with a tract 
from eps15 that also bind to the AP-2 β2 appendage sandwich subdomain. (B) Approximately 40 µg of 
His6-tagged β2 hinge + appendage immobilized on Ni-NTA-agarose was incubated with ~10 µg GST 
(lanes a and b), GST-PIPKIγ (460-661) wild type (WT, lanes c and d), or GST-PIPKIγ (460-661) 
containing W642A (lanes e and f), W642F (lanes g and h), Y644A (lanes i and j), or Y644F (lanes k and 
l) mutations in the presence of carrier BSA. After centrifugation, aliquots of ~4% of each supernatant (S) 
and ~25% of each washed pellet (P) were resolved by SDS-PAGE and stained with Coomassie blue. 
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Figure 2.13: Delineation of key anchor residues that mediate PIPKIγ661 binding to the β2 
appendage, continued. 
(A) Approximately 250 µg GST (lanes a and b), GST-PIPKIγ (460-661) wild type (WT, lanes c and d), or 
GST-PIPKIγ (460-661) containing W642A (lanes e and f), W642F (lanes g and h), Y644A (lanes i and j) 
or Y644F (lanes k and l) mutations immobilized on glutathione-Sepharose was incubated with rat brain 
cytosol as indicated. After centrifugation, aliquots of ~3.5% of each supernatant (S) and ~10% of each 
pellet (P) were resolved by SDS-PAGE and either stained with Coomassie blue or transferred to 
nitrocellulose. A portion of the blot was probed with anti-β1/β2-subunit mAb 100/1 and anti-clathrin 
heavy chain (HC) mAb TD.1. (B) Approximately 100 µg GST (lanes a and b), GST-PIPKIγ (624-661) 
wild type (WT, lanes c and d) or GST-PIPKIγ (624-661) containing I633A (lanes e and f), Y634A (lanes 
g and h),  F635A (lanes i and j), W642A (lanes k and l), Y644A (lanes m and n) or Y649A (lanes o and p) 
mutations immobilized on glutathione-Sepharose was incubated with rat brain cytosol as indicated. After 
centrifugation, aliquots of ~1.5 supernatant (S) and ~10% of each pellet (P) were resolved by SDS-PAGE 
and either stained with Coomassie blue or transferred to nitrocellulose. Portions of the blot were probed 
with anti-β1/β2-subunit mAb 100/1 and anti-clathrin heavy chain (HC) mAb TD.1 or anti-talin mAb 8d4. 
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efficiently (Figure 2.10A), presumably in part because of the natural Phe-for-Tyr substitution.  
The pair of aromatics at the end of the Iγ635 sequence are also important; a double 
Tyr634 and Phe635 to Ala substitution (YF→AA) in the context of the GST-Iγ (460-661) fusion 
protein diminishes AP-2 binding to the level seen with just the 26 amino-acid extension of the 
Iγ661 isoform (data not shown). Separate Y634A and F635A mutations in the GST-PIPKIγ (624-
661) fusion backbone reveal that Phe635 is critical while Tyr634 is somewhat less so, as there is 
still some AP-2 bound to the fusion protein with a Y364A mutation (Figure 2.13B). By contrast, 
converting Ile633 to Ala does not diminish the binding of AP-2 when compared with the wild-
type protein. As seen with the GST-Iγ (460-661) fusions, Trp642 and Tyr644 are vital residues 
for β subunit engagement. The Y649A switch, located 13 residues after the intersection between 
the 635 and 661 splice forms, shows that this amino acid also contributes weakly to AP-2 
binding. The lack of a bulky aromatic residue equivalent to Tyr649 in the Iγ687 longest-splice 
isoform, as well as other substitutions, may also contribute to the poor interaction with AP-2. 
This set of mutations has a different effect on talin binding. Only the W642A and Y644A 
mutants exhibit greatly diminished binding to cytosolic talin (Figure 2.13B), which is in accord 
with the mapped talin binding region (see Figure 2.9) (Di Paolo et al., 2002; Ling et al., 2002; 
Ling et al., 2003) and structural studies of the talin FERM F3 subdomain engaged with PIPKIγ 
peptide (de Pereda et al., 2005; Kong et al., 2006). Altogether, these data indicate that aromatic 
residues contribute to β2-sandwich subdomain binding possibly through inserting into 
complementary hydrophobic surfaces in the appendage. The results also confirm the important 
role of Tyr644 in AP-2 binding (Bairstow et al., 2006), but argue strongly against the kinase-AP-
2 interaction being YXXØ-mediated, because those interactions are critically dependent on the 
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proximal tyrosine that cannot be replaced functionally by phenylalanine (Collawn et al., 1990; 
Jadot et al., 1992). 
2.3.9 Clathrin is displaced from the AP-2 β2 appendage by PIPKIγ661 
An additional endocytic coat protein that binds to the sandwich subdomain of the AP-2 β2 
appendage is the clathrin heavy chain (Owen et al., 2000; Edeling et al., 2006a; Knuehl et al., 
2006; Keyel et al., 2008). Rather than utilizing a short unstructured interaction motif to contact 
the β2 appendage, the clathrin heavy chain interaction surface is located within the distal leg 
(Knuehl et al., 2006), comprised of repeating antiparallel α-helices in a solenoid-type fold (ter 
Haar et al., 1998; Ybe et al., 1999). Although clathrin is a functional trimer, we nevertheless 
examined whether PIPKIγ661 and clathrin compete for a common binding surface on the β2 
appendage. Supplementing whole cytosol with a PIPKIγ 624-661 polypeptide interferes with 
clathrin binding to immobilized GST-β2 appendage in a dose-dependent manner (Figure 2.14A). 
The peptide competitor also abolishes endogenous PIPKIγ661 and AP180 binding, but leaves 
epsin 1 still attached to the β2 appendage, further arguing that it binds to the sandwich 
subdomain. By contrast, adding a Iγ 624-661 peptide containing a W642A substitution has a 
weak, if any effect on clathrin, PIPKIγ661 or AP180 binding (Figure 2.14A).  
If clathrin engagement by the larger β2 subunit hinge + appendage domains is followed 
under the same conditions, the triskelia bind much more avidly to the immobilized GST-β2 
fragment (Figure 2.14B, compare lanes f and j). The Iγ 624-661 peptide now competes with 
clathrin only weakly (Figure 2.14B, compare lanes j and l). Yet the added excess peptide does 
effectively compete PIPKIγ and AP180 off the β2 hinge + appendage, 
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Figure 2.14: Mutually exclusive engagement of the β2 appendage sandwich by either PIPKIγ661 or 
clathrin. 
(A) Approximately 100 µg GST (lanes a and b) or GST-β2 appendage (lanes c-l) immobilized on 
glutathione-Sepharose was incubated with rat brain cytosol alone (lanes a-d) or cytosol supplemented 
with 46 µM wild type (lanes e and f) or W642A (lanes i and j) PIPKIγ (624-661) peptide or 139 µM wild 
type (lanes g and h) or W642A (lanes k and l) PIPKIγ (624-661) peptide. After centrifugation, aliquots of 
~1.5% of each supernatant (S) and ~10% of each washed pellet (P) were resolved by SDS-PAGE and 
either stained with Coomassie blue or transferred to nitrocellulose. Portions of the blots were probed with 
anti-clathrin heavy chain (HC) mAb TD.1, anti-PIPKIγ mAb clone 12, anti-AP180 mAb clone 34 or 
affinity-purified anti-epsin 1 antibodies. Notice that although epsin 1 binding to the β2 appendage is 
affected by the addition of the PIPKIγ peptide, particularly at the highest concentration, the sandwich-
binding partners are clearly much more sensitive to the competitor. (B) Approximately 100 µg GST 
(lanes a-d), GST-β2 appendage (lanes e-h) or GST-β2 hinge + appendage (lanes i-l) immobilized on 
glutathione-Sepharose was incubated with rat brain cytosol alone (lanes a, b, e, f, i and j) or rat brain 
cytosol supplemented with 113 µM PIPKIγ (624-661) polypeptide (lanes c, d, g, h, k and l). After 
centrifugation, aliquots of ~1.5% of each supernatant (S) and ~10% of each washed pellet (P) were 
resolved by SDS-PAGE and either stained with Coomassie blue or transferred to nitrocellulose. Portions 
of the blots were probed with anti-clathrin heavy chain (HC) mAb TD.1, anti-PIPKIγ mAb clone 12, or 
anti-AP180 mAb clone 34. 
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Figure 2.15: Mutually exclusive engagement of the β2 appendage sandwich by either PIPKIγ661 or 
clathrin, continued. 
(A) Approximately 100 µg GST-β2 appendage immobilized on glutathione-Sepharose was incubated with 
rat brain cytosol alone (lanes a and b) or cytosol supplemented with 113 µM wild type (lanes c and d) or 
W642A (lanes e and f) PIPKIγ (624-661) polypeptide or 113 µM wild type (lanes g and h) or W642A 
(lanes i and j) PIPKIγ (460-661) polypeptide. After centrifugation, aliquots of ~1.5% of each supernatant 
(S) and ~10% of each washed pellet (P) were resolved by SDS-PAGE and either stained with Coomassie 
blue or transferred to nitrocellulose. Portions of the blots were probed with anti-clathrin heavy chain (HC) 
mAb TD.1, anti-PIPKIγ mAb clone 12, or anti-AP180 mAb clone 34. (B) Fractions (20 µg) from a 
preparation of rat brain clathrin-coated vesicles were resolved by SDS-PAGE and either stained with 
Coomassie blue or transferred to nitrocellulose. Portions of the blots were probed with anti-clathrin light 
chain (LC) mAb Cl57.3, anti-µ2 subunit serum, affinity-purified anti-HIP1 antibodies, or anti-PIPKIγ 
mAb clone 12. Only the relevant portions are shown. Note the strong enrichment of clathrin, AP-2 and 
HIP1 (arrowheads) but exclusion PIPKIγ (open arrowhead) in the coated-vesicle fraction. 
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however (Figure 2.9B, compare lanes j and  l). This selectively refractory behavior is because the 
extra β2 hinge region contains additional clathrin binding determinants that contact the N-
terminal β-propeller of the clathrin heavy chain (Gallusser and Kirchhausen, 1993; Owen et al., 
2000; ter Haar et al., 2000). The additional points of contact increase the apparent affinity of 
clathrin for the β2 chain versus PIPKIγ661 or eps15 (Cupers et al., 1998; Edeling et al., 2006a). 
Thus, the AP-2 β2 subunit binds more tightly to multivalent clathrin trimers than monovalent 
PIPKIγ661. 
Like the PIPKIγ 624-661 segment, the whole C-terminal Iγ 460-661 polypeptide also 
interferes with clathrin binding in the presence of cytosol, while the W642A mutant does not 
(Figure 2.15A). A corollary of these results is that clathrin engagement could displace prebound 
PIPKIγ661 from AP-2 as the lattice assembly process progresses toward the deeply invaginated 
state. Circumstantial evidence for this contention comes from the marked de-enrichment of 
PIPKIγ661 in preparations of rat brain clathrin-coated vesicles (Figure 2.15B) (Wenk et al., 
2001). These results imply that the temporal residence of PIPKIγ661 at the bud site may be 
determined by the extent of clathrin lattice polymerization.  
2.4 DISCUSSION 
Phosphoinositides are biologically useful signaling molecules in part because they fail to 
transfer rapidly between different membrane compartments in the absence of vesicular transport. 
These phospholipids can rapidly move laterally within the plane of the membrane. Bound to 
PtdIns(4,5)P2, the diffusion coefficient of the PLCδ1 PH domain (Brough et al., 2005; Hammond 
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et al., 2009) approximates that of lipid alone within the plasma membrane bilayer (Yaradanakul 
and Hilgemann, 2007; Golebiewska et al., 2008); this could impact the action of PtdIns(4,5)P2 at 
discrete membrane patches on the cell surface. In addition, the inositol-lipid head group can be 
rapidly remodeled upon delivery to a new organelle, or even while within a forming coated bud 
or membrane-bounded transport vesicle. This plasticity of the head group, coupled with vectorial 
membrane flow, allows for differentially phosphorylated PtdInsPs to play critical regulatory 
roles along the secretory and endosomal pathways. Here, we demonstrate that the PIPKIγ661 
isoform binds physically to the sandwich subdomain of the AP-2 β2 subunit appendage. This 
interaction allows for the 5-kinase to be strategically positioned during clathrin-coat assembly 
and to augment PtdIns(4,5)P2 production focally. A precedent for this type of localized 
regulation already exists; the talin FERM domain engages the longer-splice isoforms of PIPKIγ 
(using a sequence that overlaps the β2-appendage interaction motif), and this association 
coordinates PtdIns(4,5)P2 production at focal adhesion sites (Di Paolo et al., 2002; Ling et al., 
2002).  
In eukaryotes, alternative splicing can increase genomic complexity and diversity. The 
organization of the C-terminal splice sites allows the synthesis of three distinct PIPKIγ variants: 
one (PIPKIγ687) can bind selectively to talin via the C-terminal extension, one (PIPKIγ661) to 
both talin and AP-2, and one (PIPKIγ635) to neither protein. This flexibility could impart 
importantly different biological functions to each isoform (Mao et al., 2009). An additional level 
of regulation can fine-tune this variation as phosphorylation of Ser645 impedes AP-2 (Figure 
2.5; (Nakano-Kobayashi et al., 2007)) and talin (Lee et al., 2005) binding, while Tyr644 (Tyr649 
in the human isoform) phosphorylation enhances the association with talin (Ling et al., 2003; 
Lee et al., 2005; Kong et al., 2006). Intriguingly, Tyr634 is also subject to phosphorylation in 
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response to growth factors (Sun et al., 2007b). In the brain, PIPKIγ661 is the major isoform at 
the presynaptic plasma membrane (Wenk et al., 2001; Di Paolo et al., 2004) suggesting that the 
endocytic function of the kinase is paramount in this tissue.  
We mapped the AP-2 interaction motif in PIPKIγ to a more expansive sequence than 
those typically recognized by the α appendage (DP[FW], FXDXF and WXX[FW]X[DE]n) or 
even the platform site on the β2 appendage ([DE]nX1-2FXX[FL]XXXR). The sequence differs 
too from the 721SFGDGFADF region of murine eps15 that also binds to the β2 sandwich 
subdomain (Schmid et al., 2006). A co-crystal with the β2 appendage shows the eps15 sequence 
tract forms a tight turn that depends critically on the central Gly for proper positioning of the 
three Phe side chains (Schmid et al., 2006). Because of the lack of a Gly within β2 binding 
region of PIPKIγ661, and the altered spacing of the aromatic residues (Figure 2.12A), it seems 
unlikely that the kinase and eps15 engage the β2 sandwich site in precisely the same manner. 
Yet, the strict selectivity of PIPKIγ661 for the sandwich subdomain makes the binding to AP-2 
subject to interference by clathrin, which can occupy the same interaction site (Edeling et al., 
2006a; Keyel et al., 2008). More important is that in the context of the assembled polyhedral 
lattice, the clathrin heavy chains project a profusion of terminal domains down into the interior 
of the assemblage (ter Haar et al., 1998; Edeling et al., 2006a). In our view, this high density of 
clathrin coupled with the capability of the β2 chain of AP-2 to engage the clathrin heavy chain 
through at least two binding sites, will strongly favor AP-2 associations with clathrin in regions 
of extensively assembled coat. In fact, in biochemical assays eps15, which also binds to the AP-2 
β2 appendage sandwich (Edeling et al., 2006a; Schmid et al., 2006) but not to clathrin, is 
displaced from AP-2 by polymerizing clathrin (Cupers et al., 1998). Accordingly, eps15 is 
restricted to the outer edge of clathrin lattices on the cell surface (Tebar et al., 1996; Edeling et 
 75 
al., 2006a). We propose that this hierarchical binding phenomenon offers a mechanism for 
temporal and spatial control of PtdIns(4,5)P2 formation as a function of the extent of 
polymerized clathrin lattice.  
Coincidence detection is a common theme in the coordinated placement of clathrin-coat 
components necessary to drive bud progression (Di Paolo and De Camilli, 2006). We therefore 
cannot rule out that PIPKIγ661 utilizes this by establishing secondary associations with the µ2 
subunit of AP-2, either through the YXXØ-interaction surface (Bairstow et al., 2006) or by 
binding of the catalytic core region to a distinct portion of µ2 (Krauss et al., 2006). Conceivably, 
these additional contacts could be precisely regulated by phosphorylation, as exposure of the µ2 
subunit to accommodate YXXØ sorting signals requires phosphorylation of Thr156 (Olusanya et 
al., 2001). Perhaps this allows PIPKIγ661 binding to be variably regulated at different points in 
the coat assembly cycle. However, because PIPKIγ661 is not enriched in clathrin-coated vesicles 
purified from rat brain (Figure 2.15B; (Wenk et al., 2001), and immunoEM reveals PIPKIγ on 
synaptic plasma membrane adjacent to, but not within, clathrin-coated buds (Wenk et al., 2001), 
we favor the β2 appendage as the site most able to manage this spatial positioning of the 5-
kinase during clathrin-mediated endocytosis at the nerve terminal. Intriguingly, PIPKIγ661 binds 
to the AP-2 β2 appendage as well as the β1 subunit of the AP-1 heterotetramer (Nakano-
Kobayashi et al., 2007). In this regard, it is interesting that AP-1 is implicated in return of certain 
integral membrane proteins from the recycling endosome compartment and PtdIns(4,5)P2 is the 
necessary phosphoinositide (Crottet et al., 2002). Similar regulation by the clathrin heavy chain 
and/or possibly eps15 could occur as eps15 is located on endosomes and the TGN (Chi et al., 
2008), and the key residues that constitute the interaction surface on the β2 appendage sandwich 
subdomain are all conserved in the AP-1 β1 chain (Keyel et al., 2008). 
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The structurally related AP-2 α and β2 appendages contact a rich constellation of binding 
partners, some of which are common to both but nevertheless engage structurally non-equivalent 
surfaces on each appendage (Edeling et al., 2006a; Schmid et al., 2006). A major, currently 
unresolved question is why certain proteins have evolved specific combinations of dissimilar 
AP-2 (and clathrin) interaction motifs as opposed to utilizing standardized, generic connection 
elements? Also, given the relatively low affinity of these interactions in general, how does a 
timed succession of protein occupancies lead to progressive coat assembly without misdirected 
protein placement or catastrophic entanglement? One explanation is that binding events that 
occur at different locations upon the appendages utilizing particular peptide motifs generate 
different functional consequences, enabling the two proximate domains to act in concert to 
coordinate coat assembly. The coordination of PtdInsP metabolism at coated buds seems to be 
emblematic of this type of regulation. The 5-kinase activity of PIPKIs is stimulated several fold 
by PtdOH (Jenkins et al., 1994; Ishihara et al., 1998). Clathrin-mediated endocytosis ceases 
rapidly (<5 min) upon administration of 1-2% 1-butanol to cultured cells, and new lattice 
assembly is prevented (Boucrot et al., 2006), illustrating the likely involvement of PtdOH in coat 
assembly and progression. We have shown previously that, in vitro, PtdOH can promote limited 
translocation of AP-2 to biological membranes in the absence of PtdIns(4,5)P2 synthesis 
(Arneson et al., 1999). In fact, a positive feedback loop operates as the product of PIPKI activity, 
PtdIns(4,5)P2, is a required activator of phospholipase D (PLD) (Figure 5.2) (Arneson et al., 
1999; Morris, 2007). Primary alcohols interfere with PLD-catalyzed hydrolysis of 
phosphatidylcholine (PtdCho) because a phosphatidylalcohol and not PtdOH is produced 
(Jenkins and Frohman, 2005). An alternative pathway for the generation of PtdOH is through the 
phosphorylation of DAG by diacylglycerol kinase (DGK; Figure 5.2) (Merida et al., 2008). 
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Intriguingly, the PH domain-containing type II DGK, DGKδ2, partly colocalizes with clathrin-
coated structures and binds directly to AP-2, in this case to the platform subdomain of the α 
appendage (Kawasaki et al., 2007). Although DGKδ2 is widely expressed, mRNA transcripts for 
the enzyme are not particularly abundant in brain (Sakane et al., 2002). Therefore, at the 
synapse, this enzyme may not be recruited to presynaptic coated buds concomitantly with 
PIPKIγ661. Perhaps in different cell types, PtdIns(4,5)P2 and PtdOH production at clathrin-
coated regions is managed by different enzymes associating with distinct sites on the AP-2 
appendages.  
Like PIPKIγ, the phosphoinositide polyphosphatase synaptojanin 1 is subject to 
alternative splicing (Ramjaun and McPherson, 1996). Somewhat unexpectedly, the ubiquitously 
expressed large-splice isoform, SJ170, is present within clathrin-coated structures at the cell 
surface throughout the assembly cycle (Perera et al., 2006). SJ170 also associates physically with 
AP-2 (Haffner et al., 2000; Jha et al., 2004) and, similar to PIPKIγ661, we mapped the principal 
interaction motif to a WXX[FW]X[DE]n motif within the C-terminal extension of SJ170 (Jha et 
al., 2004). This type of interaction motif selectively engages the sandwich subdomain of the AP-
2 α appendage (Mishra et al., 2004; Ritter et al., 2004; Walther et al., 2004). Thus, PIPKIγ661, 
DGKδ2 and SJ170 can all associate directly with AP-2, albeit though different contact sites on 
the appendages (Figure 5.2). By binding to different surfaces of the α or β2 appendage, the 
various enzymes that modulate PtdInsP metabolism at the growing bud can be subject to 
different regulatory inputs. Therefore, the α and β2 appendages appear to operate as 
organizational scaffolds, in part to optimize the regional lipid environment necessary for 
clathrin-coat formation. Indeed, this seems to be a general requirement for efficient receptor 
internalization because β-arrestin 2, a CLASP that promotes the uptake of stimulated G protein-
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coupled receptors (Lefkowitz and Shenoy, 2005; Marchese et al., 2008), also associates directly 
with DGK (Nelson et al., 2007). β-arrestin 2 also binds physically to PIPKI in a PtdIns(4,5)P2-
sensitive fashion (Nelson et al., 2008). The ability of other CLASPs to engage PIPKIs is in 
accord with much data showing that, under certain experimental circumstances, internalization of 
discrete transmembrane cargo molecules continues in an AP-2 gene-silenced background 
(Hinrichsen et al., 2003; Motley et al., 2003; Huang et al., 2004; Barriere et al., 2006; Keyel et 
al., 2006; Maurer and Cooper, 2006; Eden et al., 2007). 
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2.5 ADDITIONAL DATA 
 
Figure 2.16: Crystal structure of AP-2 β2 appendage in complex with the human PIPKIγ668 C 
terminus. 
Ribbon and space-filling models of human AP-2 β2 appendage (green) and human PIPKIγ668 C terminal 
peptide (blue) in complex (Protein Data Bank code 3H1Z). The key PIPKIγ668 anchoring residues are 
labeled with the corresponding mouse residues in parentheses. The β2 appendage sandwich binding 
pocket residues are depicted in yellow and labeled. Structure solved by (Kahlfeldt et al., 2010). 
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Figure 2.17: Titration of AP-2 β2 appendage sandwich partner binding. 
Approximately 5, 10 or 20 µg GST (lane a), GST-β2 appendage (lanes b, d and f) or GST-β2 hinge and 
appendage (H+A) (lanes c, e and g) were bound to glutathione-Sepharose  and incubated with rat brain 
cytosol. The pellets were washed and resolved by SDS-PAGE and stained with Coomassie Blue (top) or 
transferred to nitrocellulose and probed with antibodies to clathrin heavy chain (HC) mAb TD.1, affinity 
purified anti-eps15 rAb or anti-PIPKIγ mAb clone 12 (bottom). Notice the higher apparent affinity of 
eps15 for β2 appendage over PIPKIγ and the reduced binding of eps15 and increased clathrin binding to 
the hinge and appendage at lower concentrations (lanes b and c). 
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3.0  THE AP-2 ADAPTOR β2 APPENDAGE SCAFFOLDS ALTERNATE CARGO 
ENDOCYTOSIS* 
*Portions reprinted from Molecular Biology of the Cell, (2008, volume 19, pp. 5309-5326) with 
permission from The American Society for Cell Biology 
3.1 ABSTRACT 
The independently-folded appendages of the large α and β2 subunits of the endocytic 
AP-2 adaptor coordinate proper assembly and operation of endocytic components during 
clathrin-mediated endocytosis. In addition to binding a variety of adaptors and accessory factors, 
the β2 subunit binds clathrin and is central to the polymerization of clathrin into a lattice. 
Though it is clear that clathrin polymerization causes displacement of some β2 appendage 
binding partners, there has been some dispute as to the precise location of clathrin binding. One 
proposal is that clathrin binding to the C-terminal β2 appendage platform subdomain displaces 
adaptors that are retained within assembling vesicles through association with clathrin. β-
arrestins are adaptors that recognize G protein-coupled receptors (GPCRs) and target them to 
clathrin-coated pits through association with the AP-2 β2 appendage platform and clathrin. A β-
arrestin 1 mutant, which engages coated structures in the absence of any GPCR stimulation, is 
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shown to colocalize with β2-YFP and clathrin even in the absence of an operational clathrin-
binding sequence. These findings argue against β-arrestin binding to a site upon the β2 
appendage platform that is later obstructed by polymerized clathrin. Also, the Type Iγ 
phosphatidylinositol phosphate kinase (PIPKIγ) binds to the AP-2 β2 appendage sandwich 
subdomain and the focal adhesion protein talin and expressed PIPKIγ is only found to colocalize 
with talin in non-neuronal cells. This could indicate that the β2 appendage sandwich subdomains 
in assembled clathrin lattices are obstructed by clathrin. These results are in agreement with a 
model in which clathrin assembles by binding the AP-2 β2 appendage sandwich subdomain. 
3.2 INTRODUCTION 
Clathrin-mediated endocytosis is a process through which many nutrient and signaling receptors, 
ion channels, and even pathogens, are internalized from the cell surface and delivered to 
endosomes. The process requires the fine coordination of cargo selection, membrane 
invagination, and actin dynamics (Conner and Schmid, 2003; Robinson, 2004; Edeling et al., 
2006b; Kaksonen et al., 2006). At the plasma membrane, these diverse processes are managed, 
in part, by the AP-2 heterotetramer. The brick-like AP-2 core is composed of a small σ2 subunit, 
the cargo-selective µ2 subunit, along with the N-terminal trunks of two large chains, the α- and 
β2 subunits (Collins et al., 2002). Projecting off both α- and β2-subunit trunks, via flexible 
hinges, are bilobal appendages that contain binding sites for clathrin and numerous other 
endocytic proteins (Robinson, 2004; Edeling et al., 2006b; Schmid and McMahon, 2007).  
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The four assembled subunits permit AP-2 to coordinate various aspects of clathrin-coat 
formation. The plasma membrane-enriched lipid phosphatidylinositol 4,5-bisphosphate 
(PtdIns(4,5)P2) is engaged by both the α- and µ2 subunits (Gaidarov and Keen, 1999; Höning et 
al., 2005). YXXØ-type sorting signals (as found in the transferrin receptor) are bound directly by 
the µ2 subunit (Ohno et al., 1995) while [DE]XXXL[LIM] dileucine signals are recognized by a 
functional hemicomplex of the α and σ2 subunit (Janvier et al., 2003; Coleman et al., 2005; 
Chaudhuri et al., 2007). Various assembly protein and clathrin associations are established 
through the α- and β2 appendages (Wang et al., 1995; McPherson and Ritter, 2005; Traub, 2005; 
Edeling et al., 2006b; Schmid and McMahon, 2007). The αappendage has two interaction 
surfaces, one each upon the platform and sandwich subdomains. The platform site can bind to 
DP[WF] and FXDXF interaction motifs (Brett et al., 2002; Praefcke et al., 2004), while the 
sandwich site engages the WXX[FW]Xn[DE] motif (Mishra et al., 2004; Praefcke et al., 2004; 
Ritter et al., 2004; Walther et al., 2004). These short interaction sequences are typically 
positioned within tracts of intrinsically unstructured polypeptide, and proteins bearing the former 
class of motifs are typically involved in cargo selection and lattice polymerization. Proteins 
bearing the latter set generally include regulatory proteins such as AAK1, cyclin G-dependent 
kinase (GAK) and the phosphoinositide polyphosphatase synaptojanin 1 (Jha et al., 2004; 
Praefcke et al., 2004; Walther et al., 2004). Some of the regulatory proteins, like synaptojanin 1, 
also contain platform binding sites, potentially allowing them to compete previously bound 
clathrin-associated sorting proteins (CLASPs) off AP-2 (Mishra et al., 2004; Praefcke et al., 
2004). Thus, the α appendage regulates the temporal organization of the developing clathrin 
lattice through binding sites that permit the recruitment of first lattice assembly and cargo 
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selective factors, followed by regulatory proteins that control bud formation and likely promote 
release of proteins from AP-2 once their role in endocytosis is complete. 
Similar to the α appendage, the structurally related β2 appendage also contains two 
interaction surfaces, one analogous to the α appendage-platform site, and one positioned on the 
opposite side from the cognate a appendage-sandwich site (Edeling et al., 2006a; Schmid et al., 
2006). The contact sites on the β2 appendage do not appear to control accessory proteins in 
precisely the same manner as the hierarchical α appendage-binding sites. Biochemical studies 
suggest the β2 appendage-platform site is largely dedicated to CLASPs, such as the β-arrestins, 
which concentrate G protein-coupled receptors (GPCRs) (Kim and Benovic, 2002; Laporte et al., 
2002; Milano et al., 2002), the autosomal recessive hypercholesterolemia (ARH) protein, which 
decodes the FXNPXY-type sorting signal (He et al., 2002; Mishra et al., 2002b), and epsin 1, 
which recognizes poly/multiubiquitinated cargo (Barriere et al., 2006; Hawryluk et al., 2006). 
These discrete classes of cargo internalization signal do not bind directly to AP-2. The β2 
appendage-sandwich site, along with a type I clathrin box in the β2-hinge, allows AP-2 to 
polymerize clathrin and regulate eps15 positioning within the assembling lattice (Cupers et al., 
1998; Owen et al., 2000; Edeling et al., 2006a), though the β2 appendage-platform site has been 
suggested to be the clathrin binding site on this appendage (Owen et al., 2000; Schmid et al., 
2006). Thus, the β2-subunit contains functionally distinct binding sites that could simultaneously 
allow privileged access of certain CLASPs to the lattice along with clathrin recruitment. Overall, 
AP-2 acts as a master adaptor, binding to the plasma membrane, sorting YXXØ- and 
[DE]XXXL[LIM]-bearing cargo, and coordinating clathrin vesicle formation while 
simultaneously providing access for alternative types of cargo by scaffolding CLASPs. 
Accordingly, targeted gene disruption or mutation of AP-2 µ2- or α- subunit genes is 
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homozygous lethal in mice (Mitsunari et al., 2005), Drosophila (Gonzalez-Gaitan and Jackle, 
1997) and C. elegans (Shim and Lee, 2000).  
Structurally, β-arrestins contain an N-terminal bi-lobed arrestin fold that simultaneously 
binds phosphorylated GPCRs and PtdIns(4,5)P2, and an unstructured C-terminus containing a 
type I clathrin box and the β2 appendage-binding sequence (Krupnick et al., 1997a; Gaidarov et 
al., 1999; Laporte et al., 2000; Han et al., 2001). GPCR activation, phosphorylation, and β-
arrestin binding is intimately tied to receptor endocytosis because the β2 appendage binding 
sequence is bound back on the arrestin fold, stabilizing the inactive state, but is released by β-
arrestin recognition of phosphorylated GPCR cytosolic loops (Edeling et al., 2006a; Burtey et 
al., 2007). The consensus β2-binding sequence [DE]nX1-2FXX[FL]XXXR binds to the β2 
platform as well as the β-arrestin core through the anchoring Phe/Arg residues (Edeling et al., 
2006a), though an upstream Iso/Val (X1-2 position) stabilizes the core interaction and mutation to 
Ala releases the C-terminus and constitutively targets β-arrestin to preformed clathrin coats 
(Burtey et al., 2007). 
In this study I made use of the constitutively active IV→AA β-arrestin 1 mutant to 
examine the importance of clathrin binding to maintain β-arrestin within internalizing clathrin-
coated structures. I find that that IV→AA β-arrestin 1 is constitutively targeted to clathrin 
structures at the cell surface in the absence of GPCR stimulation and that its presence there is 
unaffected by mutation of the clathrin box motif. Furthermore, clathrin box mutants disappear 
from the cell surface concomitantly with AP-2. The wildtype and clathrin binding deficient 
IV→AA β-arrestin 1 also mediates downregulation of the angiotensin receptor and colocalizes 
with angiotensin ligand on endosomes. I also examined the subcellular localization of the AP-2 
β2 appendage sandwich subdomain-binding protein PIPKIγ (Chapter 2). Neither full length 
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PIPKIγ or a truncation mutant harboring the β2 appendage binding site colocalizes with AP-2 in 
vivo though full length PIPKIγ colocalizes with its other binding partner talin. These data support 
a model where clathrin assembles around the AP-2 β2 appendage sandwich subdomain, blocking 
this site but leaving the β2 platform subdomain open. 
3.3 RESULTS 
3.3.1 Clathrin binding surface on the β2 subunit appendage 
In addition to engaging ARH and β-arrestins, the β2-subunit appendage also binds physically to 
clathrin (Owen et al., 2000; Lundmark and Carlsson, 2002; Edeling et al., 2006a; Knuehl et al., 
2006; Schmid et al., 2006). Yet the precise molecular basis for this association is currently 
controversial. There is general agreement that by binding bivalently to the clathrin heavy chain, 
some β2-subunit partners could be controlled spatiotemporally as the extent of polymerized 
clathrin lattice increases (Edeling et al., 2006a; Knuehl et al., 2006; Schmid et al., 2006; Schmid 
and McMahon, 2007; Ungewickell and Hinrichsen, 2007). We recently mapped the clathrin 
binding surface to a site, including Tyr815, on the N-terminal sandwich subdomain (Edeling et 
al., 2006a), and our prior results indicate that clathrin binding to the β2-appendage sandwich can 
displace interaction partners like eps15 and AP180, which bind to the same site. Because clathrin 
trimers stoichiometrically outnumber AP-1/2 in preparations of biochemically purified clathrin-
coated vesicles (Blondeau et al., 2004; Girard et al., 2005), the excess of clathrin heavy chain 
terminal domains, which project into the interior of the assembled coat (Musacchio et al., 1999; 
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Edeling et al., 2006b), can bind avidly to AP-2 through the β2 subunit. Indeed, we (Edeling et 
al., 2006a) and others (Tebar et al., 1996) localize eps15 to only the periphery of clathrin-coated 
structures. Similar conclusions have been drawn for the mode of engagement of the monomeric  
GGA adaptor proteins and clathrin, where the C-terminal GAE domain of the GGAs only 
contains a sandwich subdomain (Knuehl et al., 2006). Since activation of GPCRs leads to the 
rapid translocation of an activated GPCR⋅β-arrestin complex to preexisting clathrin-coated 
structures at the cell surface (Laporte et al., 2000; Santini et al., 2002; Scott et al., 2002) and 
because ARH (He et al., 2002; Mishra et al., 2002b) and β-arrestins (Kim and Benovic, 2002; 
Laporte et al., 2002) specifically engage the platform subdomain of the β2 appendage, we 
proposed that the β2 platform interaction surface represents a relatively privileged binding site 
(Mishra et al., 2005; Brett and Traub, 2006; Edeling et al., 2006a). Challenging these findings 
and calling our conclusions “misleading”, McMahon and colleagues assert that it is the platform 
subdomain, and not the sandwich site, that is the location of the second point of contact between 
the clathrin heavy chain and the β2 (and β1) hinge + appendage (Schmid et al., 2006; Schmid 
and McMahon, 2007). In this model, clathrin interference dislodges CLASPs like β-arrestin and 
ARH from the β2 appendage but, because both these proteins also have an adjacent but separate 
clathrin binding sequence, the proteins would remain associated with assembling clathrin coats 
despite occupancy of the β2 platform with a distal leg segment of the heavy chain (Schmid et al., 
2006; Schmid and McMahon, 2007). This is a chief feature of the “changing hubs” model 
formulated to account for the vectorial nature of the clathrin coat assembly process (Schmid and 
McMahon, 2007). Clearly then, these opposing models have importantly different implications 
for the molecular basis of ARH- and β-arrestin-mediated cargo capture within forming clathrin 
coats.  
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Figure 3.1: Clathrin-binding deficient β-arrestin 1 associates with AP-2. 
HeLa SS6 cells stably expressing β2-YFP were transiently transfected with wild type (WT) tdRFP-β-
arrestin 1 (A), tdRFP-β-arrestin 1 with the IV→AA activating mutation (B), or tdRFP-β-arrestin 1 
(IV→AA) + clathrin box mutation LIEL→AAEA (C) or + clathrin box deletion ∆LIELD (D). 
Approximately 18 hours post-transfection cells were imaged by TIR-FM to selectively observe the ventral 
surface. Representative images show tdRFP-β-arrestin 1 (left column), β2-YFP (middle column), and 
merged (right column) signals. Note that despite a considerable cytosolic pool, there is near complete co-
localization of β2-YFP puncta with the tdRFP-β-arrestin 1 (IV→AA) alone or with either clathrin box 
disruption. Scale bar = 10 µm. 
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To attempt to distinguish between the two models, we utilized a mutant form of β-
arrestin 1. Wild-type β-arrestins remain diffusely cytosolic in the absence of GPCR stimulation 
(Laporte et al., 2000; Santini et al., 2002; Scott et al., 2002) (Figure 3.1A) by maintaining a 
basal, inactive conformation. Several closely spaced residues within the C-terminal [DE]nX1-
2FXX[FL]XXXR motif interact with the major folded N-terminal region of β-arrestin, rigidifying 
the protein and attenuating the CLASPs ability to engage the assembling clathrin machinery 
(Kim and Benovic, 2002; Gurevich and Gurevich, 2004; Edeling et al., 2006a; Burtey et al., 
2007). In β-arrestin 1, immediately preceding the proximal Phe388 of the β2 platform binding 
motif are Ile386 and Val387. Double substitution of these residues to Ala (IV→AA) results in 
constitutive association of β-arrestin 1 with clathrin-coated structures in the absence of any 
GPCR activation (Burtey et al., 2007). If β-arrestins only remain associated with surface coated 
structures by switching to clathrin when assembling clathrin binds the AP-2 β2 subunit 
appendage, then deletion or mutation of the β-arrestin 1 clathrin box sequence 376LIELD should 
prevent the IV→AA mutant from colocalizing extensively with clathrin-coated structures at the 
plasma membrane. 
Using TIR-FM to inspect the ventral surface of HeLa SS6 cells stably expressing β2-
YFP, we confirm that tdRFP-β-arrestin 1 is soluble while a portion of the IV→AA mutant 
concentrates at preexisting, β2-subunit positive clathrin-coated structures (Figure 3.1A and B) 
(Burtey et al., 2007). In the IV→AA background, the colocalization of neither a LIEL→AAEA 
substitution nor a ∆LIELD mutant with coated structures at the plasma membrane marked by β2-
YFP is obviously different from the protein containing an intact clathrin box (Figure 3.1C and 
D). While 0.6 ± 0.3% of AP-2 structures colocalize with tdRFP-β-arrestin 1, 99.1 ± 0.6% of AP- 
 90 
 
Figure 3.2: Clathrin-binding deficient β-arrestin 1 dynamically associates with AP-2. 
HeLa SS6 cells stably expressing β2-YFP were transiently transfected with tdRFP-β-arrestin 1 (IV→AA) 
(A-C) or tdRFP-β-arrestin 1 (IV→AA+∆LIELD) (D-F). Approximately 18 hours post-transfection cells 
were imaged by TIR-FM at one frame every five seconds. (A) Representative frames from the tdRFP-β-
arrestin 1 (IV→AA) expressing cells. β-arrestin 1 (left frame) and β2-YFP (middle frame) show extensive 
co-localization (right frame). (B) A sequence of frames at 25 second intervals shows the simultaneous 
disappearance of tdRFP-β-arrestin 1 (IV→AA) (middle row) and β2-YFP (bottom row) from the 
evanescent field. The spot is the same as that boxed in (A). (C) A line drawn along the axis of the box in 
(A) was used to create a kymograph. tdRFP-β-arrestin 1 IV→AA (left column) and β2-YFP (middle 
column) leave the evanescent field together (right column). (D) tdRFP-β-arrestin 1 (IV→AA+∆LIELD) 
expressing cells likewise show significant overlap with β2-YFP as in (A). (E) The boxed spot in (D) 
containing tdRFP-β-arrestin 1 (IV→AA+∆LIELD) (middle row) and β2-YFP (bottom row) disappears 
from the field (solid arrowhead) at 100 seconds as a second spot containing both proteins appears (open 
arrowhead). (F) A line drawn along the axis of the box in (D) was used to create a kymograph. tdRFP-β-
arrestin 1 (IV→AA+∆LIELD) (left column) and β2-YFP (middle column) disappear together while the 
appearance of arrestin in the second spot is slightly preceded by β2-YFP. All horizontal scale bars =10 
µm (A, D), while vertical time bars = 60 seconds (C, F). 
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2-positive spots contain tdRFP-β-arrestin (IV→AA). For the tdRFP-β-arrestin 
(IV→AA+LIEL→AAEA) and tdRFP-β-arrestin (IV→AA+∆LIELD) mutants, 95 ± 2% and 89 ± 
3% of AP-2 structures contain β-arrestin, respectively. 
There are several distinct classes of clathrin-coated structures on the ventral surface of 
HeLa SS6 cells (Keyel et al., 2004) and the IV→AA β-arrestin 1 mutants localize to all of these. 
Analysis of the dynamics of de novo-forming puncta reveals that, like the tdRFP-β-arrestin 1 
(IV→AA) (Figure 3.2A-C), the IV→AA∆LIELD mutant concentrates at, and then disappears 
with, β2-YFP-tagged AP-2 structures (Figure 3.2D-F). We do not observe earlier loss of the 
IV→AA∆LIELD tdRFP-β-arrestin 1 mutant from these patches that would indicate failure to 
switch to a strictly clathrin-dependent mode of association. Very similar results are obtained 
using BS-C-1 cells stably expressing GFP-tagged clathrin light chain (data not shown), a cell line 
that exhibits de novo coat formation almost exclusively (Ehrlich et al., 2004).  
It is important to note that in these experiments, the activation of the β-arrestin 1 
(IV→AA) mutant occurs in the absence of any GPCR ligand addition, but HeLa SS6 cells also 
do express endogenous β-arrestins. While there is currently some doubt that non-visual arrestins 
oligomerize at physiological concentrations (Hanson et al., 2008a), overexpressed β-arrestins 
can form multimers (Storez et al., 2005; Milano et al., 2006). Oligomerization requires inositol 
hexakisphosphate binding and pertains to the soluble form of β-arrestin, as the contact sites for 
dimer and tetramer assembly are located on the concave surface that engages an activated 
receptor (Milano et al., 2006; Hanson et al., 2008a; Hanson et al., 2008b). Solution oligomers 
therefore do not bind to GPCRs, and exposure of the C-terminal region, which couples β-
arrestins to the clathrin machinery, destabilizes oligomers (Hanson et al., 2008a). We thus 
believe it unlikely that hetero-oligomerization with endogenous β-arrestins accounts for the  
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Figure 3.3: Clathrin-binding deficient β-arrestin 1 associates with clathrin-coated structures in the 
absence of endogenous β-arrestins. 
Wild-type and β-arrestin 1/2 null mouse embryonic fibroblasts were lysed and resolved by SDS-PAGE 
(A, left) and transferred to nitrocellulose (A, right). Portions of the blots were probed with an anti-β-
arrestin polyclonal antibody, anti-clathrin HC mAb TD.1 and anti-β1/β2 subunit mAb 100/1, or anti-
tubulin mAb E7. Protein size markers noted in kDa. Alternatively, β-arrestin 1/2 null mouse embryonic 
fibroblasts were transiently transfected with tdRFP-β-arrestin 1 (red) wild type (B), the tdRFP-β-arrestin 
1 (IV→AA) activating mutation (C), IV→AA + clathrin box mutation LIEL→AAEA (D), or IV→AA + 
clathrin box deletion ∆LIELD (E). At 18 hours post-transfection cells were incubated with 25 µg/mL 
Tf488 (green) on 4°C on ice for one hour to label transferrin receptor in clathrin-coated structures, then 
rapidly imaged at 17°C by TIR-FM. Under these conditions, transferrin is found both at clathrin coated 
structures on the cell surface and already in peripheral endosomes. Magnified insets are denoted by white 
boxes; the IV→AA and IV→AA + clathrin box disruption β-arrestin mutants (middle inset) both co-
localize with Tf488 (top inset), as denoted by arrowheads. Scale bar = 10 µm. 
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Figure 3.4: Down-regulation of the type 1 angiotensin II receptor by both clathrin-binding deficient 
β-arrestins. 
HEK293 cells stably expressing FLAG-tagged type I angiotensin II receptor were transiently transfected 
with tdRFP-β-arrestin 1 (IV→AA) (A) or tdRFP-β-arrestin 1 (IV→AA+∆LIELD) (B). Cells were starved 
for one hour in starvation medium and then stimulated with 100 nM angiotensin II conjugated to 
Alexa488 (AngII, green) for 0, 5 or 20 minutes. Cells were washed, fixed, and examined by confocal 
microscopy. Representative images of medial focal planes are shown. Before stimulation, β-arrestin is 
largely diffuse in the cytosol but also present at the plasma membrane (arrows) or at a juxtanuclear 
location (asterisks). After five minutes of stimulation, β-arrestin clusters with angiotensin II at the plasma 
membrane (closed arrowheads), and on endosomes (open arrowheads). At 20 minutes after stimulation, 
nearly all β-arrestin and angiotensin II co-localize on larger endosomes. Scale bar = 10 µm. 
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association of the IV→AA + clathrin box mutants with surface clathrin-coated structures. 
Supporting this view is that transfection of the tdRFP-β-arrestin 1 (IV→AA) clathrin-binding 
mutants into β-arrestin 1/2 nullizygous fibroblasts (Kohout et al., 2001) still results in 
constitutive accumulation of the tagged β-arrestin at membrane puncta that are also positive for 
surface transferrin (Figure 3.3).  
Finally, like the β-arrestin 1 (IV→AA) mutant, the compound (IV→AA+∆LIELD) 
mutant translocates rapidly to the surface of angiotensin II-stimulated HEK cells stably 
expressing the type I angiotensin II receptor (Figure 3.4). At 5 min, both the β-arrestin mutants 
colocalize with fluorescent angiotensin II at cell-surface patches and peripheral endosomes 
while, after 20 min, both angiotensin II and β-arrestin 1 (IV→AA+∆LIELD) are found in larger, 
juxtanuclear endosomes, typical of a class B GPCR (Hamdan et al., 2007). These results show 
that deletion of the β-arrestin clathrin box does not have a major negative affect on GPCR 
downregulation and are fully consistent with a doubly-mutated IV→AA+LIEF→AAEA β-
arrestin 2 mutant clustering activated thyrotropin-releasing hormone receptors at AP-2-positive 
clathrin-coated structures and orchestrating endocytic uptake roughly equivalent to wild-type β-
arrestin 2 at 10 min (Burtey et al., 2007). We conclude that β-arrestin switching to a clathrin-
dependent mode of association is not an obligate step during the formation of clathrin-coated 
vesicles, and that the [DE]nX1-2FXX[FL]XXXR binding surface upon the platform subdomain of 
the β2 appendage does represent a privileged interaction site, as it can be rapidly accessed by β-
arrestin in the face of ongoing endocytic activity. 
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3.3.2 Accessibility of the β2 subunit appendage sandwich subdomain 
Having shown that binding partners of the AP-2 β2 appendage platform subdomain have 
privileged access to the growing bud and are not displaced by polymerized clathrin, we sought to 
show the opposite: that an AP-2 binding partner that solely binds the β2 appendage sandwich 
domain is displaced as clathrin polymerizes. PIPKIγ is the predominate PtdIns(4)P 5-kinase in 
the brain and generates PtdIns(4,5)P2 for compensatory CME at nerve terminals (Wenk et al., 
2001; Di Paolo et al., 2004). While its role in CME in non-neuronal cells is unknown, the 
PIPKIγ661 isoform binds to AP-2 through the β2 appendage sandwich subdomain (Chapter 2 
(Thieman et al., 2009)). Its residency at endocytic structures on the cell surface may then be 
regulated by clathrin. To examine this, HeLa SS6 cells were transfected with monomeric Cherry 
(mCherry) conjugated PIPKIγ661 and examined by immunofluorescence for AP-2 (Figure 3.5 
top). PIPKIγ661 is localized to the plasma membrane as seen by the strong ring of fluorescence 
at the cell edge from the out of focus side membranes. PIPKIγ661 is found in large and small 
puncta, however these puncta do not colocalize with AP-2 (Figure 3.5 top). However AP-2 and 
PIPKIγ661 puncta were often found adjacent to each other (arrowheads). In contrast, another 
PIPKIγ661 binding partner, the focal adhesion protein talin (Di Paolo et al., 2002; Ling et al., 
2002), colocalizes robustly at large and small PIPKIγ661 puncta (Figure 3.5 bottom, arrows). 
The vicinity of AP-2 structures to the PIPKIγ661 puncta could indicate that these kinase 
assemblies are excluded from assembling endocytic structures or that PtdIns(4,5)P2 generated at 
these talin-positive structures is diffusing and promoting clathrin assembly nearby. 
Observation of mCherry-PIPKIγ661 over time in β2-YFP HeLa SS6 cells failed to show 
enrichment of PIPKIγ661 at the early phases of AP-2 accumulation (data not shown). Similar  
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Figure 3.5: PIPKIγ661 localizes adjacent to AP-2 on the ventral surface of HeLa cells. 
HeLa SS6 cells were transiently transfected with mCherry-PIPKIγ661 (red) and processed for 
immunofluorescence at 18 hours post-transfection with monoclonal antibodies against AP-2 α subunit 
(top) or talin (bottom) (green). The ventral plasma membrane of cells was imaged by confocal 
microscopy. mCherry-PIPKIγ661 localizes to individual puncta and larger structures that are frequently 
adjacent to AP-2 (arrowheads). There is extensive colocalization of mCherry-PIPKIγ661 with talin 
(arrows). Scalebars = 10 µm. 
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results were obtained when using clathrin light chain-GFP expressing BS-C-1 cells (Ehrlich et 
al., 2004), or clathrin light chain-GFP expressing CHO cells (Yim et al., 2005), although BS-C-1 
and CHO cells did have PIPKIγ661 puncta that may correspond to talin-positive structures (data 
not shown). As an alternative approach, CCSs in BS-C-1 and CHO cells were depleted and 
reassembled by incubating cells in 1.5% 1-butanol for a few minutes to inhibit PtdOH production 
and as a result stimulation of PIPKI followed by washout to reassemble adaptors and clathrin. 
Staged depletion of PtdIns(4,5)P2 also failed to recruit PIPKIγ661 to nascent CCSs in these cells. 
The inability to detect PIPKIγ661 at AP-2 structures even transiently may indicate a greater 
concentration of binding-competent talin, whose binding sequence in PIPKIγ661 overlaps with 
the AP-2-binding sequence (de Pereda et al., 2005), or phosphorylation of Ser645, inhibitory for 
AP-2 binding (Nakano-Kobayashi et al., 2007), by endogenous kinases in these cell lines. 
A final possibility is that the PIPKIγ661⋅AP-2 interaction is of very low affinity. To 
circumvent this, a double and triple repeat of the AP-2 binding sequence from PIPKIγ661 
(residues 630-661) was expressed in frame with mCherry in HeLa cells (Figure 3.6). A single 
copy of the AP-2 binding tract ((630-661)x1, (Thieman et al., 2009)) failed to colocalize with 
AP-2 like the full length kinase, but also failed to accumulate in puncta that may have 
colocalized with talin (Figure 3.5 and 3.6). Expression of GFP-PIPKIγ(460-661) in primary 
hippocampal neurons did not result in targeting to synaptic boutons any more than a binding-
incompetent peptide, despite being able to inhibit FM4-64 uptake (Nakano-Kobayashi et al., 
2007). Interestingly, expression of the double ((630-661)x2) or triple ((630-661)x3) binding 
sequence also resulted in diffuse localization of the mCherry-peptide, but caused an increase in 
the size of AP-2 structures (Figure 3.7A) and a decrease in the density of AP-2 structures (Figure 
3.7B). The triple binding sequence with a critical Trp mutated ((630-661)x3 W642A) had an  
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Figure 3.6: Overexpression of the PIPKIγ661 C terminus disrupts the steady-state AP-2 structure 
morphology. 
HeLa SS6 cells were transiently transfected with a plasmid encoding mCherry alone (empty) or with 
PIPKIγ residues (630-661) as a single (x1), double (x2) or triple (x3) insertion in frame, or as a triple 
sequence containing the W642A substitution (x3 W642A) (competitor column). At approximately 18 
hours post-transfection cells were processed for immunofluorescence with a monoclonal antibody against 
AP-2 α subunit (middle column). The ventral plasma membrane of cells was imaged by confocal 
microscopy. Cells expressing (630-661)x2 or x3 display an apparent enlargement of AP-2 puncta. Scale 
bars = 10 µm. 
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Figure 3.7: Quantitation of AP-2 morphology changes from PIPKIγ661 C terminus overexpression. 
(A) AP-2 structures on the ventral surface of HeLa cells prepared as in Figure 3.6 were measured for their 
surface area. Based on the size distribution of the global population of structures three bins were created: 
0-0.065 µm2, 0.065-0.41 µm2, and 0.41-4 µm2. In each condition, the percentage of AP-2 structures 
falling into each bin from 30 cells was averaged. The (630-661)x2 and x3 expression vectors cause an 
increase in the percentage of AP-2 structures in the large group and decrease in the smallest group. (B) 
100 µm2 square regions encompassing the ventral membrane of cells imaged as in Figure 3.6 were used to 
measure the number of AP-2 structures and the number from 30 cells was averaged. *, p<0.05 relative to 
empty vector, #, p<0.05 relative to x3 W642A. Error bars represent standard error. 
 100 
intermediary phenotype with increased AP-2 sructure size but relatively normal AP-2 density. 
An explanation for these results may be that even when present in multiple copies, this AP-2 
interaction motif is of sufficiently low enough affinity that it has a high on-off rate. It could still 
interfere with clathrin binding to the β2 appendage sandwich site on AP-2 and in doing so cause 
an expansion of AP-2 on the plasma membrane from decreased clathrin-mediated budding. 
 
3.4 DISCUSSION 
ARH and the β-arrestins differ significantly from eps15 and several other CLASPs and accessory 
factors in that they both display only a single AP-2 binding determinant with an absolute 
selectivity for the platform subdomain of the β2 appendage (Laporte et al., 2000; He et al., 2002; 
Mishra et al., 2002b). Substantial data attest to the critical and selective importance of the β2 
appendage in the initial recruitment of GPCR⋅β-arrestin complexes to preexisting sites of clathrin 
assembly. The clathrin box is located within a flexible, unstructured C-terminal loop (Milano et 
al., 2002), even in the basal β-arrestin conformation. Yet β-arrestins are cytosolic in the absence 
of GPCR activation (Hamdan et al., 2007) so, although the clathrin box is potentially accessible 
to the clathrin terminal domain, if the distal [DE]nX1-2FXX[FL]XXXR sequence is 
conformationally restrained, β-arrestins fail to associate appreciably with clathrin-coated 
structures. Similarly, when fused to GFP, the C-terminal region of β-arrestin 2 populates AP-2-
positive clathrin structures at the cell surface but this colocalization is completely lost if the 
[DE]nX1-2FXX[FL]XXXR sequence is disrupted, even with an intact adjacent clathrin box 
 101 
(Schmid et al., 2006). Also, the β-arrestin 1 IVF→AAA triple mutant is not colocalized with 
AP-2 at steady state, despite the conformation relaxation affected by the IV to AA substitution 
(Burtey et al., 2007). Mutagenic inactivation of the AP-2 binding sequence in β-arrestin 2 still 
allows translocation of this CLASP to agonist-stimulated GPCRs on the cell surface, but 
clustering at AP-2-positive puncta is lost, again despite an intact clathrin box (Laporte et al., 
2000). Indeed, bioluminescence resonance energy transfer studies show that β-arrestin binding to 
liganded GPCRs temporally precedes an AP-2 β2 appendage interaction (Hamdan et al., 2007), 
and that mutation of the interaction surface on the β2 platform subdomain prevents energy 
transfer to AP-2 (Hamdan et al., 2007). By contrast, even with an inactivating mutation or 
complete deletion of the clathrin box, β-arrestin 1 still targets to clathrin-coated structures 
(Figures 3.1 – 3.4). Altogether, this argues strongly that the [DE]nX1-2FXX[FL]XXXR sequence 
is the principal determinant governing initial linkage of GPCRs with the endocytic machinery 
(Laporte et al., 2000).  
The binding affinity of ARH (and β-arrestin) for the β2-appendage is greater than its 
affinity for any other binding partner. ARH binds to the β2-appendage with a KD of ~1 µM 
(Mishra et al., 2005), compared with 22 µM for a type I clathrin box LLDLD binding to clathrin 
(Miele et al., 2004), 10-100 µM for the Shc PTB domain binding to PtdIns(4,5)P2 (Zhou et al., 
1995) and 2-5 µM for various PTB domains binding to FXNPXY peptides (Li et al., 1998; 
Howell et al., 1999; Stolt et al., 2003; Stolt et al., 2005). In a sequential hub model for clathrin-
coated vesicle assembly, it is proposed that AP-2-dependent interactions are diminished as 
clathrin buds progress toward late-stage events (Schmid et al., 2006; Schmid and McMahon, 
2007). In fact, it is conjectured that ARH and β-arrestins only remain associated with deeply 
invaginated buds by interacting directly with clathrin heavy chains (Schmid et al., 2006). Given 
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the tenfold difference in binding affinity for the β2 appendage and the clathrin terminal domain, 
which is also subject to direct competition by numerous other CLASPs and accessory proteins 
that have tandemly repeated clathrin boxes and are massed at the bud site (Robinson, 2004; 
Sorkin, 2004; Maldonado-Baez and Wendland, 2006), the biological advantage of moving to an 
apparently lower affinity association (at the clathrin hub) is not obvious.  
The changing hub model was formulated, in part, to account for the inherent 
directionality of the clathrin-coat assembly process (Schmid et al., 2006; Schmid and McMahon, 
2007). Although our view is that CLASPs like ARH and β-arrestin, which associate physically 
with AP-2 through the β2 appendage, do not necessarily switch to a clathrin-dependent 
interaction mode in a temporally-defined manner, our observations certainly do not generally 
invalidate the model, which invokes changing degrees of freedom as a function of ongoing 
lattice assembly events. Nor do our findings indicate that the clathrin box in β-arrestin is 
functionally insignificant (Krupnick et al., 1997b; Laporte et al., 2000; Kim and Benovic, 2002; 
Santini et al., 2002; Garuti et al., 2005). Rather, our data agree with several independent 
investigations showing the β-arrestin⋅AP-2 interaction typically initiates clustering of GPCRs 
into clathrin-coated structures and simply preclude ARH and β-arrestins from the set of potential 
endocytic factors subject to displacement by assembling clathrin triskelia. Intriguingly, because 
of the clear functional redundancy between the adaptor β1 and β2 subunits, and because only a 
single pool of cytosolic clathrin is used to construct all clathrin-coats within the cell, utilization 
of neither the [DE]nX1-2FXX[FL]XXXR motif nor the clathrin box will ensure translocation of 
β-arrestin or ARH to only those AP-2 and clathrin-containing structures positioned at the cell 
surface. However, both the β-arrestins (Gaidarov et al., 1999; Milano et al., 2002) and ARH 
(Mishra et al., 2002b) bind to PtdIns(4,5)P2, a lipid concentrated in the inner leaflet of the plasma 
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membrane. The phenomenon of coincidence detection, involving simultaneous contacts with 
transmembrane cargo receptors, lipids, AP-2 and then clathrin, likely provides the necessary 
selectivity. The striking translocation of the cytosolic pool of β-arrestin 1 upon angiotensin II 
application (Figure 3.4) is a graphic demonstration of this avidity-based phenomenon. 
PIPKIγ661 specifically binds to the AP-2 β2 appendage sandwich subdomain (Chapter 2 
(Thieman et al., 2009)) along with other CLASPs eps15 and AP180 and clathrin itself (Edeling 
et al., 2006a). Ultrastructural localization of eps15 within clathrin lattices shows it is selectively 
found at the edge where clathrin is absent or not fully polymerized (Tebar et al., 1996; Edeling et 
al., 2006a). Therefore clathrin may regulate positioning of sandwich binding partners during 
assembly. Consistent with this, PIPKIγ661 does not colocalize with AP-2 by confocal 
microscopy. PIPKIγ661 instead colocalizes with another one of its binding partners talin (Figure 
3.5). Talin localizes to focal contacts and activates integrins for inside-out signaling to promote 
focal adhesion formation (Moser et al., 2009). Talin also recruits PIPKIγ661 to generate 
PtdIns(4,5)P2 in a positive feedback loop that promotes recruitment of other focal adhesion 
proteins including talin (Di Paolo et al., 2002; Ling et al., 2002). This exclusive colocalization of 
PIPKIγ661 within talin could indicate a higher affinity for the talin binding site. Indeed, the 
dissociation constant for the PIPKIγ661⋅talin interaction is ~270 nM (de Pereda et al., 2005) 
compared with 22 µM for PIPKIγ661⋅AP-2 β2 (Kahlfeldt et al., 2010). Alternatively, few 
unoccupied β2 appendages may make detection of PIPKIγ661 at the edge of clathrin lattices 
difficult to detect. However immunofluorescence for eps15 in HeLa cells clearly shows its 
colocalization with AP-2 (data not shown, see Chapter 4). Still, AP-2 structures were frequently 
found adjacent to PIPKIγ661 puncta suggesting some connection (Figure 3.5). Furthermore, 
although the isolated β2 interaction peptide of PIPKIγ661 did not colocalize with AP-2 or talin, 
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it undoubtedly caused morphological changes to endocytic structures when present in multiple 
copies (Figure 3.6). Therefore, the inability to detect fluorescent proteins at clathrin lattices may 
not indicate their complete absence at these sites in our microscopy setup. These enlarged AP-2 
structures may accumulate from reduced endocytic ability as a result of interference of clathrin 
binding to the β2 sandwich site. Overall, the β2-appendage of AP-2 represents one hub within an 
intricate web of protein–protein interactions that promotes selective cargo endocytosis by 
facilitating initial CLASP recruitment.  
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4.0  THE ENDOCYTIC EFC-DOMAIN PROTEINS FCHO1 AND FCHO2 ARE NON-
ESSENTIAL MODULATORS OF CLATHRIN ASSEMBLY 
4.1 ABSTRACT 
The precise mechanistic basis for clathrin coat initiation at discrete sites on the plasma 
membrane is uncertain although phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) plays a 
key role. We find the PtdIns(4,5)P2-binding FCHO1/2 proteins appear as pioneer components at 
clathrin bud sites, often preceding clathrin deposition. Although HeLa cells produce mRNA 
transcripts encoding FCHO1 and FCHO2, only FCHO2 is detectable in endocytic clathrin-coated 
structures at steady state. RNAi-mediated depletion of FCHO2 in HeLa cells reduces, but does 
not eliminate, the number of clathrin-coated structures at the cell surface and slows, but does not 
prevent, cargo internalization. The remaining clathrin-coated structures appear aggregated or 
expanded. Simultaneous silencing of both FCHO1 and FCHO2 with siRNAs results in an 
analogous phenotype. This extent of large clathrin plaque expansion and/or clustering is 
infrequent in the control or mock-RNAi-silenced HeLa cells but prominent in MCF-7 cells. 
Expressed FCHO2 can reduce the size of endocytic structures in both cell lines. The regular size 
and distribution of surface AP-2- and clathrin-positive puncta is reconstituted in FCHO2-
depleted HeLa cells by synchronous expression of either FCHO1 or FCHO2. Together, our data 
indicate that FCHO1/2 are early coat components with somewhat overlapping functions that play 
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a significant, albeit non-essential, role in clathrin coat operation. There appears to be several 
parallel routes to sustain functional clathrin-mediated endocytosis. 
4.2 INTRODUCTION 
Intracellular compartmentalization is a defining feature of all eukaryotic cells. The evolution of 
different internal compartments allowed specialization of biosynthetic and catabolic reactions 
within compositionally distinct, physically discrete subcellular organelles. Yet most membrane-
bounded compartments depend on continual contact with other intracellular compartments to 
ensure proper long-term functioning. Exchange between different organelles typically relies on 
small, short-lived, tubulovesicular transport carriers, which generally cluster appropriate 
transmembrane protein cargo molecules and regulatory fusion factors into incipient buds while 
concurrently preventing efficient conveyance of inappropriate membrane components from the 
donor compartment (Bonifacino and Glick, 2004). A necessary intermediate in the budding 
process involves the deformation of an often planar or spherical donor membrane into a 
perpendicularly oriented cylindrical projection (Zimmerberg and Kozlov, 2005). Due to the 
universal importance of this membrane restructuring process, several structurally distinct 
families of soluble proteins can translocate to a bud site to couple membrane bending with 
vesicular transport. For example, along the endocytic pathway, the BAR 
(Bin1/amphiphysin/Rvs) domain proteins amphiphysin, endophilin (Ringstad et al., 1999) and 
sorting nexin 9 (Soulet et al., 2005; Taylor et al., 2011) participate in clathrin-mediated 
endocytosis. The BAR-PH (pleckstrin homology) domain protein APPL1 (Li et al., 2007; Zhu et 
al., 2007) is positioned on very early peripheral endosomes (Erdmann et al., 2007; Schenck et 
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al., 2008; Zoncu et al., 2009; Taylor et al., 2011), while other sorting nexins with a PX (ph
One class of membrane-binding, crescent-shaped endocytic proteins are the EFC 
(extended 
ox)-
BAR domain organization are found on maturing sorting endosomes (Cullen, 2008). Two 
common features of many of these membrane-associated proteins is the presence of a rigid 
crescent-shaped surface that closely apposes the bilayer and a propensity to oligomerize into 
rings or spirals. These properties seem to promote the physical forces necessary to constrain the 
bilayer for local bud restructuring (Zimmerberg and Kozlov, 2005; Frost et al., 2009). 
FCH (Fes/CIP4 homology)) domain proteins (Suetsugu et al., 2010), which have 
alternatively been dubbed F-BAR proteins because of the overall structural similarity of the 
helical bundle EFC and BAR domain fold (Frost et al., 2009). In all known EFC proteins, the 
EFC domain is positioned near the N terminus forming antiparallel α-helical homodimers but six 
discrete subfamilies are classified depending upon the presence of other modular domains within 
the polypeptide chain (Heath and Insall, 2008; Suetsugu et al., 2010). The EFC domain proteins 
FCHO1 and FCHO2 (FCH only protein 1 and 2) (Katoh, 2004; Henne et al., 2007) are 
characterized by a C-terminal µ homology domain (µHD), distantly related in primary sequence 
but with an analogous fold to the cargo-selective µ2 subunit of the heterotetrameric AP-2 
clathrin adaptor (Reider et al., 2009). This combination of an EFC domain with a µHD is unique 
and phylogenetically conserved. Since all other known proteins or protein complexes that 
contain a µHD (AP-1 to AP-4, COPI and stonin 1/2) handle cargo selection during the formation 
of transport vesicles (Ohno et al., 1995; Owen and Evans, 1998; McMahon and Mills, 2004; 
Maritzen et al., 2010), FCHO1/2 are candidate sorting adaptors. Indeed, the Saccharomyces 
cerevisiae orthologue, Syp1p, acts as a sorting adaptor for the transmembrane protein Mid2p at 
cortical actin patches (Reider et al., 2009; Stimpson et al., 2009), which correspond to clathrin-
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dependent sorting stations at the cell surface. Here, we characterize the mammalian FCHO1 and 
FCHO2 proteins as integral endocytic components.  
4.3 RESULTS 
4.3.1 FCHO1 and FCHO2 are endocytic components 
Human FCHO1 (KIAA0290; located on chromosome 19) and FCHO2 (on chromosome 5) 
display ~50% overall amino acid identity and a similar domain organization (Figure 4.1A) 
(Katoh, 2004). These paralogous proteins have orthologues in chordates, arthropods and 
nematodes (Katoh, 2004), as well as in unicellular eukaryotes (Reider et al., 2009; Stimpson et 
al., 2009). In the budding yeast Saccharomyces cerevisiae, Syp1p has an analogous architecture 
to FCHO1/2 despite limited (<20%) overall primary sequence identity (Figure 4.1A). 
Phylogenetic dendrograms  (TreeFam TF328986) (Ruan et al., 2008) show that SGIP1 is more 
closely related to FCHO2 than to FCHO1, but this protein, while containing a modular C-
terminal µHD, lacks the folded N-terminal helical EFC domain (Figure 4.1A) (Uezu et al., 
2007). RT-PCR analysis with gene-specific primers reveals that both FCHO1 and FCHO2 
transcripts can be detected in HeLa cells, although the specific FCHO1 amplicon is weak (Figure 
4.1B). The presence of the appropriate FCHO1 PCR product is consistent with full-length cDNA 
clones (CR597235, CR620485 and CR625849) isolated from HeLa cells, and also with the 
identification of FCHO1- and FCHO2-derived peptides in proteomic analysis of HeLa cell 
extracts (www.humanproteinpedia.org) (Beausoleil et al., 2006). Similar PCR products are found 
in the neuroblastoma-derived SH-SY5Y cell line (Biedler et al., 1978), along with an appropriate  
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Figure 4.1: FCHO1 and FCHO2 are endocytic proteins. 
(A) The muniscin family of Homo sapiens FCHO1, FCHO2 and SGIP1 and Saccharomyces cerevisiae 
Syp1p are shown schematically. The EFC domain is displayed in blue and µ homology domain in orange. 
Approximate domain boundary residue numbers are shown. (B) RT-PCR reactions with primers specific 
for a variety of endocytic proteins resolved on agarose gels from HeLa cell (top) and SH-SY5Y cell 
(bottom) lysates. The DNA ladder sizes are indicated at the left. Representative single confocal sections 
of the ventral membrane of HeLa SS6 cells transfected with GFP-FCHO1 (C,E), tdRFP-FCHO2 (E) or 
immunolabeled for endogenous FCHO2 (D) and AP-2α (C-E) are shown. (F) A representative medial 
confocal section of GFP-FCHO1 transfected HeLa SS6 cells immunolabeled for LC3. The vertical order 
of all insets is the same as the labels. Scalebar, 10µm. 
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PCR amplicon indicating the presence of the SGIP1 message (Figure 4.1B). Although SGIP1 is 
reported to be neuron specific (Trevaskis et al., 2005; Uezu et al., 2007), ESTs derived from 
some non-neuronal tissues are available, the SGIP1 message is evident in SWISS 3T3 cells 
(Stimpson et al., 2009), and a tryptic peptide from SGIP1 expressed in HeLa cells is reported in 
the Human Proteinpedia database.  
At steady state, both transfected FCHO1 (Reider et al., 2009; Taylor et al., 2011) and 
SGIP1 (Uezu et al., 2007; Stimpson et al., 2009) colocalize extensively with clathrin-coated 
structures, unlike several other EFC domain proteins (CIP4/FBP17/PACSIN) implicated in 
endocytosis (Modregger et al., 2000; Kamioka et al., 2004; Taylor et al., 2011). Consistent with 
the PCR results, using three different polyclonal antibodies that do recognize transfected 
FCHO1, we cannot detect endogenous FCHO1 in HeLa cells by either immunoblot or 
immunofluorescence microscopy (data not shown). However, at low relative levels of 
expression, ectopic GFP-FCHO1 is found scattered over the ventral surface in both diffraction-
limited spots and in larger, long-lived patches positive for the clathrin adaptor AP-2 (Figure 
4.1C,E). By contrast, both endogenous (Figure 4.1D) and expressed FCHO2 (Figure 4.1E) 
colocalize very well with AP-2. Co-expressed GFP-FCHO1 and tdRFP-FCHO2 populate 
common AP-2-positive puncta at the cell surface (Figure 4.1E). In confocal X-Z projections, 
transfected FCHO1 or FCHO2 is present at AP-2-positive spots on both the upper and lower 
membrane surfaces, although enrichment at the ventral side is more marked (Figure 4.2A). At 
moderate levels of expression, FCHO1 saturates discrete AP-2-positive structures with the 
exception of those at the periphery and the excess FCHO1 uniformly labels the plasma 
membrane (Figure 4.1C; middle cell), likely due to the lipid binding properties of the EFC 
domain (Henne et al., 2007). At the highest levels of overexpression FCHO1 accumulates in 
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Figure 4.2: FCHO1 and FCHO2 are endocytic proteins, continued. 
(A) X-Z projections of HeLa SS6 cells expressing GFP-FCHO1 or GFP-FCHO2 and immunolabeled for 
AP-2α showing FCHO distribution at the ventral (lower) and dorsal (upper) cell membranes. (B) Deep-
etch electron microscopy of the ventral membrane of HeLa SS6 cells with 15-nm immunogold labeling 
(pseudocolored yellow) for FCHO2. The arrow indicates a region of clathrin lattice discontinuitiy while 
the arrowheads label deeply invaginated buds. Scalebars, 10µm for (A), 100nm for (B). 
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 larger cytoplasmic puncta, which are not LC3 positive (Figure 4.1F), indicating these are not 
autophagosome-encapsulated protein aggregates. Some of the core clathrin coat components are 
not colocalized with these ectopic structures (data not shown). While heavily overexpressed 
GFP-FCHO1 accumulates at large intracellular foci (Figure 4.1F) (Nakajima et al., 2005), we do 
not observe specific juxtanuclear localization of the protein at the trans-Golgi network (Sakaushi 
et al., 2007). FCHO1 aggregation appears to be mediated by the µHD with possible contribution 
from the central unstructured segment as truncation mutants lacking these regions do not form 
intracellular puncta (data not shown). And unlike GFP-SGIP1-transfected COS-7 cells (Uezu et 
al., 2007), intracellular tubules emanating from either large or small GFP-FCHO1-labelled 
membrane structures are rarely observed in fixed HeLa cells (Sakaushi et al., 2007). Even at high 
relative levels of expression, FCHO2 does not display a similar tendency to form larger 
aggregates revealing distinct protein biochemistry between FCHO1 and FCHO2. 
Endogenous HeLa cell FCHO2 is selectively detected at assembled regions of planar 
clathrin lattice and rounded de novo forming coated buds by immunogold labeling and deep-etch 
electron microscopy (Figure 4.2B). FCHO2 labeling is discernable principally around the 
perimeter of these structures on the ventral plasma membrane and only rarely in the center. This 
spatial dichotomy is not an artifact of poor antibody penetration into the assembled lattice as 
other coat constituents can be detected throughout the coat by this method (Edeling et al., 2006a; 
Keyel et al., 2006). In some larger clathrin assemblies, FCHO2 appears to be positioned at 
geometric discontinuities within the polymeric coat (arrow). The anti-FCHO2 antibodies do not 
decorate the domed portion of deeply contoured pits (arrowheads). 
Like other established clathrin coat constituents, clustered GFP-FCHO1 in low-
expressing cells exchanges rapidly (t1/2 = 12.8 ± 0.9 sec, average ± standard error, n = 33) with  
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Figure 4.3: Dynamic exchange of FCHO1 and FCHO2 at CCSs. 
HeLa SS6 cells transfected with GFP-FCHO1 (A) or GFP-FCHO2 (B) were imaged continuously at 
2s/frame and were bleached with a 405nm laser for 2s at time 0 while simultaneously imaging with a 
488nm laser (C). (D) The fluorescence intensity of individual FCHO1/2 spots present throughout the 
experiment were measured and plotted relative to the pre-bleach intensity. Curve-fitting was used to 
determine the time of half-maximal recovery, t1/2 (E), and percent of maximal recovery (F). Asterisk 
indicates p<0.05. Error bars represent standard error. Suc, cells cultured in 0.45M sucrose. Scalebar, 10 
µm. 
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the soluble population in FRAP experiments (Figure 4.3A,C). Interestingly, while GFP-FCHO2 
exchanges similarly, it has a significantly faster recovery rate (t1/2 = 8.1 ± 0.9 sec, n = 33, 
p<0.05) and greater maximal recovery (88 ± 2% versus 82 ± 2%, p<0.05) (Figure 4.3D-F), 
suggesting that FCHO2 undergoes more rapid exchange with the reserve cytosolic pool and has a 
larger mobile fraction than FCHO1. In parallel control experiments with 0.45 M extracellular 
sucrose, which halts clathrin coat protomer exchange activity (Wu et al., 2003; Hoffmann et al., 
2010), both FCHO1 and FCHO2 are essentially static. These findings reiterate that FCHO1 and 
FCHO2 are dynamically interchanging constituents of surface clathrin-coated structures.  
4.3.2 Chronology of FCHO1/2 association with endocytic structures 
BS-C-1 cells (Hopps et al., 1963) differ from HeLa and most other cultured cells in the 
conspicuous uniformity of clathrin-coated structures at the cell surface (Ehrlich et al., 2004; 
Loerke et al., 2009; Saffarian et al., 2009). Still, transfected tdRFP-FCHO1 targets to clathrin-
coated structures in BS-C-1 cells (Figure 4.4A), restating that this endocytic protein is not a 
selective constituent of long-lived clathrin structures as opposed to the de novo-forming buds 
typical of BS-C-1 cells (Saffarian et al., 2009).  
To better understand the role of FCHO1 and FCHO2 in clathrin-coated vesicle formation, 
the temporal properties of individual clathrin-coated structures in FCHO1-expressing cells were 
examined by total internal reflection fluorescence microscopy (TIR-FM). In BS-C-1 cells stably 
expressing clathrin light chain-GFP, tdRFP-FCHO1 is present in nearly all clathrin-positive 
surface structures (94%, Figure 4.4A). FCHO1 (Figure 4.4B, D) or FCHO2 (not shown) is often 
found preclustered at discrete regions of the plasma membrane prior to clathrin recruitment to 
these nascent, diffraction-limited bud sites, consistent with previous results (Henne et al., 2010).  
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Figure 4.4: FCHO proteins are early components of de novo forming CCVs. 
BS-C-1 cells stably expressing GFP-clathrin light chain were transfected with tdRFP-FCHO1 (A-C), or 
tdRFP-eps15 (E) and imaged by TIR-FM. (A) A transfected cell shows extensive colocalization of 
FCHO1 and clathrin at steady state. (B) The temporal appearance of FCHO1 relative to clathrin at an 
individual spot is shown. (C) Multiple recruitment profiles for FCHO1 are observed over time as 
represented by the Y (y-axis)-T (x-axis) kymograph. These spots appeared during image acquisition in the 
circular regions indicated in (A). ‘F’ indicates only FCHO1 is present, ‘B’ indicates both FCHO1 and 
clathrin are present and ‘C’ indicates only clathrin is present. (D) The order of appearance/disappearance 
of FCHO1 and clathrin were manually scored for 120 spots. The percentage of observances for particular 
profiles using the same nomenclature as in (C) are indicated by numbers on the pie chart. (E) The 
recruitment of the FCHO1/2 binding partner tdRFP-eps15 to a single clathrin-coated structure is shown. 
This was the most typical recruitment profile similar to (B) for FCHO1. Numbers below image sequences 
indicate seconds. Scalebar in A, 10µm. Timebar in C, 1 minute. 
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Analogous time-resolved TIR-FM imaging of BS-C-1 cells expressing tdRFP-eps15, a physical 
binding partner of FCHO1 and FCHO2 (Reider et al., 2009; Henne et al., 2010), shows that 
eps15 is also a pioneer component at emergent bud sites, similarly preceding the arrival of 
clathrin (Figure 4.4E). This is clearly analogous to the temporal behavior of Syp1p and Ede1p 
(the yeast eps15 orthologue) at endocytic cortical actin patches (Boettner et al., 2009; Stimpson 
et al., 2009). Analyzing global translocation of FCHO1 to assembling structures we find a 
majority (40.8%, Figure 4.4D) exhibit recruitment profiles in which FCHO1 appears prior to 
clathrin, both proteins then colocalize at the assemblage for some time, and then FCHO1 exits 
prior to clathrin disappearing from the evanescent field (Figure 4.4B). While various temporal 
behaviors are observed in BS-C-1 cells, 76.3% of examined structures display early recruitment 
of FCHO1 and 54.9% show FCHO1 loss prior to clathrin disappearance (Figure 4.3D) (Henne et 
al., 2010; Taylor et al., 2011). At individual buds, FCHO1 can appear 24 ± 3 seconds (average ± 
standard error, n = 86) before clathrin and disappear 22 ± 4 seconds (n = 66) prior to clathrin in 
structures with this behavior. Transfected tdRFP-FCHO2 does not display as noticeable an early 
arrival profile, perhaps reflecting the faster exchange dynamics. 
To verify that the FCHO1-containing clathrin-coated structures are indeed functional, 
tdRFP-FCHO1 transiently transfected BS-C-1 clathrin light chain-GFP cells were pulsed with 
fluorescent transferrin while illuminating with TIR-FM (Figure 4.5A). Initially, transferrin is 
dispersed over the cell surface but quickly binds to clustered transferrin receptors by ~20 
seconds. In these image sequences, tdRFP-FCHO1 molecules are already massed at incipient 
import sites at 10 seconds, while clathrin begins to accumulate around 30 seconds, 
approximately the same time the transferrin concentrates at the site. The transferrin-positive  
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Figure 4.5: FCHO1-containing CCSs are functional and CCVs contain detectable levels of FCHO1. 
(A) During acquisition of a BS-C-1 GFP-clathrin light chain cell expressing tdRFP-FCHO1, transferrin-
Alexa647 (Tf, blue) was added to the media at time point 0 and the progression of an individual clathrin 
spot is shown. (B) Rat brain fractions (~20 µg) were resolved by SDS-PAGE and stained with Coomassie 
(left) or transferred to nitrocellulose and probed with antibodies to clathrin and various adaptors (middle 
and right). Molecular weight marker standards in kiloDaltons are shown. Some FCHO1 degradation 
products in the cytosol fraction (lane b) are indicated by a yellow bracket. Numbers below image 
sequences indicate seconds.  
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clathrin-coated vesicle buds at about 130 seconds while FCHO1 dissipates ~10 seconds earlier. 
These kinetics of cargo sequestration and vesicle budding clearly indicate that the tdRFP-
FCHO1-labelled structures are functional for cargo endocytosis. Our data thus confirm that 
FCHO1 (and FCHO2) are early arriving pioneer molecules at regions of the plasma membrane 
destined to become clathrin-coated vesicles (Henne et al., 2010; Taylor et al., 2011). 
Because some tdRFP-FCHO1 puncta leave the evanescent field concurrently with 
punctate clathrin-containing structures (Figure 4.4C,D), we evaluated whether FCHO1 is found 
in purified clathrin-coated vesicles. The Allen Brain Atlas (www. mouse.brain-map.org) shows 
extensive FCHO1 RNA message expression in mouse brain by in situ hybridization with an 
antisense riboprobe, and many FCHO1 EST sequences have been obtained from human, mouse 
and rat brain tissue. In rat brain homogenate, an endogenous ~100-kDa FCHO1 band is 
identified on immunoblots with two affinity-purified anti-FCHO1 antibodies (Figure 4.5B). Less 
of the intact form is found in a high-speed cytosolic fraction, but the protein is present in purified 
clathrin-coated vesicles (Figure 4.4B), albeit not strongly enriched as other endocytic 
components, like AP180 and Huntington Interacting Protein 1 (HIP1) (Mishra et al., 2001; 
Blondeau et al., 2004; Thieman et al., 2009), along with AP-2 and clathrin. A striking feature of 
these immunoblots is the extent of degradation of endogenous FCHO1 in brain cytosolic 
extracts. Considerable proteolysis is also apparent for full-length FCHO1 transiently expressed in 
HeLa cells (Figure 4.17); the protein may be subject to rapid proteolytic turnover. FCHO2 is 
expressed at very low levels in brain and is not found in coated vesicles comparably with 
FCHO1 (not shown). This agrees with recent findings (Henne et al., 2010) and, along with the 
differential aggregation of FCHO1 upon forced expression (Figure 4.1F), suggests some 
separable properties for these apparently redundant paralogues. 
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4.3.3 FCHO1/2 regulate endocytic structure morphology on the ventral cell surface 
Compatible with the low abundance of the FCHO1 transcript and inability to detect endogenous 
protein, transfecting a pool of FCHO1-targetting siRNA oligonucleotides into HeLa cells has no 
overt effect on AP-2 distribution (Figure 4.7B), discrepant with recent RNAi results in BS-C-1 
cells (Henne et al., 2010). That the siRNA duplexes indeed silence the appropriate mRNA is 
plainly seen by the dramatic loss of GFP-FCHO1 expression (Figure 4.6A-B). RNAi-mediated 
suppression of FCHO2 does, by contrast, have a significant effect on coat morphology (Figure 
4.7C,E,G). Both ectopic GFP-FCHO2 and endogenous FCHO2 are depleted upon RNAi and the 
efficiency of protein knockdown is high (Figure 4.6A,C). Similar results are obtained with two 
independent FCHO2 transcript-targeting siRNAs (Figure 4.7C,E). Despite the dramatic change 
in endocytic structures on the ventral cell surface, AP-2 positive structures on the dorsal cell 
surface are minimally affected by FCHO2 knockdown as seen by X-Z projections (Figure 4.7H). 
In silenced HeLa cells, an obvious change in the number and positioning of large abutting 
clathrin plaques occurs at the expense of the diffraction-limited population. In these cells, the 
average number of AP-2 structures per 100 µm2 drops from 62 ± 3 in mock cells to 34 ± 2 
(p<0.05) in FCHO2 knocked-down cells (Figure 4.7I). Coats on the ventral surface become 
heterogeneous, more clustered and irregular compared with the mock RNAi-treated cells. On 
average, the AP-2 patches in FCHO2 and FCHO1 + FCHO2 knockdown cells increase in size 
(Figure 4.7J). The average fluorescence intensity of AP-2 positive clathrin-coated structures >0.2 
µm2 increases by 9% when FCHO2 is extinguished (Figure 4.7C and data not shown). Together, 
this indicates that more AP-2 molecules are present at these structures. The incidence of  >0.6  
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Figure 4.6: RNAi silencing of FCHO1 and FCHO2. 
(A) HeLa SS6 cells were treated with two rounds of a mock, single siRNA (siRNAs) or siRNA pool 
(siRNAp) and cotransfected with GFP-FCHO1 or GFP-FCHO2 on the second round. Cell lysates were 
resolved by SDS-PAGE, transferred to nitrocellulose, and portions of the blot were probed with anti-GFP, 
anti-FCHO2, TD.1 anti-clathrin HC and 100/1 anti-AP-1/2 beta1/2, or anti-tubulin antibodies. 
Alternatively cells grown on coverslips were treated with siRNA by the same method except that they 
were cotransfected with tdRFP and GFP-FCHO1 (B) or GFP-FCHO2 (C) during the second round of 
RNAi. Cells were fixed and examined by confocal microscopy. Scale bar, 10 µm. 
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Figure 4.7: FCHO2 regulates CCS morphology. 
HeLa SS6 cells were mock-treated (A,F) or transfected with FCHO1 pool (B), FCHO2 single (C,G), or 
FCHO1+FCHO2 siRNA (D) or FCHO2 pool siRNA (E) and prepared for immunofluorescence with AP.6 
anti-AP2 α antibody (A-E) or X22 anti-clathrin heavy chain antibody (F-G). (H) X-Z projections of two 
mock or FCHO2 siRNA treated cells showing the distribution of AP-2 on dorsal and ventral membranes. 
(I) Quantitation of the concentration of AP-2 structures per 100 µm2 in cells treated as in (A-D). Asterisk, 
p<0.05 relative to mock, # p<0.05 relative to FCHO1 siRNA, n=30 cells per condition. (J) Average AP-2 
structure size in µm2 in cells treated as in (A-D). Mock (n=1862 spots), FCHO1 (n=1410 spots), FCHO2 
(n=1018 spots), FCHO1+2 (n=876 spots). (K) AP-2 structures in mock and FCHO2 siRNA-treated cells 
were binned into 3 groups: roughly diffraction-limited and small (<0.2 µm2), medium (0.2-0.6 µm2), and 
large (>0.6 µm2) and compared. The percentage of total AP-2 structures falling into each of the three 
groups (left) or percent of the total surface area of AP-2 labeling contributed by each bin (right) were 
compared for mock and FCHO2 siRNA-treated cells. Percentage numbers are given below the graph. 
Asterisk, p<0.05. Error bars represent standard error. Scalebars in A and H 10µm. Scalebar in A inset, 
2µm. 
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µm2 AP-2 patches increases sixfold (Figure 4.7K left) and, strikingly, these large structures now 
account for >30% of the assembled AP-2 at the bottom of FCHO2-silenced cells (Figure 4.7K, 
right). The smallest AP-2 structures, <0.2 µm2, contribute only half as much of the total area in 
FCHO2 knockdown cells, a decrease not fully accounted for by the drop in this population 
(Figure 4.7K, left), implying that these structures are smaller in size as well. Also, there is little 
difference between FCHO2 or FCHO1 + FCHO2 siRNA-treated cells, affirming a very small 
pool of functional FCHO1 protein in these cells. 
The expanses of AP-2 we observe on the ventral membrane of cells following FCHO1/2 
silencing may represent clustering of individual CCSs or dilation of individual clathrin lattices. 
To try to differentiate between the two we performed deep-etch electron microscopy of adherent 
HeLa cell ventral membranes. The electron micrographs clearly show that the extent of clathrin 
polymerization is greater in FCHO2 siRNA treated cells (Figure 4.8). The surface area of 
individual CCSs is greater in knockdown cells than in mock treated cells. What is more, FCHO2 
structure (Henne et al., 2007) and in vitro membrane tubulation assays (Henne et al., 2010) 
suggest that FCHO2 is involved in membrane bending at CCSs, yet we still detect shallow and 
highly curved clathrin coats. Also, small de novo forming clathrin structures are seen in both 
conditions. 
In reciprocal experiments, overexpression of GFP-FCHO1 or GFP-FCHO2 also causes 
changes in the morphology of endocytic structures on the ventral membrane of HeLa SS6 cells 
by light microscopy (Figure 4.9A-C). The average size of AP-2 structures is reduced from 0.197 
± 0.007 µm2 in GFP expressing cells to 0.114 ± 0.006 µm2 in GFP-FCHO1 expressing cells and 
0.103 ± 0.004 µm2 in GFP-FCHO2 expressing cells (n=45 cells) (Figure 4.9D). The 
concentration of AP-2 structures also increases from 63 ± 2 structures per 100 µm2 in GFP  
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Figure 4.8: FCHO2 silencing causes expansion of ventral CCSs. 
HeLa SS6 cells grown on coverglass where mock treated or treated with two rounds of FCHO2 siRNAs. 
Cells were unroofed by sonication, fixed and processed for deep-etch electron microscopy. CCSs are 
pseudocolored magenta to demonstrate distribution and size. Boxed areas are magnified on the right. Note 
the invaginating coats in FCHO2 siRNA-treated cells (arrowheads). Scale bars, 500 nm. 
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Figure 4.9: FCHO1 and FCHO2 overexpression alters the size and distribution of endocytic 
structures. 
HeLa SS6 cells were transfected with GFP (A), GFP-FCHO1 (B) or GFP-FCHO2 (C) (left panels) and 
prepared for immunofluorescence for AP-2 α (middle panels). A decrease in the size of AP-2 structures 
(D) and an increase in the concentration of AP-2 structures (E) is quantified and can be seen as a result of 
FCHO expression (inset). An apparent decrease in fluorescence intensity (F) is also seen. Error bars 
represent standard error. Asterisk, p<0.05. Scalebar, 10 µm. 
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Figure 4.10: FCHO1 and FCHO2 reduce the size of native large CCSs. 
MCF-7 cells were transfected with GFP-FCHO1 (A), GFP-FCHO2 (B), GFP-FCHO1(1-610) (C) or GFP-
FCHO1(1-275) (D) and prepared for immunofluorescence with antibodies against AP-2 α. GFP-FCHO1 
and GFP-FCHO2 colocalize with AP-2 and reduce the size of puncta relative to adjacent untransfected 
cells. GFP-FCHO1(1-610) causes a similar phenotype but does no colocalize with AP-2 while GFP-
FCHO1(1-275) neither changes AP-2 morphology or colocalizes with the structures. 
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 transfected control cells to 81 ± 3 or 77 ± 2 structures per µm2 in GFP-FCHO1 or FCHO2 
expressing cells respectively (Figure 4.9E). The average intensity of structures also falls in 
FCHO overexpressing cells (Figure 4.9F). 
A substantial variability in CCS morphology and dynamic behavior at the plasma 
membrane of various cultured cell lines exists: this includes the diffraction-limited (<200 nm 
diameter), de novo forming CCSs in BS-C-1 cells (Ehrlich et al., 2004; Loerke et al., 2009), and 
a combination of de novo forming and large (>500 nm), long-lived, non-terminal budding CCS 
in HeLa (Keyel et al., 2006; Saffarian et al., 2009) and NIH 3T3 cells (Taylor et al., 2011) 
among others. The breast carcinoma cell line MCF-7 (Soule et al., 1973) displays numerous, AP-
2-positive puncta, rings and lines on the ventral plasma membrane that are quite large (Figure 
4.10, untransfected cells) when cultured under our conditions. Consistent with the results in 
HeLa cells but much more marked, GFP-FCHO1 and GFP-FCHO2 expression in these cells 
resulted in AP-2 structures that were smaller and more uniform in size (Figure 4.10A,B). 
Overall, FCHO1/2 play an important role in determining the number and size of clathrin-coated 
structures. 
4.3.4 Clathrin-coated structures are dynamic and functional in the absence of FCHO2 
Assembled CCSs contain a range of adaptors and accessory factors in addition to AP-2 and 
clathrin (Traub, 2005) and being an early arriving protein, FCHO2 may influence the positioning 
of some of these components. Steady-state components of normal endocytic clathrin coats, like 
eps15, epsin 1 and Dab2 (Keyel et al., 2006), are still present at enlarged lattices in FCHO2-
silenced HeLa cells (Figure 4.11). This indicates that although eps15 and eps15R bind directly to 
the FCHO1/2 µHD (Reider et al., 2009; Henne et al., 2010), this association is not required for  
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Figure 4.11: Adaptor content of CCSs in FCHO2 silenced cells. 
HeLa SS6 cells treated with two rounds of mock or FCHO2 pool siRNA were fixed and labeled with 
antibodies to Dab2 (A), epsin 1 (B), or eps15 (C) and AP.6 anti-AP2α (A,C) or X22 anti-clathrin heavy 
chain (B). Scalebar, 10 µm. 
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placement of eps15/R in surface coats; instead the capability of eps15/R to interact with 
numerous other endocytic proteins probably assures incorporation into polymerizing lattice 
devoid of FCHO2. We are unable to replicate the published penetrant FCHO1/2 RNAi 
phenotype of complete loss of endocytic clathrin coats in BS-C-1 cells (Henne et al., 2010) 
despite obviously efficient silencing of FCHO2 in the whole cell population (Figure 4.16A,F). 
To determine if these enlarged AP-2 patches in HeLa cells are possibly arrested 
intermediates, we first conducted FRAP experiments with FCHO2 knocked-down cells (Figure 
4.12A). In mock-treated cells, AP-2 recovers in bleached zones with a t1/2 = 37 ± 6 s (n = 33) 
(Figure 4.12B, C). This is slower than previously published (Wu et al., 2003; Hinrichsen et al., 
2006) and is probably due to the fact that this stable cell line expresses low levels of the β2-YFP 
subunit that incorporates into <10% of AP-2 molecules at steady state. Depleting FCHO2 does 
not significantly affect the return rate (t1/2 = 42 ± 4 s, n = 33) or the extent of recovery (83 ± 5% 
compared with 78 ± 5% for mock) (Figure 4.12D). Therefore, the AP-2 in clathrin-coated 
structures at the surface exchanges with the reserve cytosolic pool at similar rates in either the 
presence or absence of FCHO2 and can likely rely on the cohort of endocytic proteins at 
assembled lattices for its targeting. 
Next, we examined the lifetime of AP-2 positive structures on the ventral surface of 
HeLa cells in the presence or absence of FCHO2. HeLa cells differ fundamentally from BS-C-1 
cells in that they contain numerous long-lived clathrin-coated structures termed patches or 
plaques (Maupin and Pollard, 1983; Wu et al., 2003; Keyel et al., 2008; Saffarian et al., 2009) 
(Figure 4.12E). Ablation of FCHO2 significantly reduces the number of AP-2 spots observed 
over a 10-min period by ~60% (Figure 4.12E-G); this is largely a result of a drop in the total  
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Figure 4.12: Enlarged endocytic structures in FCHO2 knockdown cells have dynamic properties 
similar to control cells. 
(A) HeLa SS6 cells stably expressing AP-2 β2-YFP were mock treated or treated with two rounds of 
FCHO2 siRNA and imaged by confocal microscopy. At time point zero, a 5 µm circular region was 
bleached for 2 seconds and imaged continuously. (B) The fluorescence intensity of 33 spots within bleach 
regions per condition were averaged and plotted relative to pre-bleach intensity. The recovery curves 
were fitted and used to calculate the time of half-maximal recovery, t1/2 (C), and percent of maximal 
recovery (D). (E-F) HeLa SS6 β2-YFP cells were treated as in (A) and imaged by TIRF microscopy. A 
three-pixel wide line (red line) was used to create an X-T kymograph from a 10 minute experiment. Both 
stable assemblies and transient structures (arrowheads) are observed. (G) The total number of AP-2 spots 
in a 400 µm2 region over a 10 minute period were averaged for mock and FCHO2 knockdown cells (n=12 
cells). Asterisk, p<0.05. All error bars represent standard error. Scalebars in A and E, 10 µm. Timebar in 
F, 3 minutes. 
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number of structures/µm2 (see Figure 4.7). However both stable and short-lived endocytic 
structures are seen in both conditions. 
In S. cerevisiae, an overt general endocytic defect is not apparent in a syp1∆ strain 
(Reider et al., 2009; Stimpson et al., 2009). Likewise, the essentially normal exchange dynamics, 
coat lifetimes and CLASP deposition in FCHO2- (and FCHO1 and FCHO2)-depleted cells all 
suggest that the large clathrin assemblies are likely operational. Indeed, transferrin receptor is 
found populating AP-2 structures in FCHO2 knockdown cells (Figure 4.13A). Still, a 
fundamental functional distinction between large clathrin plaques and diffraction-limited clathrin 
buds has been proposed (Saffarian et al., 2009). The transferrin receptor, a prototypical cargo 
receptor, is internalized through recognition of a YXXØ-type sorting signal within its cytosolic 
domain (Jing et al., 1990) by the µ2 subunit of AP-2 (Ohno et al., 1998; Owen and Evans, 1998). 
The low density lipoprotein (LDL) receptor, by contrast, displays an FXNPXY sorting signal 
(Chen et al., 1990) recognized by the PTB domain CLASPs Dab2 and ARH (He et al., 2002; 
Keyel et al., 2006; Maurer and Cooper, 2006). As the FCHO1/2 µHD can bind to Dab2 (Henne 
et al., 2010), internalization of these two cargo molecules may differ in cells in which FCHO2 is 
extinguished. Following a 10-min pulse of fluorescently labeled transferrin at 37°C, FCHO2 
siRNA-treated HeLa cells show a modest but significant decrease in endocytosis (82 ± 2% the 
level of mock-treated cells, p<0.05, n = 146 cells) (Figure 4.13B,D). Providing FCHO2 knocked-
down cells with fluorescently labeled LDL continuously for 20 min at 37°C produces a similar 
result, with cells internalizing 81 ± 2% the level of mock-treated cells (p<0.05, n = 144 cells) 
(Figure 4.13C,D). These data show that while FCHO2 silenced cells have a grossly altered AP-2 
and clathrin distribution, only a subtle effect is observed on bulk endocytosis. In addition,  
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Figure 4.13: Ablation of FCHO2 causes a slight inhibition of endocytosis. 
(A) Mock and FCHO2 siRNA-treated HeLa SS6 cells were incubated on ice for one hour with fluorescent 
transferrin (Tf, red) and then prepared for immunofluorescence of AP-2 (green). Ligand-bound transferrin 
receptor colocalizes with AP-2 in both conditions. In separate experiments, mock and FCHO2 siRNA-
treated HeLa SS6 cells were incubated in the continuous presence of fluorescent Tf for 10 minutes (B) or 
the continuous presence of fluorescent low density lipoprotein particles (LDL) for 20 minutes (C) at 37°C 
and then processed for AP-2 immunofluorescence. Representative confocal sections of the ventral cell 
membrane (AP-2) and maximum Z-projections of the entire cell volume (ligand) are shown. (D) 
Quantitation shows a ~20% reduction of internalized Tf and LDL following FCHO2 kockdown. Asterisk, 
p<0.05. Error bars represent standard error. Scalebar, 10 µm. 
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transmembrane cargo recognized by the core adaptor AP-2 and cargo recognized by the CLASPs 
Dab2 and ARH are equally affected suggesting a general retardation in the kinetics of uptake. 
4.3.5 Molecular dissection of FCHO1/2 in its regulation of clathrin-coated structures  
The FCHO2 knockdown phenotype in HeLa cells is obtained with two independent siRNA 
preparations, but to confirm that this is not due to off-target effects, we performed rescue 
experiments by expressing GFP-FCHO1, tdRFP-FCHO2, or various truncation/chimera 
constructs (Figures 4.14A and 4.15). Cotransfecting cells with siRNA and GFP produces the 
typical altered morphology of more sparsely distributed AP-2-positive structures that are larger 
with brighter apparent fluorescence. By contrast, cotransfection with full-length GFP-FCHO1 or 
tdRFP-FCHO2 restores the number and more regular size of AP-2 structures (Figures 4.14A and 
4.15). Despite a variation in the mouse FCHO2 nucleotides surrounding the siRNA target 
sequence relative to human FCHO2, this murine transgene is still partially silenced (Figure 4.15). 
This may explain the lower rescue efficiency observed (Figure 4.14C). These results validate that 
the morphological phenotype is specific to loss of FCHO2, and that FCHO1 and FCHO2 are 
functionally redundant in this aspect of their operation. 
Tellingly, our failure to abrogate completely clathrin-mediated endocytosis upon FCHO1 
+ FCHO2 RNAi (Figure 4.16) is not restricted to just HeLa cells. In the human fibrosarcoma cell 
line HT-1080 (Rasheed et al., 1974) and the breast carcinoma MCF-7 (Soule et al., 1973) 
fluorescent transferrin is transported from the cell surface to endosomes despite effective 
silencing of the FCHO2 mRNA and dramatic loss of the protein (Figure 4.16B-F). FCHO1 + 2-
silenced HT-1080 cells display a less prominent change in the arrangement of surface clathrin 
structures than knocked-down HeLa cells but the MCF-7 cells show large clustered clathrin- and  
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Figure 4.14: Rescue of the FCHO2 knockdown phenotype. 
(A) HeLa SS6 cells were treated with two rounds of mock or single FCHO2 siRNA and on the second 
round were cotransfected with various GFP or tdRFP plasmids. Cells were prepared for 
immunofluorescence of AP-2 and representative confocal images of the ventral membrane of plasmid 
expressing cells are shown. (B) Random fields of FCHO2 siRNA-treated and GFP or tdRFP expressing 
cells were captured and the plasmid was scored for its ability to restore the wildtype distribution of AP-2 
as defined by spot concentration and size. Constructs tested include GFP (n=101 cells), GFP-FCHO1 (full 
length human 1-889, n=68 cells), GFP-FCHO1(1-610) (n=63 cells), GFP-FCHO1(1-275) (n=63 cells), 
GFP-ENTH-µHD (epsin1 ENTH+FCHO1(276-889), n=81 cells), GFP-ENTH-F1linker (epsin1 
ENTH+FCHO1(276-610), n=90 cells), GFP-ENTH (n=72 cells), GFP-µHD (FCHO1(610-889) (n=65 
cells), GFP-ENTH(L6Q)-µHD (n= 103 cells), tdRFP (n=59 cells), tdRFP-FCHO2 (full length mouse 1-
809, n=96 cells), tdRFP-FCHO2(1-525) (n=95 cells), tdRFP-FCHO2(1-302) (n=64 cells). Error bars 
represent standard error. 
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Figure 4.15: Biochemical confirmation of FCHO2 knockdown and rescue. 
Cells treated as in Figure 4.14 were lysed in sample buffer and resolved by SDS-PAGE. After transferring 
to nitrocellulose, portions of the blot were probed with antibodies against FCHO2, GFP, or tubulin. Note 
the partial silencing of tdRFP-FCHO2. Positions of molecular weight standards (in kDa) are shown on the 
left. 
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Figure 4.16: Survey of FCHO1/2 knockdown in a variety of mammalian cell lines. 
BS-C-1 cells stably expressing GFP-clathrin light chain (CLC) (A), human fibrosarcoma HT-1080 cells 
(B) and human breast adenocarcinoma MCF-7 cells (D) were mock treated or treated with two rounds of 
FCHO1 and FCHO2 pool siRNA. HT-1080 (C) and MCF-7 cells (E) were incubated for 10 minutes at 
37°C in the continuous presence of 25 µg/mL Tf, washed, and all cells were fixed and prepared for 
immunofluorescence with antibodies against AP-2 α (A,B) or clathrin heavy chain (D). (F) BS-C-1 GFP-
CLC, HT-1080 and MCF-7 cells were treated as above with either FCHO1 and FCHO2 pool siRNA 
(FCHO1+2p), FCHO1 pool and FCHO2 single siRNA (FCHO1+2s), FCHO1 pool siRNA (FCHO1) or 
FCHO2 pool siRNA (FCHO2p), lysed in sample buffer and resolved by SDS-PAGE. After transferring to 
nitrocellulose, portions of the blot were probed with TD.1 anti-clathrin heavy chain, GD/1 anti-AP1/2 
β1/β2 subunits, anti-FCHO2, and anti-β-tubulin antibodies.  
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Figure 4.17: Endocytic protein composition of cell lines examined. 
Equal concentrations (~70 µg) of untreated HeLa SS6, MCF-7 and HT-1080 lysates were resolved by 
SDS-PAGE, transferred to nitrocellulose and probed with antibodies against various clathrin coat 
components. The extra lane in the FCHO1 immunoblot is from HeLa cells transiently transfected with 
GFP-FCHO1 as a positive control. The bracket is to show where the endogenous FCHO1 band would be 
expected. 
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AP-2-positive patches in the absence of FCHO1 + 2 RNAi (Figure 4.16D). Interestingly, this 
morphological alteration is not due to a lack of expression of FCHO2 protein although it 
resembles strongly the phenotype that ensues extinguishing these proteins in HeLa cells. A431 
squamous carcinoma cells similarly contain large clustered, often ring-like clathrin assemblages 
on the ventral surface (Hawryluk et al., 2006) and express moderate FCHO2 mRNA transcript 
levels (www.proteinatlas.org). Dual transfection of MCF-7 cells with FCHO1 and FCHO2 
silencing siRNAs does not dramatically alter the morphology of endocytic clathrin structures on 
the bottom surface of these cells. These results indicate that alone the FCHO1 and/or FCHO2 
protein concentration is not the only regulator of clathrin-coated structure aggregation and patch 
size.  I suspect that the relatively mild (HT-1080) or nonexistent (MCF-7) phenotype associated 
with FCHO1 + 2 knockdown compared with the phenotype in HeLa cells may reflect variations 
in FCHO1/2 binding partner expression in these cell lines. For instance, in MCF-7, intersectin 
and Dab2 are barely detectable and in HT-1080 cells they are a fraction of the expression level in 
HeLa cells (Figure 4.17). In contrast, the levels of FCHO2 and its other binding partners eps15/R 
are quite similar (Figure 4.17).  
The rescue assay allowed us to further probe the structural properties of FCHO1/2 
necessary for steady-state endocytic site morphology. While the FCHO1 EFC domain (residues 
1-275, Figure 4.1A) alone is not capable of reversing the FCHO2 knockdown phenotype, 
unexpectedly the EFC and unstructured linker (residues 1-610) do restore cells to a phenotype 
similar to the normal AP-2 distribution, even though this truncated protein is generally not 
targeted stably to AP-2 structures at steady state (Figure 4.14). The same is observed for the 
FCHO2 EFC domain (1-302) and FCHO2 EFC and unstructured linker (1-525) (Figure 4.14B). 
This suggests that the µHD (residues 610-889 in FCHO1 or 527-810 in FCHO2) plays an 
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important role in retaining FCHO1/2 at AP-2-positive structures. These data also indicate that a 
region within the unstructured linker is important for proper maintenance of AP-2/clathrin bud 
site morphology. In fact, the ability of FCHO1 to reduce the size of large steady-state endocytic 
structures in MCF-7 cells is also dependent on the unstructured linker but not the µHD (Figure 
4.10A,C,D).  
This is further exemplified by reconstituting FCHO2-silenced HeLa cells with a chimeric 
protein composed of the PtdIns(4,5)P2-binding epsin 1 ENTH (epsin N-terminal homology) 
domain fused in frame to the unstructured linker and µHD (residues 276-889) of FCHO1 
(ENTH-µHD; Figure 4.12A,B). Truncating this construct prior to the µHD still allows rescue of 
surface clathrin morphology to the same extent (Figure 4.14B). Some evidence suggests that the 
epsin 1 ENTH domain promotes membrane deformation/tubulation by inserting an amphipathic 
α helix, ordered around the PtdIns(4,5)P2 head group, into the bilayer (Ford et al., 2002). If 
plasma membrane curvature generated by the FCHO1/2 EFC domain is important for the steady-
state distribution of AP-2, this property of the ENTH domain could explain the ability of this 
chimera to rescue. However mutation of Leu6 on the ENTH amphipathic α helix, a residue 
important for in vitro tubulation but not PtdIns(4,5)P2-rich membrane binding (Ford et al., 2002), 
did not abrogate rescue of FCHO2 knockdown (GFP-ENTH(L6Q)-µHD, Figure 4.14B). A 
caveat of these data is that while rescue of morphology is assessed, function is not, such that 
these ENTH and truncation chimeras may not rescue protein exchange or wild type levels of 
endocytosis. 
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4.4 DISCUSSION 
FCHO1/2 are early-arriving elements of the endocytic clathrin coat machinery. The steady state 
positioning of these proteins is a manifestation of the inherent affinities for PtdIns(4,5)P2, 
eps15/R, intersectin and Dab2 (Reider et al., 2009; Henne et al., 2010) and, in the case of 
FCHO1, the AP-2 α appendage (unpublished observation). Unlike other EFC domain proteins 
tentatively linked to clathrin-mediated endocytosis including Toca1 (Bu et al., 2010), FBP17 
(Kamioka et al., 2004), CIP4 (Feng et al., 2010) and PACSINs (Qualmann and Kelly, 2000; 
Taylor et al., 2011), the muniscins are undoubtedly components that govern the positioning and 
operation of coated structures. Here we demonstrate that FCHO1 and FCHO2 play a role in 
determing the number of CCSs in some cell types, regulate the size of flat clathrin lattices on the 
ventral plasma membrane, and have separable properties from each other that may differentiate 
their precise functions in vivo. 
FCHO1/2 are argued to be master levers of CME by remodeling the initial membrane 
patch and recruiting eps15 and intersectin prior to AP-2 (Henne et al., 2010). Generally, the 
expression levels of FCHO1/2 do impact the number of CCSs, at least in certain cell types. There 
was an apparent loss of structures upon FCHO2 knockdown and increase in structures on 
FCHO1/2 expression in HeLa cells. Also, FCHO1/2 expression in MCF-7 cells appeared to 
increase the number of endocytic structures perhaps as a result of breaking up the large 
continuous network of AP-2 staining. However, at most the loss of structures from FCHO2 
knockdown was only ~50% and certainly not a complete removal despite complete knockdown. 
Furthermore we and others (Henne et al., 2010; Taylor et al., 2011) have shown that FCHO1/2 
and interacting partner eps15 are clearly early components of de novo forming CCSs, often 
appearing before the onset of AP-2 and clathrin, a behavior not known for any other components 
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of clathrin assemblies. This positioning is optimal for initiating assembly. While our data do 
support a clear role in coat initiation, they argue that muniscin-mediated regulation is more 
complex than a binary actuator of clathrin nucleation.  
We believe that FCHO1/2 are not absolutely required for initiation of CME for the 
following reasons: 1. Depletion of FCHO2 does not alter the ability of AP-2 to exchange with 
AP-2 molecules in the cytosol (Figure 4.12). In the model proposed earlier (Henne et al., 2010), 
AP-2 is tethered by FCHO1/2 through eps15/intersectin so that depletion of the FCHO1/2 would 
certainly hinder AP-2s ability to target to the membrane. In assembled clathrin lattices, other 
factors present likely allow for exchange. 2. Although the total number of AP-2 structures 
forming at the surface is reduced in FCHO2 knockdown cells, there are still populations of short 
and long-lived endocytic structures indicating that FCHO1/2 do not selectively regulate a subset 
of endocytic structures (Figure 4.12). 3. Endocytosis of transferrin and LDL particles is reduced 
in knockdown cells, consistent with point 2, but this reduction is modest (~20%) (Figure 4.13 
and 4.16). The remaining structures are competent for endocytosis. 4. Invaginating clathrin 
assemblies are still observed in FCHO2 knockdown cells (Figure 4.8). Clathrin can still stabilize 
curvature induced by itself or other EFC or BAR domain proteins or possibly by epsin 1. 5. The 
adaptor content of CCSs is not drastically altered in the absence of FCHO2 (Figure 4.11). 6. A 
multiparametric high-throughput siRNA screen of proteins to determine their involvement in 
endocytosis placed FCHO1 and 2 in groups for their role in endosome positioning, not 
modulation of Tf or EGF endocytosis (Collinet et al., 2010). Endosomes were more peripheral 
for FCHO2 knockdown similar to what we saw (Figure 4.13), and could be a result of a small 
reduction in uptake. 7. In yeast, the FCHO1/2 orthologue Syp1p is not required for endocytosis 
(Stimpson et al., 2009). 
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An important question is whether or not early sculpting of the bud site by FCHO proteins 
prior to assembly of clathrin is a prerequisite for clathrin-coated vesicle formation as proposed 
(Henne et al., 2010)? This obviously pertains more to de novo buds on the scale of 100-200 nm 
diameters than large flat clathrin lattices. In the HeLa SS6 cells we use, knockdown of clathrin 
results in patches of AP-2 that are invariably flat (Hinrichsen et al., 2006). Presumably FCHO2 
is present but is not inducing curvature. In human skin fibroblasts, staged reassembly of clathrin-
coated structures by hypotonic shock and recovery followed by deep-etch electron microscopy 
showed that early clathrin-coated structures are flat and only round up at later time points 
(Larkin et al., 1986). Finally, rescue experiments with the ENTH-µHD chimera, particularly the 
amphipathic helix mutant deficient for in vitro tubulation, was able to rescue CCS size and 
placement suggesting that EFC domain-generated membrane curvature was not necessary for 
steady state morphology of flat clathrin lattices present in these cells. Because it is reasonable to 
suggest that the ability of FCHO1/2 to promote membrane curvature is regulated by its 
concentration at bud sites and its oligomeric state, it seems that initially FCHO1 and FCHO2 
function primarily in coat assembly rather than for membrane bending but could function in such 
a role at later stages during their peak concentrations. 
A second major finding from this study is that FCHO1 and FCHO2 regulate the size of 
clathrin assemblies on the ventral membrane of cultured cells. This likely arises from the fact 
that expressed FCHO1 and FCHO2 are more highly enriched at AP-2 structures on the ventral 
membrane rather than the dorsal membrane (Figure 4.2A) and FCHO2 knockdown has a greater 
effect on the distribution and morphology of ventral CCSs (Figure 4.7H). Reduction of FCHO1/2 
protein levels increases CCS size in some of the cell types examined reciprocal to the effect on 
CCS number, while increasing FCHO1/2 expression reduces CCS size. Changes in clathrin 
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lattice size could happen by either promoting or limiting clathrin polymerization at lattice edges 
or through increased or decreased non-terminal budding which may occur at the edges of these 
structures (Rappoport et al., 2004; Traub, 2009; Taylor et al., 2011). Consistent with a role in 
regulating lattice size, FCHO2 is found at the periphery of de novo and long-lived ventral CCSs 
(Figure 4.2B). 
These observations have led us to propose two, not mutually exclusive models. In one 
model FCHO1 and FCHO2 act as scaffolds to properly arrange pioneer constituents to promote 
swift polymerization of de novo coated buds. As assembly continues, the peripheral ring of 
FCHO1/2 might allow ordered assembly of AP-2, other CLASPs and regulatory factors in the 
growing coat coupled to membrane deformation through its EFC domain. At pre-existing 
clathrin lattices, FCHO1/2 may promote CCV budding from the edges again coupling ordered 
assembly through eps15/R and intersectin and membrane bending. In the absence of FCHO2, de 
novo buds could still form, but may take longer, hence slowed uptake. Slowed or reduced 
budding from the edges of long-lived clathrin lattices could yield expanded CCSs if the balance 
between assembly and removal is skewed. Or moderately slowed uptake may represent the 
increased diffusion time of transmembrane cargo required to encounter the larger plaques as they 
are less abundant on the plasma membrane. Conversely, higher concentrations of FCHO1/2 
could promote nucleation of more de novo structures or promote greater budding from lattices.  
FCHO2 is positioned at the edges of flat clathrin-lattices and de novo buds (Figure 4.2B) 
similar to eps15 (Tebar et al., 1996; Edeling et al., 2006a). The interactions of FCHO2 with 
eps15 and intersectin through the µHD and also the occupancy of the eps15 (Edeling et al., 
2006a) and intersectin (Pechstein et al., 2010a) binding sites on the AP-2 β2 appendage 
sandwich subdomain by assembled clathrin may dictate the positioning of these proteins. At the 
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edges of the lattices where clathrin assembly is incomplete, eps15 and intersectin could promote 
AP-2 and clathrin assembly perhaps in concert with FCHO2 induced membrane invagination. 
Removal of FCHO1/2 and eps15 from de novo structures just prior to budding (Figure 4.4 and 
(Henne et al., 2010), and the absence of detectable levels of FCHO2 on deeply invaginated buds 
(Figure 4.2B)) could be accomplished by a combination of occupancy of all AP-2 molecules by 
clathrin with no further AP-2 deposition and membrane curvature of the bud that begins to 
exceed the intrinsic curvature of the FCHO EFC domain, thus weakening its interaction with the 
membrane. The fact that FCHO1/2 typically depart from the assemblage before the final budding 
event could explain how overexpression changes the dynamics of clathrin-coated structures. 
Increased FCHO1 or -2 concentration by forced expression changes the equilibrium and spots 
become longer lived and more static in BS-C-1 cells (data not shown). This argues that exit of 
the majority of FCHO1/2 is required for rapid budding, perhaps because the oligomer must be 
disassembled. 
Yet a precise role of scaffolding assembly early and membrane curvature at a later time is 
hard to reconcile with the capability of the ENTH-µHD (wildtype and L6Q, membrane bending-
deficient), particularly the truncated version of this chimera lacking the µHD (scaffolding 
deficient), to maintain normal coat morphology and distribution in FCHO2-silenced HeLa cells. 
Also, invaginating coats are observed at the edges of flat lattices in FCHO2 knockdown cells 
(Figure 4.8). FCHO1 and FCHO2 could interact with an unidentified protein through the 
unstructured linker region allowing it to be recruited at lower levels in the absence of the µHD. 
The identity of such a partner and how this partner contributes to reducing CCS size and 
increasing CCS number remain to be determined. 
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In the second model, FCHO1/2, eps15 and intersectin may define the outer perimeter of 
emerging coated structures. In doing so they could prevent the coalescence and fusion of 
individual CCSs, maintaining a higher number of more uniform structures. To accomplish this, 
the putative binding partner of the FCHO1/2 unstructured linker (as the µHD-truncated mutant 
can substitute) may act to directly or indirectly affect free clathrin triskelion leg availability, 
preventing or not favoring the anti-parallel engagement of free legs by adjacent lattices. This 
could be an important role for these proteins as flat clathrin lattices can persist on the plasma 
membrane for periods greater than 10 minutes (Figure 4.12) (Saffarian et al., 2009). In addition, 
CCSs may move laterally within the plasma membrane actively on microtubules in some 
contexts (Rappoport et al., 2003) or experience natural lateral translations during their lifetime at 
the surface (Loerke et al., 2009). Perhaps through the µHD and eps15/intersectin, FCHO1/2 
promote CCS nucleation and at later stages the proposed linker-binding partner regulates 
adjacent lattice tethering. Reduction of FCHO2 would allow clustering of CCSs and expansion 
of individual regions of clathrin coats, but in this model it is unclear how overexpression of 
FCHO1/2 would reduce CCS size. Also while this model explains how ENTH-µHD can rescue 
the FCHO2 knockdown phenotype because less importance is placed on membrane bending, it 
cannot account for the µHD truncation mutant’s targeting to CCSs. Altogether, while the second 
model cannot fully explain some of the observations from the rescue experiments, it is better 
supported by the data.  
Because FCHO1/2 is not restricted to diffraction-limited spots in HeLa cells (Figures 4.1 
and 4.2) (Henne et al., 2010) and overexpressed FCHO1 and FCHO2 populate the majority of 
clathrin-coated structures, we do not believe that de novo clathrin-coated buds differ from the 
long-lived, static plaques by selective incorporation of either muniscin. Nor do we believe de 
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novo spots carry the bulk of cargo or represent the major carrier in receptor-mediated 
endocytosis (Saffarian et al., 2009) as the enlarged CCS in FCHO2-silenced cells are still 
operational. Reduction by ~50% of the actin-binding endocytic proteins HIP1 and Hip1R in 
HeLa cells causes the formation of large clathrin assemblies similar to what we find in 
FCHO1/2-silenced cells, yet Tf internalization is not affected (Engqvist-Goldstein et al., 2004). 
This demonstrates that altered morphology does not necessarily translate into altered function. 
Instead, a plausible scenario is that at early assembly times, the precise ratio of FCHO1/2 (and 
eps15 and intersectin) to AP-2 and clathrin may define whether a diffraction-limited spot or an 
extensive patch forms. We predict a lower ration of FCHO1/2 and its partners to AP-2, clathrin 
and epsin would bias the assemblage toward formation of a plaque-like structure. The FCHO1/2 
RNAi phenotype in HeLa cells is clearly consistent with this idea. 
However the prevailing levels of FCHO2 and adaptors and steady state clathrin 
morphology in the cell lines examined are not consistent with this idea (Figure 4.16 and 4.17). 
For instance, MCF-7 cells have the largest CCSs examined and have near undetectable levels of 
intersectin and Dab2, but HT-1080 cells have uniform and small CCSs but also have very low 
levels of these two proteins. Normal HeLa cells have a phenotype between these two cell lines 
yet have higher levels of all FCHO binding partners and in addition endogenous FCHO2 is 
present at high concentrations at large CCSs in these cells. Instead, FCHO binding partner levels 
may be more predictive of the sensitivity of a cell line to FCHO1/2 knockdown.  
FCHO1/2 control of CCS size is likely more complex. FCHO2 is a phosphoprotein; 
treatment of HeLa cells with the protein phosphatase inhibitor Calyculin A (Suganuma et al., 
1990) causes FCHO2 to migrate more slowly on gels (unpublished observations). 
Phosphorylation status could either regulate partner binding to the µHD or linker directly or 
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affect µHD conformation/orientation (Roberts-Galbraith et al., 2010). Another possibility is 
auto-inhibition. The EFC domain protein Pacsin 1 is auto-inhibited from membrane deformation 
by binding of its C-terminal SH3 domain back on the EFC domain and this inhibition is relieved 
by engagement of the SH3 domain by dynamin (Rao et al., 2010). Binding of FCHO1/2 to one of 
its binding partners could relieve µHD inhibition of EFC binding to the plasma membrane and 
ensuing curvature generation. It is unknown currently if the µHD can bind to the FCHO EFC 
domain or linker region. 
The last important finding of this study is that FCHO1 and FCHO2 are somewhat 
redundant but also have some unique properties. Both FCHO1 and FCHO2 are capable of 
restoring CCS number and size in FCHO2 silenced HeLa cells and have similar effects when 
overexpressed. Therefore we believe they are both similarly potent in ability to promote 
nucleation of CCSs and regulate clathrin lattice size. Biochemically these proteins are quite 
different. FCHO1 is very sensitive to aggregation upon exogenous expression and native and 
expressed FCHO1 was slightly degraded (Figures 4.1F, 4.5B. 4.17). Considering its ability to 
aggregate, controlled proteolysis may prevent complications from this byproduct. FCHO1 also 
makes additional interactions that FCHO2 does not: with AP-2 through the unstructured linker 
and CALM and HIV-1 Rev binding protein (Hrb) through the µHD (unpublished observations). 
What is more, FCHO1 recovers more slowly in FRAP experiments perhaps as a result of slower 
exchange at CCSs from these additional contacts.  
The ability to bind CALM and Hrb may impart indirect sorting abilities on FCHO1 as 
there is evidence these proteins sort SNAREs (Harel et al., 2008; Pryor et al., 2008). Also, while 
FCHO2 is expressed in all cell lines tested, FCHO1 is not. Tissue specific expression of FCHO1 
may be important for cargo sorting. The presence of FCHO1 in purified CCVs is consistent with 
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a role in cargo sorting and although live-cell experiments show the majority of FCHO1 exiting 
the evanescent field, trace fluorescence could often be seen until clathrin budding (Figure 4.4). 
Furthermore, a high-throughput screen for protein-protein interactions in the Transforming 
Growth Factor β pathway identified an interaction between FCHO1 and Activin receptor-like 
kinase 2 (Alk2) (Barrios-Rodiles et al., 2005). Alk2 is a Ser/Thr kinase transmembrane receptor 
involved in gastrulation (Gu et al., 1999), so FCHO1 may act as a CLASP to regulate signaling 
pathways during development. Future studies will need to determine if FCHO1 and FCHO2 can 
sort cargo molecules directly similar to Syp1p in yeast (Reider et al., 2009).  
In conclusion, FCHO1 and FCHO2 are partially redundant endocytic proteins. They are 
non-essential regulators of CCS nucleation and actively maintain the morphology of individual 
CCS. The precise mechanistic details of lattice size regulation remain to be determined as does 
the identity of the postulated linker-binding partner that is important for this activity. FCHO1/2 
are also potential cargo-sorting proteins based on structural and evolutionary evidence and the 
uptake of various cargo in their absence will remain an intriguing avenue of study. 
 
 
 148 
5.0  CONCLUSIONS 
5.1 INTRODUCTION 
The field of clathrin-mediated endocytosis is an incredibly rich area of study because of the 
many participating researchers, the many normal and disease state processes it touches on and its 
relatively long history, going back to 1964. Yet within the discipline of vesicular traffic, 
particular aspects of CME, such as the precise mechanism of vesicle nucleation, remain quite 
unclear when compared with other types of coated vesicles. A partial explanation for this is the 
apparent near-dizzying array of proteins implicated in endocytosis in mammals that have arisen 
during the course of evolution and have limited the reach of genetic studies in yeast. Still, 
multiple concepts of CCV nucleation, some now defunct, have been offered that have helped 
shape our understanding of this complex process. 
This thesis has helped further define the mechanisms by which clathrin-coated structures 
nucleate on the cell plasma membrane in preparation for endocytosis by clarifying one model 
and modifying another. Careful biochemical investigation of how the brain-enriched 
PtdIns(4,5)P2 generating enzyme PIPKIγ interfaces with the endocytic machinery has identified 
the binding site on the sandwich subdomain of AP-2 β2 appendage and given rise to a model in 
which PtdIns(4,5)P2 generation for vesicle nucleation can be temporally regulated. Also, in vivo 
studies in this thesis have confirmed previous biochemical studies of the AP-2 β2 appendage 
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platform and sandwich binding sites, showing different levels of accessibility to various binding 
partners during assembly. The AP-2 β2 appendage binds to clathrin and thus plays an important 
role in vesicle nucleation as well. Finally, experiments of siRNA-mediated knockdown of the 
recently identified endocytic proteins FCHO1 and FCHO2 have revealed their involvement in 
clathrin-coated structure nucleation; they are not absolutely required but may contribute to 
efficiency and size regulation. My results strengthen the model of PtdIns(4,5)P2-driven vesicle 
nucleation for CME but also highlight how multiple pathways might operate in parallel to initiate 
budding. 
5.2 COORDINATION OF LOCALIZED LIPID METABOLISM BY AP-2 
5.2.1 Defining the AP-2 β2 subunit appendage sandwich subdomain binding site 
The work from Chapter 2 of this thesis along with subsequent studies have greatly helped our 
understanding of the endocytic accessory factor/adaptor binding sites on the AP-2 β2 appendage. 
Of the four appendage binding sites, one upon the platform and one upon the sandwich 
subdomain of both the α and β2 appendages, the β2 sandwich site is the most recently 
discovered and characterized (Edeling et al., 2006a; Schmid et al., 2006). Yet it also plays a 
critical role in assembly through binding clathrin (Edeling et al., 2006a) and a variety of other 
proteins, including PIPKIγ (Chapter 2) (Nakano-Kobayashi et al., 2007). Therefore defining this 
site will aid in a deeper understanding of assembly during CME and will enable the use of 
protein-protein interaction data in the future to build predictive, computational models of CCS 
assembly (Gong et al., 2008). 
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Using previously identified residues on the AP-2 β2 appendage sandwich subdomain 
(Edeling et al., 2006a; Schmid et al., 2006) and mutagenesis along with binding assays for 
interaction with PIPKIγ661, I have confirmed that the sandwich site binding pocket is delimited 
by residues Gln804, Tyr815, Lys808 and Gln756 in a clockwise circle (see Figure 2.11 and 
2.16). I also established that residues Phe635, Trp642 and Tyr644 of the mouse PIPKIγ661 
isoform are necessary for binding, similar to other hydrophobic appendage binding motifs. 
Gratifyingly, my results were subsequently confirmed by the crystal structure of human 
PIPKIγ668 C-terminal peptide 639YFPTDERSWVYSPLH653 in complex with the β2 appendage 
(Kahlfeldt et al., 2010). Phe640 (Phe635 in mouse) and Trp647 (Trp642 in mouse) anchor the 
kinase by inserting into the binding pocket while a short α-helix in the intervening residues 
positions the side chains (Figure 2.16). Tyr644 stabilizes this interaction through an electrostatic 
interaction with β2 Lys808.  
Eps15 binds to the same site in a similar but different fashion. A co-crystal of the murine 
eps15 peptide 721SFGDGFADFSTL732 with the β2 appendage sandwich domain reveals how 
Phe722 occupies the same pocket as Phe640 in PIPKIγ and Phe729 inserts into the space for 
Trp647 of PIPKIγ (Schmid et al., 2006). However Phe726 occupies a shallow pocket unutilized 
by PIPKIγ and requires a tight turn accommodated by adjacent Gly725. Also, PIPKIγ668 makes 
additional contacts with its downstream residues 650SPLH653 as it wraps around the sandwich 
subdomain bringing its total interface to 774 Å compared with 395 Å for eps15 (Kahlfeldt et al., 
2010). These differences may explain the lower dissociation constant of the PIPKIγ668 peptide 
(22 µM) (Kahlfeldt et al., 2010) in comparison with eps15 (46 µM) (Schmid et al., 2006), 
however eps15 has a much higher apparent affinity for β2 appendage in our pull-down assays 
(Figure 2.17). The entire length of this short eps15 peptide was crystallized (Schmid et al., 2006) 
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so perhaps additional downstream residues not included in the peptide wrap around the sandwich 
domain like they do in PIPKIγ or multivalent interactions exist. 
A third recent co-crystal of intersectin 1 with the β2 appendage sandwich site reveals the 
complexity of this binding surface (Pechstein et al., 2010a). Human intersectin 1 
847PNNWADFSSTWP858 peptide inserts Trp850 into the pocket that accommodates eps15 
Phe722 or PIPKIγ Phe640 and Phe853 into the site for eps15 Phe729 or PIPKIγ Trp647. This 
configuration connects the two aromatic-accepting pockets with the least number of intermediate 
residues in contrast to the short α-helix of PIPKIγ or tight turn loop of eps15. The unifying 
theme of these modes of binding are two variably spaced Phe or Trp residues that insert into the 
two pockets on β2 and additional flanking contacts that stabilize the interaction. 
Alignment of eps15 and PIPKIγ661 did not show any significant homology other than the 
spacing for the distal anchoring Phe and Phe/Trp residues (Figure 2.12). Scanning the C-termini 
of other AP-2 β2 appendage sandwich partners including AP180, CALM and amphiphysin I/II 
did reveal some homology to eps15, however (Figure 5.1). These proteins all had at least one 
sequence in which the first and second anchoring Phe residues of eps15 are conserved in spacing. 
Also the eps15 Asp724 is conserved in all proteins accept CALM. However these proteins do not 
have the required Gly in analogous position to eps15 Gly725 that is required to place the 
adjacent Phe in the middle of a tight turn and they lack the third anchoring Phe at eps15 position 
729 (Figure 5.1). Perhaps these proteins are not required to make this tight turn and only utilize 
two anchoring aromatic residues. Reading the AP180 primary sequence in reverse places a Gly 
in this position but the position for the third anchoring Phe residue is replaced by Val or Ile. If 
these sequences really do make up the sandwich binding motif in these proteins, this may explain 
the higher sensitivity of their binding to mutations in the sandwich sidechains relative to eps15  
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Figure 5.1: Alignment of β2 appendage sandwich subdomain binding proteins. 
Primary sequences from mouse endocytic proteins were aligned in ClustalW. Key known (eps15, 
intersectin) and prospective anchoring residues are boxed. The starting residue numbers and NCBI 
accession numbers are indicated. 
 
 
 
(Edeling et al., 2006a). Alternatively, these proteins could anchor two aromatic residues into the 
sandwich pocket in a manner similar to PIPKIγ without the need for glycines and a tight loop. 
Intersectin 1 does align nicely with eps15 but intersectin Trp850 binds to the pocket of β2 that 
Phe722 of eps15 engages, not the shallow Phe726 pocket as explained above. 
The plasticity of the β2 sandwich site in its ability to bind unstructured motifs of different 
lengths and conformations makes it rather unique among the appendage binding sites. This is 
especially true in light of the fact that it also binds the structured distal leg of clathrin (Edeling et 
al., 2006a; Knuehl et al., 2006). Defining a consensus motif for the sandwich subdomain is 
difficult but may conform to one or more of the following: 1. [F/L]XXGFXDF for eps15 and 
related sequences (Schmid et al., 2006), 2. FXnWXY for PIPKIγ and related sequences (Chapter 
2), 3. WXXF for intersectin 1 and related sequences (Pechstein et al., 2010a) or 4. FXDXF for 
other proteins (Figure 5.1), though this is also an α appendage platform binding sequence. 
Whether these slightly different modes of engaging the β2 appendage sandwich site have 
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different effects on recruitment of these proteins or their sensitivity to clathrin assembly remain 
to be determined.  
5.2.2 Kinase-mediated PtdIns(4,5)P2 production for neuronal and somatic cell CME 
An important question arising from this thesis dissertation is: does targeting of PIPKIγ661 (668 
in humans) to AP-2 for localized PtdIns(4,5)P2 generation and stimulation of  CCS nucleation 
constitute a general mechanism for endocytosis in all cell types? Genetic studies in mice suggest 
that PIPKIγ and its PtdIns(4,5)P2-hydrolyzing counterpart synaptojanin 1 are required for proper 
CCV generation at the synapse during compensatory endocytosis (Cremona et al., 1999; Wenk et 
al., 2001; Di Paolo et al., 2004). Indeed, PIPKIγ mRNA and protein is highly expressed in the 
brain and one or the other can be detected in various other tissues (Ishihara et al., 1998; Wenk et 
al., 2001; Giudici et al., 2004; Schill and Anderson, 2009; Volpicelli-Daley et al., 2010). 
However specific detection of the PIPKIγ661 isoform by RT-PCR or Western blot shows that it 
is restricted to the brain with more moderate expression levels in the heart, lung and perhaps the 
liver and pancreas but is absent from the gut (Giudici et al., 2004; Schill and Anderson, 2009). 
An isolated expression pattern is hard to reconcile with a general role in nucleation during CME 
in somatic cells, nonetheless knockdown of PIPKIγ668 in HeLa cells reduces Tf internalization 
(Bairstow et al., 2006). 
Instead, PIPKIα and PIPKIβ could compensate for CME in tissue where PIPKIγ is low. 
The mRNA and protein tissue distribution of these proteins is wider (Ishihara et al., 1996; 
Loijens and Anderson, 1996; Wenk et al., 2001; Volpicelli-Daley et al., 2010). In support of this, 
forced expression of human PIPKIα and PIPKIβ (PIPKIβ and PIPKIα, respectively in mouse 
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due to independent discoveries and naming), increases Tf internalization and CCP surface 
density in HeLa cells while PIPKIγ does not (Padron et al., 2003). Likewise, only knockdown of 
PIPKIβ reduced Tf internalization. Also, an enzymatically inactive truncated mouse PIPKIβ 
(mPIPKIβ, or human PIPKIα, hPIPKIα) rescues mutant colony-stimulating factor 1 receptor 
signaling by stabilizing it at the plasma membrane through dominant-negative inhibition of 
endocytosis (Davis et al., 1997). In an extension of this, mPIPKIβ expression increased EGFR 
internalization in NR6 cells (a variant of Swiss 3T3) and trunctated mPIPKIβ blocked EGFR 
internalization, plasma membrane localization of full-length mPIPKIβ, and reduced clathrin 
labeling at the membrane (Barbieri et al., 2001). Whether these effects are due to general 
changes in PtdIns(4,5)P2 levels in these cell lines, as hPIPKIβ modulation in HeLa cells results 
in (Padron et al., 2003), or if kinase targeting to CCSs is affected and the mechanism of how this 
might occur, remain to be determined and are important avenues of study. 
Another important factor is the nucleation of CCV from static and long-lived, yet 
endocytically active CCSs observed in some cultured cell lines (Chapter 4) (Merrifield et al., 
2005; Rappoport et al., 2005; Taylor et al., 2011) and isolated primary cells (Bellve et al., 2006). 
If CCVs can nucleate from the edge of these flat clathrin lattices, the required levels of 
PtdIns(4,5)P2 for their assembly may be relaxed. The nucleation potential may come from the 
adjacent adaptors and clathrin. In this scenario, the prevailing levels of PtdIns(4,5)P2 on the 
plasma membrane may be sufficient and targeting of a lipid kinase to these structures 
unnecessary. 
If CME at the synapse and in non-neuronal cells differs in the mode of PtdIns(4,5)P2 
generation used for CCS nucleation, this may reflect the fundamental differences of this process 
at these two locations. Neuronal CME for compensatory endocytosis during neurotransmission is 
 155 
a specialized form of endocytosis that must be rapid to maintain organism homeostasis. For 
instance, the time constant of CME in most synaptic terminals is on the scale of 10-20 seconds 
(reviewed in (Royle and Lagnado, 2010)) but the productive population of CCSs of cultured 
somatic cells was measured with a time constant of 87 seconds (Loerke et al., 2009) and  
intravital imaging of CME in non-neuronal tissue reveals that it may be even slower (Roberto 
Weigert, personal communication). Neuronal CCV formation also differs structurally as there are 
numerous brain-specific endocytic proteins including AP180 (CALM homologue), auxilin (GAK 
homologue) and amphiphysin 1 (Jung and Haucke, 2007) as well as neuron-specific alternatively 
spliced transcripts for AP-2 α and clathrin light chain (Jackson et al., 1987; Ball et al., 1995). 
Lastly, the unique combination of cargo such as Syt and the neurotransmitter transporters 
VMAT2, VAchT and VGLUT1 (Jung and Haucke, 2007) and potentially high cargo 
concentration if diffusion is limited after SV fusion may also contribute to the speed of clathrin 
nucleation during CME in neurons. The mechanism of targeting PIPKIγ661 to AP-2 for rapid, 
localized PtdIns(4,5)P2 generation and equally rapid negative regulation of coupled clathrin 
assembly and kinase eviction may be an adaptation to ensure speed and directionality of CME in 
the brain. 
5.2.3 The AP-2 appendages as scaffolds for lipid metabolizing enzymes 
The evidence for a role of PtdIns(4,5)P2 in nucleating and stabilizing CCSs is now 
incontrovertible. Most of the central adaptors and accessory factors contain modular domains 
that bind to this lipid and experimentally perturbing PtdIns(4,5)P2 levels influence the number of 
CCSs at the plasma membrane of cells in culture. A third line of evidence is the expanding list of 
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phosphatidylinositol kinases and phosphatases that physically bind to the AP-2 appendages and 
thus place them appropriately to modify the lipid environment of CCSs (Figure 5.2).  
The stage for nucleation is set by PI4K enzymes that generate PtdIns(4)P at the plasma 
membrane from PtdIns (Vicinanza et al., 2008). In non-neuronal cells, PIPKIα and β likely 
contribute to global PtdIns(4,5)P2 at the plasma membrane that can diffuse and participate in 
CME or they may bind through their kinase core domain to AP-2 µ2 (Krauss et al., 2006) for 
localized production. In this scenario, the AP-2 core would probably need to undergo a transition 
from the ‘closed’ to ‘open’ state and extend the µ2 C-terminus due to steric constraints for 
binding (Kahlfeldt et al., 2010) or to position the kinase domain adjacent to its substrate. 
Therefore if binding the µ2 subunit is functionally relevant, an appreciable level of PtdIns(4,5)P2 
would need to be present initially to stabilize a few molecules of AP-2 to engage the lipid kinase.  
In neuronal cells, many endocytic proteins are termed ‘dephosphins’ because they are 
phosphorylated under resting conditions by Cdk5 and this evidently prevents physical interaction 
with partner proteins or activity (Cousin and Robinson, 2001). PIPKIγ661 is a dephosphin and is 
localized to the presynapse at resting conditions where phosphorylation of Ser645 (mouse 
residue) (Nakano-Kobayashi et al., 2007) prevents the C-terminal residues (630-661) from 
engaging the AP-2 β2 appendage sandwich subdomain (Chapter 2). The structural data suggest 
that an added phosphate group on Ser645 (Ser650 in humans) would prevent hydrogen bonding 
with the appendage backbone (Kahlfeldt et al., 2010) and weaken the interaction. Following an 
action potential and Ca2+ influx, dephosphins are dephosphorylated by calcineurin (Cousin and 
Robinson, 2001).  Allowing AP-2 to bind PIPKIγ661 stimulates the kinase activity (Nakano-
Kobayashi et al., 2007) and is additionally driven by a positive feedback loop of PtdIns(4,5)P2 
stimulation of PLD (Arneson et al., 1999). PLD hydrolyzes the phospholipid PtdCho to the 
 157 
soluble headgroup choline and membrane-bound PtdOH and this lipid product stimulates PIPKI 
activity (Jenkins et al., 1994; Ishihara et al., 1998). The positive regulator PtdOH can also be 
produced by DGKδ when it engages the α appendage platform positioning it at CCSs (Kawasaki 
et al., 2007). These appendage interactions promote PtdIns(4,5)P2 generation and stimulate local 
AP-2 accumulation and clathrin assembly. Interestingly, PtdOH production promotes limited 
CCS assembly on lysosome membranes in vitro even in the absence of ATP (and potential 
PtdOH-stimulated PtdIns(4,5)P2 production) (Arneson et al., 1999) and PtdOH specifically 
influences EGFR and not TfR endocytosis (Antonescu et al., 2010). PtdOH may perform an 
important unappreciated role in CCS nucleation, perhaps binding a subset of endocytic adaptors 
or influence membrane biochemistry or curvature. Future research should focus on how PtdOH 
regulates assembly and specific cargo internalization. 
How are positive regulators of nucleation regulated themselves? In Drosophila, excessive 
PtdIns(4,5)P2 production from overexpression of the PIPKI Skittles inhibits CME of yolk protein 
endocytosis in a superficially similar fashion to Skittles hypomorphic alleles (Compagnon et al., 
2009). Therefore controlled levels of PtdIns(4,5)P2 are important, not just its production. The 
activity of PIPKIγ661 appears to be regulated not by phosphorylation directly but through 
binding its partner proteins AP-2 and talin, a process influenced by PIPKIγ661 phosphorylation 
status (Di Paolo et al., 2002; Ling et al., 2002; Ling et al., 2003; Nakano-Kobayashi et al., 
2007). By controlling PIPKIγ661 binding to these proteins, its localization and activity could be 
controlled. The requirement for PtdIns(4,5)P2 at this later assembly stage may decrease as many 
assembly proteins become concentrated and can assist in recruitment through cooperative 
actions. This thesis has shown that clathrin binding to the β2 appendage sandwich site causes 
displacement of PIPKIγ661 and therefore could regulate continued or excessive PtdIns(4,5)P2 
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production at CCS (Figure 5.2). In a lysosome clathrin coat recruitment assay, ongoing 
PtdIns(4,5)P2 production is not required to allow some clathrin assembly (Arneson et al., 1999), 
supporting this assertion.Icannot exclude the possibility that PIPKIγ661 could switch to the µ2 
subunit following clathrin assembly through the C-terminal YSPL motif (Bairstow et al., 2006) 
or kinase domain (Krauss et al., 2006). The YSPL motif scheme seems unlikely as I showed that 
β2·µ2 hemicomplex binding was negligible, and the kinase would have to compete with YXX∅ 
motif-containing cargo. 
The AP-2 appendages also bind directly or indirectly to polyphosphoinositide 
phosphatases that regulate assembly progression and uncoating (Figure 5.2). The SH2 domain-
containing inositol phosphatase 2 (SHIP2) hydrolyzes the C-5 phosphate of PtdIns(3,4,5)P3 
(preferred substrate) and PtdIns(4,5)P2 at the plasma membrane (Hejna et al., 1995) and 
knockdown of SHIP2 causes shortening of CCS lifetimes (Nakatsu et al., 2010). SHIP2 is 
targeted to CCSs by its interaction with intersectin (Nakatsu et al., 2010) and intersectin binds to 
the α and β2 appendage sandwich subdomains (Pechstein et al., 2010a). Endocytic adaptors can 
bind PtdIns(3,4,5)P3 (Rapoport et al., 1997; Itoh et al., 2001) and  although under normal 
circumstances levels of this lipid are low in cells (Wymann and Schneiter, 2008), controlled 
hydrolysis of this binding surface for adaptors may extend CCS assembly by slightly weakening 
the assembly to allow appropriate incorporation of cargo and regulatory factors. This may be 
particularly important in non-neuronal cells where speed is not paramount but producing cargo-
laden vesicles is. Interestingly, SHIP2 is recruited to CCSs early in assembly with clathrin but 
departs the coat before budding (Nakatsu et al., 2010). Intersectin binds to the β2 appendage 
sandwich subdomain like PIPKIγ661 so that as clathrin assembles, perhaps intersectin’s and 
consequently SHIP2’s connections with the endocytic machinery are weakened and its presence  
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Figure 5.2: Phosphoinositide metabolism at clathrin-coated buds. 
Schematic representation of key enzymes responsible for PtdIns(4,5)P2 synthesis and the mapped 
interactions with the AP-2 adaptor appendages. The location of the two separate PtdIns(4,5)P2 binding 
sites on the AP-2 heterotetramer is indicated with purple spots. Dotted lines represent interactions, solid 
colored arrows represent stimulation of enzymatic activity. DAG, diacylglycerol; PLD, phospholipase D; 
PLC, phospholipase C; PIK, phosphatidylinositol 4-kinase; PtdCho, phosphatidylcholine; Ins(1,4,5)P3, 
inositol 1,4,5-trisphosphate; PtdIns, phosphatidylinositol; PtdIns(4)P, phosphatidylinositol 4-phosphate; 
PtdIns(3,4)P2, phosphatidylinositol 3,4-bisphosphate; PtdIns(3,4,5)P3, phosphatidylinositol 3,4,5-
trisphosphate; ITSN, intersectin; SHIP2, SH2-containing 5’-inositol phosphatase 2; OCRL, Oculocerebral 
Renal Syndrome of Lowe protein, 
 
 
 160 
reduced. This could allow a brief period in which stabilized PtdIns(3,4,5)P3 can exert its effect 
on assembly speed after cargo has been incorporated but prior to fully active 
phosphatidylinositol hydrolysis for uncoating. However the precise stoichiometries of these lipid 
species at the nerve terminal or CCSs makes these models only speculative. 
Synaptojanin is a phosphatidylinositol polyphosphatase that functions at the later stages 
of assembly to hydrolyze PtdIns(4,5)P2 in preparation for removal of adaptors and clathrin. 
Synaptojanin is alternatively spliced (Ramjaun and McPherson, 1996) as two ubiquitiously 
expressed isoforms: synaptojanin 145 (SJ145), a brain-enriched isoform containing an α 
appendage sandwich binding motif (WXXF), and synaptojanin 170 (SJ170), containing α 
appendage platform (DPF, FXDXF) and an additional sandwich binding motif (WXXF) (Jha et 
al., 2004; Mishra et al., 2004). Synaptojanin also binds a cohort of other SH3 domain-containing 
endocytic proteins including endophilin, amphiphysin and intersectin (Cestra et al., 1999). While 
SJ170 is present at CCS throughout the entire lifecycle, likely resulting from the additional AP-2 
contacts, SJ145 is recruited as a burst at budding and probably depends more heavily on binding 
to its late-stage binding partners endophilin and amphiphysin for its timed recruitment (Perera et 
al., 2006; Taylor et al., 2011). A recent in vitro study suggests membranes of higher curvature 
stimulate synaptojanin-mediated PtdIns(4,5)P2 hydrolysis through increased targeting by the 
BAR domain binding partner endophilin and higher phosphatase activity for PtdIns(4,5)P2 in 
highly curved membranes (Chang-Ileto et al., 2011). Combining these data for a molecular 
description, in non-neuronal cells where the SJ170 isoform predominates, extensive interactions 
of SJ170 with the AP-2 α appendage place it at CCSs during the entire lifecycle. Low basal 
activity of SJ170 controls the rate of assembly by dynamically balancing PtdIns(4,5)P2 levels, 
similar to the proposed role of SHIP2, but at deeply invaginated buds SJ170 activity is maximal 
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based on curvature and the presence of BAR domain binding partners. Perhaps SJ170 activity is 
stimulated through binding its partner proteins. Through binding only to the α appendage (and 
not the β2 sandwich) and additional contacts with other endocytic proteins, synaptojanin ensures 
its presence at late stage buds to promote the loosening of adaptor-membrane interactions in 
preparation for uncoating. 
A third phosphoinositide 5-phosphatase, OCRL1, is recruited to CCSs at a late stage just 
after scission (Erdmann et al., 2007; Taylor et al., 2011). OCRL1 binds to the clathrin terminal 
domain and also to the AP-2 α appendage via a single platform binding FXDXF motif (Figure 
5.2) (Ungewickell et al., 2004). These interactions may contribute to OCRL1’s initial 
recruitment but are soon lost as the vesicle uncoats and it might be maintained on the vesicle by 
interacting with the early endosome protein APPL1 (Erdmann et al., 2007). While the role of 
OCRL1 is not well understood it could ensure an early endosome lipid composition of high 
PtdIns(3)P and low PtdIns(4,5)P2. The extensive connections of AP-2 with lipid modifying 
enzymes, particularly three phosphoinositol phosphatases, highlight that phosphoinositide 
species are carefully monitored and fine-tuned at sites of CME (Sun et al., 2007a). 
5.3 THE AP-2 β2 APPENDAGE AS A TEMPORALLY REGULATED ASSEMBLY 
PLATFORM 
It has long been known that assembly of clathrin around the AP-2 β2 subunit causes interference 
with bound β2 appendage binding partners (Cupers et al., 1998; Owen et al., 2000). This was the 
basis of the ‘changing hubs’ model in which early in assembly the AP-2 appendages constitute 
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the primary hub, coordinating numerous interactions with accessory factors. As clathrin 
assembles, the clathrin terminal domains begin to outnumber the molecules of AP-2 and become 
the primary hub, causing a migration of endocytic proteins. This migration is facilitated by a 
displacement of a subset (β2 appendage platform binding partners) of proteins from the β2 
appendage by competition from clathrin (Schmid et al., 2006; Schmid and McMahon, 2007). In 
particular, because β-arrestin 1 binding to AP-2 β2 and clathrin was shown to be mutually 
exclusive in pull down assays and increased binding of clathrin (not present in excess) to the AP-
2 β2 appendage and hinge slightly reduced bound β-arrestin 1 in similar assays, it was concluded 
that β-arrestin 1 was maintained within CCVs through its interaction with clathrin after changing 
hubs (Schmid et al., 2006). This intriguing, albeit not well supported, model is one possible 
explanation for how forming CCSs can organize their many connections and form in an ordered, 
vectorial progression. 
In Chapters 2 and 3 of this thesis I have presented data in support of an alternate model: 
clathrin assembly causes displacement of AP-2 β2 appendage sandwich subdomain partners 
while platform binding proteins including, β-arrestin 1, are unaffected. For some proteins such as 
amphiphysin I/II and AP180, their residency within forming CCVs could be maintained by their 
additional binding to AP-2 α appendage or to the clathrin terminal domain (Edeling et al., 
2006a). Another, eps15, is lost from mature areas of assembly where clathrin is completely 
polymerized and is found only at the lattice edges where unoccupied AP-2 molecules reside 
(Tebar et al., 1996; Edeling et al., 2006a). Paradoxically, eps15 also binds to the α appendage 
through numerous DPF motifs in its C-terminus (Benmerah et al., 1996) yet is displaced from 
purified AP-2 when assembled into clathrin cages in vitro (Cupers et al., 1998). Partners of the α 
appendage are not subject to this regulation; epsin 1 (a β2 platform and α platform binder) and 
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Dab2 (α platform binder) are not removed from CCSs assembled on liposomes (Mishra et al., 
2002a). PIPKIγ661 does not bind clathrin or the α appendage directly and would be expected to 
depart the lattice or relocate to the edge like eps15 where it could generate PtdIns(4,5)P2 to 
stabilize assembly. A corollary to this is that while the α appendage does not bind clathrin and 
does not appear to be significantly affected by clathrin binding to the β2 appendage, one or more 
displacement mechanisms may operate on this appendage during the CCS lifecycle. AAK1, the 
kinase that phosphorylates AP-2 µ2 and promotes the open conformation, is displaced from the 
α appendage by the Rab5 GEF hRME-6 in a process that prepares the vesicle for uncoating by 
destabilizing AP-2 and begins the transition to an early endosome environment (Semerdjieva et 
al., 2008). 
To contrast this, I find that cargo-independent, activated β-arrestin 1 remains associated 
with CCSs throughout their lifetime whether it can bind to clathrin or not.  These β-arrestin 
mutant proteins can also mediate the downregulation of the angiotensin receptor. If β-arrestin 
was lost from AP-2 as clathrin assembles and it could not bind clathrin, it should be lost from the 
forming vesicle because the sorting CLASP does not contact the core coat components. 
Furthermore in Chapter 2, the platform protein epsin 1 was not affected by sandwich targeting 
competitive peptides that affect clathrin binding to the β2 appendage in pull down experiments. 
Therefore the β2 platform proteins β-arrestins, ARH and epsin 1 constitute a privileged set of β2 
appendage proteins that are not subject to interference by clathrin. This makes intuitive sense: 
why would the clathrin machinery want to temporarily displace proteins that incorporate cargo 
into the budding vesicle, forcing them to engage clathrin? At deeply invaginated buds, lateral 
diffusion of the adaptor-cargo pair could be slight but at small, shallow assemblies there is no 
guarantee that the adaptor-cargo complex will be recaptured. The ‘changing hubs’ model also 
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invokes the idea of using small irreversible steps, such as replacing lower affinity interactions 
with higher affinity interactions, to drive the reaction in one direction. However, for β-arrestin 1 
a switch from binding the β2 appendage platform to binding the clathrin terminal domain 
involves switching from a higher affinity (~2 µM (Edeling et al., 2006a; Schmid et al., 2006)) to 
a lower affinity (22 µM (Miele et al., 2004)) interaction. 
With the exception of PIPKIγ661, partners of the AP-2 β2 appendage sandwich site such 
as AP180, CALM, eps15 and amphiphysin I/II (Edeling et al., 2006a) are structural in nature 
(although CALM and AP180 may sort cargo as well (Harel et al., 2008)). Causing dislocation of 
such proteins is much more likely to have an effect on the general architecture and dynamics of 
the forming CCV. An attractive idea is that reducing the contacts of tentative nucleation proteins 
eps15 and intersectin 1 (Chapter 4) (Henne et al., 2010) with AP-2 through clathrin 
polymerization may be a way to segregate the nucleation phase from the assembly phase and this 
could turn out to be a necessary transition in the vectorial formation of CCVs. In support of this, 
mass spectrometry analysis of isolated CCVs failed to detect eps15 or intersectin in CCVs from 
brain (Blondeau et al., 2004) or HeLa cells (Borner et al., 2006) and hepatic CCVs were de-
enriched in eps15 based on the low number of identified peptides (Girard et al., 2005). 
5.4 CLATHRIN-COATED STRUCTURE NUCLEATION THROUGH FCHO 
PROTEINS 
The concept of a dedicated protein(s) at the plasma membrane to direct recruitment of AP-2 and 
clathrin for nucleating CCSs is not a new idea. Early models favored the cytosolic tails of cargo 
molecules (Pearse and Crowther, 1987), Syt (Zhang et al., 1994) or Arf6 GTPase (Paleotti et al., 
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2005) as the ‘docking complex’. While these intregral membrane or myristoylated protein 
nucleators have fallen out of favor more recently, the soluble EFC domain proteins FCHO1 and 
FCHO2 have emerged as playing an important role in nucleating CCSs (this thesis and (Henne et 
al., 2010)). 
A provocative model has been put forth in which FCHO1 and FCHO2 are pioneer 
components of CCSs that bind to eps15, eps15R, intersectin 1 and intersectin 2 and use these 
intermediate proteins to recruit AP-2 to regions of assembly (Henne et al., 2010). AP-2 then 
binds and recruits its other partners including clathrin. Work presented in this thesis both support 
and reject pieces of this new model. FCHO1 and -2 and their partner eps15 are undoubtedly early 
components of CCSs in cells where de novo forming buds predominate. FCHO1/2 also 
participate in CCS nucleation in some cell types because modulating their cellular levels 
similarly affects the number of CCSs. Yet never did I observe a complete loss of CCSs in the 
absence of FCHO1 and/or FCHO2 in any cell type examined. It follows that unlike 
PtdIns(4,5)P2, the presence of FCHO1/2 and its accessory factors for recruitment of AP-2 to sites 
of endocytosis is not a prerequisite for CME. Therefore backup mechanisms must operate to 
ensure that CCSs form and perhaps multiple parallel pathways help ensure ongoing operation of 
the critical process of endocytosis. 
FCHO1 and FCHO2 possess properties that distinguish them from many of the other 
clathrin-associated proteins involved in endocytosis. Most of the CME proteins bind directly to 
AP-2 and/or clathrin (and some to PtdIns(4,5)P2 and cargo molecules) (Traub, 2005, 2011). 
Notable exceptions are dynamin and actin that bind to each other and their own cohort of 
adaptors and these adaptors link them to AP-2 and/or clathrin. This positioning likely separates 
their functions spatially and temporally from the assembly machinery. While FCHO1 can bind to 
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AP-2 (unpublished observations), FCHO1/2 also primarily bind indirectly to AP-2 (but not 
clathrin) through adaptors such as eps15/R and intersectin 1/2 (Reider et al., 2009; Henne et al., 
2010). Also, FCHO1 in particular is beginning to resemble AP-2 in that it contains an 
unstructured region connecting a folded globular domain, the µHD, that coordinates multiple 
interactions with eps15, eps15R, intersectin 1, intersectin 2, Dab2 (Henne et al., 2010), CALM 
and Hrb (unpublished observations). This module may be important for maintaining CCS 
number and size in specific tissues or cell lines. Additionally, this module may account for the 
internalization of AP-2-independent cargo in AP-2 RNAi HeLa cells (Barriere et al., 2006; 
Keyel et al., 2006; Maurer and Cooper, 2006). 
Experiments in this thesis have highlighted an interesting connection between the CCS 
nucleation-associated proteins FCHO1/2 and the size of flat clathrin lattices or plaques observed 
on the ventral membrane of some adherent cells in culture. A handful of studies have shed light 
on how these AP-2 and clathrin assemblies may expand laterally. Overexpression of the long 
isoform of Dab2 (mouse p96 or rat p86) induces enlarged CCSs in NIH 3T3 cells (Morris and 
Cooper, 2001) and COS7 and HeLa cells (Chetrit et al., 2009). In BS-C-1 cells, expression of a 
chimeric receptor containing the LDLR cytosolic domain along with Dab2 is necessary to induce 
so-called giant CCSs that cover a majority of the ventral plasma membrane (Mettlen et al., 
2010). The large structures were restricted to the ventral membrane unless a membrane-targeted 
myristoylated Dab2 was expressed alone suggesting the Dab2 cargo (LDLR chimeric receptor 
and/or others) promoted large clathrin assemblies specifically on the ventral membrane.  
Intriguingly, Dab2 recognizes NPXY motifs within β-integrins and promotes their 
endocytosis for focal adhesion disassembly (Eto et al., 2008; Chao and Kunz, 2009; Ezratty et 
al., 2009; Teckchandani et al., 2009). Primary osteoclasts (Akisaka et al., 2003) and HeLa cells 
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(Maupin and Pollard, 1983) contain extensive flat clathrin assemblies at regions of the ventral 
membrane closely apposed to the substrate (12 nm) and frequently adjacent to focal contacts (10 
nm substrate-membrane spacing) (Maupin and Pollard, 1983) suggesting these structures are 
involved in adhesion or regulate adhesive properties. In support of this, myotubes grown in 
culture contain substrate-bound integrins that cluster in focal adhesions and CCSs, and the CCSs 
can be competed from the integrins by NPXY motif-containing peptides encoding the integrin 
cytoplasmic domain (De Deyne et al., 1998). High concentrations of integrins could recruit Dab2 
and, as a consequence, AP-2 and clathrin. Perhaps then cargo plays an important role in large, 
flat CCSs generation. Because FCHO1/2 bind Dab2 through their µHD, FCHO1/2 may regulate 
large CCSs in cells with specific integrin expression patterns or underlying substrate 
compositions. The absence of FCHO1/2 could promote unregulated Dab2-mediated assembly. 
Circumstantial evidence could implicate actin assembly in modulating the size of large 
CCs on the ventral surface of adherent cells. Hip1R, a CCV component, simultaneously can bind 
PtdIns(4,5)P2, clathrin light chain and filamentous actin (Engqvist-Goldstein et al., 1999). 
Knockdown of Hip1R in HeLa cells causes stable association of CCSs with actin and 
enlargement of these CCSs (Engqvist-Goldstein et al., 2004). This results from derepression of 
the actin nucleation promoting factor (NPF) cortactin (Le Clainche et al., 2007), a Hip1R 
binding partner. Cortactin can then activate Arp2/3 that promotes branched actin formation.  
Intriguingly, yeast Syp1p binds to Las17p, the yeast homologue of mammalian WASP, through 
the linker region between the EFC domain and µHD and negatively regulates its activity 
(Boettner et al., 2009). Las17p/WASP act as actin NPFs for Arp2/3, similar to cortactin. 
Therefore if the Syp1p-Las17p interaction is conserved in a vertebrate FCHO-WASP interaction, 
FCHO1/2 knockdown could result in unregulated branched actin formation. How this could 
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result in large CCSs, such as in the absence of Hip1R, is unclear. Perhaps actin polymerization at 
flat clathrin lattices, as opposed to invaginating buds with an inward trajectory, could push these 
assemblies into each other or somehow promote clathrin polymerization at the edges. Such an 
interaction could explain my results where the µHD-truncated FCHO1/2 can rescue CCS 
morphology in FCHO2 knockdown cells. Though our lab has been unable to detect an FCHO-
WASP interaction by GST pulldown assays, this may be a weak interaction that warrants further 
investigation. 
What exactly are FCHO1/2 doing at bud sites prior to the arrival of AP-2 and how are 
they clustered in the absence of AP-2? Certainly FCHO1/2 bind PtdIns(4,5)P2 to target to the 
plasma membrane (Henne et al., 2010) so that by any proposed mechanism, CCS nucleation 
requires PtdIns(4,5)P2. Through a combination of FCHO1/2 oligomerization (Henne et al., 2010) 
and crosslinking by homodimerization of eps15 (Tebar et al., 1997) and heterodimerization of 
eps15-intersectin (Koh et al., 2007), clustered patches can form on the membrane. How such 
nascent assemblies would be prevented from uncontrolled or non-productive deposition remains 
to be determined. Is the role of these FCHO assemblies to optimize the membrane environment 
through clustering PtdIns(4,5)P2 and locally increasing its concentration? Perhaps FCHO1/2 also 
bind a type I PIPK to generate this lipid. It was proposed that FCHO1/2 initiate sculpting of the 
bud site (Henne et al., 2010), but the presence of operational flat clathrin lattices in normal HeLa 
cells appears to lessen this claim. FCHO1/2 may increase the efficiency of recruiting AP-2 to the 
plasma membrane, but it is hard to imagine an absolute requirement for this step when CCS can 
be reconstituted on cellular membranes in vitro through the addition of purified CCV proteins of 
which FCHO proteins are de-enriched or of sub-stoichiometric levels (Mahaffey et al., 1989). 
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In light of the data presented in this thesis, are there multiple pathways that contribute 
simultaneously to CCS nucleation? A goal in recent years has been to catalog the timing of 
individual endocytic proteins at CCSs in order to understand the encoded, sequential assembly 
instructions built into the machinery (Liu et al., 2009; Taylor et al., 2011). This approach will 
likely yield useful information, however another way to think of CCS nucleation and assembly is 
as analogous to the energy landscape model of protein folding (Onuchic and Wolynes, 2004). An 
unfolded protein can assume many different conformations of high entropy, but as it folds it 
moves down the sides of its folding funnel to its native conformation of lowest free energy and 
lowest entropy. There are multiple pathways (or sides of the funnel) to reach the same final 
protein fold. CCSs may form in a similar fashion in which different components could have the 
ability to contribute at different times. Different cell types also may use slightly different 
endocytic components and adaptors, yet as adaptors and clathrin triskelion begin to assemble 
they limit the possible number of subsequent conformations of the forming coated-pit and drive 
the process forward vectorially. Different tissues may depend to a varying extent on FCHO-
mediated or purely PtdIns(4,5)P2-driven CCS nucleation, though PtdIns(4,5)P2 will underlie all 
CCV generation events. 
Very little work has focused on the EFC domain proteins FCHO1 and FCHO2 until 
recently. Future studies will surely tease apart their precise function in nucleation and assembly. 
Of importance would be knockout studies in mice to see if FCHO1/2 are critical to life such has 
been done for other endocytic proteins (Wenk et al., 2001; Ferguson et al., 2007; Chen et al., 
2009). If FCHO1 is important during development by regulating endocytosis of Alk2, this will 
likely further our understanding of the process. If FCHO knockout is lethal, embryonic 
fibroblasts could still be obtained and further studies of CCS nucleation and endocytosis could be 
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performed in the complete absence of FCHO1/2. This would be a tractable system for further 
rescue experiments. Synaptosome-derived membrane recruitment assays (Chapter 2) provide 
another powerful system to examine FCHO1/2 involvement in nucleation. FCHO proteins could 
be immunodepleted from brain cytosol or exogenous mutant FCHO proteins could be added, 
particularly FCHO1/2 lacking the µHD. This system will allow examination of assembly prior to 
the establishment of steady state morphology in siRNA-treated cells. 
5.5 CLOSING COMMENTS 
In this dissertation, I have helped clarify the sequence of events that give rise to clathrin-coated 
structures on the plasma membrane. The nucleation phase of clathrin-mediated endocytosis 
remains one of the least well understood and yet one of the most critical. In its simplest form it 
involves the lipid PtdIns(4,5)P2 and the coordinated interaction and recruitment of endocytic 
adaptors and clathrin to the plasma membrane. In the brain, where a rapid, specialized form of 
clathrin-mediated endocytosis occurs, PtdIns(4,5)P2 is generated by PIPKIγ. I have presented a 
precise molecular description of the requirements for interaction between the C-terminus of 
PIPKIγ and the clathrin adaptor AP-2 β2 subunit appendage for focal PtdIns(4,5)P2 production. 
This interaction is likely critical for rapid PtdIns(4,5)P2 generation, adaptor recruitment and 
subsequent clathrin assembly for compensatory endocytosis during neurotransmission. In 
addition, the binding of PIPKIγ to the sandwich subdomain of the β2 appendage subjects PIPKIγ 
to displacement from clathrin binding to the same site, effectively limiting activity and preparing 
the vesicle for uncoating after scission. I also have shown that clathrin binding leaves the other 
β2 appendage binding site, the platform, unoccupied for the continued engagement of adaptors 
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such as β-arrestin or ARH. Finally, I have shown that the recently implicated endocytic proteins 
FCHO1 and FCHO2 are not absolutely required for the nucleation of clathrin-coated structures 
in cell culture. Instead these proteins are important for maintenance of the steady state 
distribution of clathrin-coated structure number and size. While other coated vesicle pathways 
such as COPI (Beck et al., 2009) and COPII (Miller and Barlowe, 2010) are nucleated by 
GTPases, clathrin-mediated endocytosis may not rely on a proteinaceous nucleating factor which 
may afford the process more flexibility and tissue-specific specializations. 
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6.0  MATERIALS AND METHODS 
6.1 CHAPTER 2 MATERIALS AND METHODS 
6.1.1 DNA constructs 
The recombinant proteins consisting of glutathione S-transferase (GST) fused to PIPKIγ (mouse 
residues 460-635, 460-661, 636-661, 630-661, and 624-661) were generated by polymerase 
chain reaction (PCR) using a mouse PIPKIγ661 cDNA as a template followed by digestion and 
ligation into EcoRI/XhoI-cleaved pGEX-4T-1. Point mutations (I633A, Y634A, F635A, 
W642A, Y644A, Y649A, and S645E) were generated by QuikChange site-directed mutagenesis 
(Stratagene). The GST-PIPKIγ(460-687) construct was generated by PCR using rat PIPKIγ687 
cDNA kindly provided by Robin Irvine (University of Cambridge, Cambridge, UK) as a 
template followed by digestion and ligation into EcoRI/XhoI-cleaved pGEX-4T-1. A GST-
human PIPKIγ668 C-terminal 28 amino acid fusion was generated by PCR utilizing overlapping 
synthetic oligonucleotides and cloned into pGEX-4T-1. The GST conjugated AP-2 αC 
appendage (mouse residues 701-938) (Traub et al., 1999), AP-2 β2 appendage (rat residues 714-
951) (Mishra et al., 2005), eps15 (622-736) and a cytosolic portion of the cation-independent 
mannose 6-phosphate receptor (CI-MPR YSKV, residues 2337-2372) (Doray et al., 2007) have 
been described previously. The FLAG-tagged AP-2 β2 subunit and µ2 subunit pFastBac Dual 
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plasmid for baculovirus production was generated as described (Doray et al., 2007). The β2 
trunk version was made from the full-length protein by deleting residues 593-951, placing the 
FLAG epitope after His592. PIPKIγ (630-661) was cloned into EcoRI/BamHI-digested pGBKT7 
while AP-2 β2 appendage (rat residues 700-937) was cloned into EcoRI/XhoI-cut pGADT7. 
Upon confirmation of the sequences, indicated mutations in the β2 appendage were created by 
QuikChange site-directed mutagenesis (Stratagene). The hexahistidine (His6) tagged AP-2 β2 
hinge and appendage (rat AP-2 β2 residues 592-951) was kindly provided by Tom Kirchhausen 
(Harvard University, Boston, MA, USA). GST conjugated epsin ENTH domain (rat epsin1 
residues 1-163) was described previously (Hawryluk et al., 2006). All clones and mutations were 
verified by automated dideoxynucleotide sequencing. 
6.1.2 Antibodies and immunoblotting 
Affinity-purified polyclonal antibody directed against epsin 1 (Drake et al., 2000) and HIP1  
(Mishra et al., 2001) were produced in our laboratory by standard procedures. Affinity-purified 
WI54 peptide antibodies directed against the 26 amino acid insert of PIPKIγ661 have been 
described (Ling et al., 2002). The anti-clathrin heavy chain monoclonal antibody (mAb) TD.1 
was generously provided by Frances Brodsky (UCSF, San Francisco, CA, USA) and the light 
chain mAb Cl37.3 by Reinhard Jahn. The anti-AP-1/2 β1/β2-subunit mAb 100/1 and rabbit 
polyclonal anti-eps15 serum were kind gifts of Ernst Ungewickell (Medizinische Hochschule 
Hannover, Hannover, Germany). The rabbit R11-29 polyclonal anti-AP-2 µ2 subunit serum was 
a generous gift from Juan Bonifacino (National Institute of Health, Bethesda, MD, USA) while 
the rabbit polyclonal anti-NECAP antibody was a kind gift of Peter McPherson (McGill 
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University, Montreal, Quebec, Canada). The anti-PIPKIγ, anti-AP180, and anti-amphiphysinI/II 
mAbs were purchased from B.D. Transduction Laboratories. The anti-FLAG M1 and M2 and 
anti-talin mAbs were purchased from Sigma. 
Samples were resolved on SDS-PAGE with an altered acrylamide-bis-acrylamide 
(30:0.4) ratio stock solution. After electrophoresis, proteins were either stained with Coomassie 
blue or transferred to nitrocellulose in ice-cold 15.6 mM Tris and 120 mM glycine. Blots were 
usually blocked overnight in 5% skim milk in 10 mM Tris-HCl (pH 7.8), 150 mM NaCl and 
0.1% Tween 20 and then portions incubated with primary antibodies as indicated in individual 
figure legends. After incubation with horseradish peroxidase-conjugated anti-mouse or anti-
rabbit immunoglobulin G, immunoreactive bands were visualized with enhanced 
chemiluminescence. 
6.1.3 Protein and tissue extract preparation 
GST and various GST fusion proteins were produced in Escherichia coli BL21 cells. Bacteria 
were induced by shifting log-phase cultures (OD600 ~0.6) from 37°C to room temperature and 
then adding isopropyl-1-thio-β-D-galactopyranoside to a final concentration of 100 µM with 
constant shaking for 3 hours or, in some instances, to 200 µM with constant shaking overnight 
(~16 hours). The bacteria were recovered by centrifugation at 15,000 x gmax at 4°C for 15 min 
and used immediately or stored at -80°C. Lysis was performed in 50 mM Tris-HCl, pH 7.5, 300 
mM NaCl, 0.2% (w/v) Triton X-100, 10 mM β-mercaptoethanol with sonication on ice. 
Insoluble material was removed by centrifugation at 23,700 x gmax at 4°C for 30 min, and then 
the GST fusions were collected on glutathione-Sepharose. After extensive washing in PBS, GST 
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fusions were eluted with 25 mM Tris-HCl, pH 8.0, 200 mM NaCl, 10 mM glutathione, 5 mM 
DTT on ice and dialyzed into PBS, 1 mM DTT before use in binding assays. In some instances, 
purified fusion proteins were cleaved from the GST with thrombin (GE Biosciences) while still 
immobilized upon glutathione-Sepharose. Digestion was as recommended by the manufacturer, 
followed by addition of the irreversible thrombin inhibitor D-Phe-Pro-Arg chloromethyl ketone 
(Calbiochem) to a final concentration of 25 µM. His6-β2 hinge + appendage was produced in E. 
coli BL21 (DE3) by induction of log-phase cultures with 1 mM isopropyl 1-thio-β-D-
galactopyranoside at room temperature for 3 h. Cleared lysates were incubated with Ni-NTA-
agarose, and bound protein was eluted in 50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 200 mM 
imidazole. 
Cytosol was prepared from frozen rat brains (PelFreez) by sequential differential 
centrifugation after homogenization in 25 mM HEPES-KOH, pH 7.2, 250 mM sucrose, 2 mM 
EDTA, and 2 mM EGTA supplemented with 1 mM phenylmethylsulfonyl fluoride and Complete 
(Roche Applied Science) protease inhibitor mixture. The 105,000 x gmax supernatant is defined as 
cytosol and was stored in small aliquots at -80°C. Before use in binding assays, thawed samples 
of rat brain cytosol were adjusted to 25 mM HEPES-KOH, pH 7.2, 125 mM potassium acetate, 5 
mM magnesium acetate, 2 mM EDTA, 2 mM EGTA, and 1 mM DTT (assay buffer) by addition 
of a 10x stock and then centrifuged at 245,000 x gmax (TLA-100.4 rotor) at 4°C for 20 min to 
remove insoluble particulate material. Lysates from infected Sf9 cells (Doray et al., 2007) were 
prepared by solubilization of pelleted cells in assay buffer with 0.4% Triton X-100 and 
supplemented with 1 mM phenylmethylsulfonyl fluoride and Complete (Roche Applied Science) 
protease inhibitor mixture. After incubation on ice for 15 min, the lysates was sonicated on ice 
three times for 15 sec and centrifuged at 500 x gmax. The supernatants were carefully aspirated 
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and stored in aliquots at -80°C. Prior to use, thawed Sf9 cell lysates were centrifuged at 125,000 
x gmax to remove aggregated material. Hemicomplexes were immunoprecipitated from 1 ml of 
clarified lysate using 35 µl packed anti-FLAG M2 agarose (Sigma) equilibrated in assay buffer 
lacking DTT. After extensively washing the anti-FLAG agarose, bound proteins were eluted with 
200 µg/ml FLAG peptide.  
Rat brain clathrin-coated vesicles were prepared exactly as described previously (Mishra 
et al., 2001). Synaptosomes were prepared from rat brain homogenized in 5 mM HEPES-KOH, 
pH 7.4, 320 mM sucrose with a Potter-Elvehjem tissue disruptor on ice (Fischer von Mollard et 
al., 1991). The supernatant from a 2 min 3,000 x gmax spin at 4°C was recentrifuged at 13,000 x 
gmax for 12 min, the pellet resuspended in homogenization buffer and again centrifuged at 13,000 
x gmax for 12 min. The resuspended pellet was layered over a discontinuous gradient of 
13%/9%/6% Ficoll 400 in homogenization buffer and centrifuged at 86,600 x gmax for 35 min at 
4°C. Cream/white-colored synaptosomes were harvested from the 6%/9% and 9%/13% 
interfaces and concentrated by centrifugation at 27,000 x gmax at 4°C for 12.5 min after dilution 
with homogenization buffer. Tenfold dilution of synaptosomes into ice-cold 5 mM Tris-HCl, pH 
8.0 followed by disruption in a Potter-Elvehjem homogenizer was used to generate synaptic 
plasma membranes. After adjusting the lysed membranes to 1.105 M sucrose, the sample was 
overlayed with 0.92 M and then 0.32 M sucrose and centrifuged at 60,000 x gave at 4°C for 60 
min. The turbid, white-colored synaptosome plasma membrane-enriched fraction at the 0.92 
M/1.105 M interface was collected and concentrated by centrifugation after dilution in 5 mM 
Tris-HCl, pH 8.0. 
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6.1.4 Kinase assays and thin layer chromatography 
Phosphoinositide synthesis on synaptic membranes was assayed in assay buffer in a final volume 
of 50 µl, precisely as described previously (Arneson et al., 1999). Briefly, the final 
concentrations were 0.5 mg/ml for membranes, 5 mg/ml for gel-filtered cytosol, and 500 µM for 
[γ-32P]ATP (0.5–1 Ci/mmole). Reactions were terminated after 10 min at 37°C by addition of 
chloroform:methanol:conc. HCl (200:100:0.75), followed by vigorous mixing. After carrier 
phosphoinositides (50 µg/tube) were added, a biphasic mixture generated by addition of 0.6 M 
HCl. Samples were centrifuged at 200 x gave for 5 min, the lower organic phase removed and 
transferred to a new tube, washed twice with chloroform:methanol:0.6 M HCl (3:48:47) and then 
dried under a stream of N2 gas at about 40°C. Dried lipid films were resuspended in 
chloroform:methanol:H2O (75:25:1) and spotted onto oxalate-impregnated, heat-activated silica 
gel HPTLC plates and resolved in chloroform:acetone:methanol:acetic acid:water 
(160:60:52:48:28). Autoradiographs were quantitiated using ImageJ (Abramoff et al., 2004). 
6.1.5 Limited proteolysis 
Purified, thrombin-cleaved PIPKIγ (460-635) and PIPKIγ (460-661) (20 µg) were incubated with 
fivefold serial dilutions of trypsin (Worthington Biochemical Corp.) in 50 mM Tris, pH 8.0, 150 
mM NaCl, 5 mM CaCl2, and 1 mM DTT at 37°C for 1 hour. Proteolysis was stopped by addition 
of 95°C 2x sample buffer and 10% of each reaction was analyzed by SDS-PAGE. 
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6.1.6 Binding assays 
Typically, 100-250 µg of GST or GST fusion proteins were first immobilized upon ~25 µL of 
packed glutathione-Sepharose by incubation at 4°C for 1 h with continuous mixing. The 
Sepharose beads containing the required immobilized proteins were then washed and 
resuspended to 50 µL in assay buffer. A 250 µL volume of clarified rat brain cytosol was usually 
added and the tubes incubated at 4°C for 60 min with continuous mixing. For the peptide 
competition assay, thrombin-cleaved protein was added directly to the assay mixture in the 
presence of 25 µM D-Phe-Pro-Arg chloromethyl ketone. The glutathione-Sepharose beads were 
recovered by centrifugation at 10,000 x gmax for 1 min, and then an aliquot of each supernatant 
removed and adjusted to 100 µL with SDS-sample buffer. After washing the Sepharose pellets 
four times each with ~1.5 mL of ice-cold PBS by centrifugation, the supernatants were aspirated, 
and each pellet resuspended in SDS-sample buffer up to ~80 µL. Unless otherwise noted, 10 µL 
aliquots, corresponding to approximately 1.5% of each supernatant and 12.5% of each pellet, 
were analyzed. 
For direct interaction assays between His6-β2 hinge + appendage and GST fusion 
proteins, typically 5 µg His6-tagged protein was bound to 5 µL packed Ni-NTA-agarose in 
20mM HEPES-HCl, pH 7.5, 20 mM imidazole, 120 mM potassium acetate, 0.1% (w/v) Triton 
X-100 and 0.1 mg/mL Bovine Serum Albumin (BSA) (binding buffer) for 1 h at 4°C with 
continuous mixing. After washing, immobilized proteins were incubated with 25 µg GST or GST 
fusion proteins in a 300 µL volume for 1 h at 4°C with continuous mixing. Proteins were 
recovered by centrifugation at 10,000 x gmax for 1 min. An aliquot of each supernatant was 
removed and adjusted to 100 µL with sample buffer.  Pellets were washed in ~1.5 mL ice-cold 
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binding buffer without BSA by centrifugation, the supernatants were aspirated, and each pellet 
was resuspended in SDS-sample buffer up to ~40 µL. Unless otherwise noted 10 µL aliquots, 
corresponding to approximately 2.5% of each supernatant and 25% of each pellet, were 
analyzed. 
6.1.7 Circular dichroism 
Appropriate GST fusion proteins immobilized on glutathione –Sepharose were incubated with 
thrombin and the soluble fraction dialyzed into 25 mM potassium phosphate, pH 7.4, 1 mM 
DTT. Circular dichroism spectra were measured on an AVIV Model 202 Spectrometer. Five 
(PIPKIγ) or three (ENTH domain) reproducible spectra were obtained from samples of 
concentrations between 0.09-0.11 mg/ml at 25°C in the near-UV wavelength region (190-280 
nm). Spectra were averaged, smoothed (Savitzky and Golay, 1964), and baseline corrected by 
subtraction of similarly collected, averaged, and smoothed data for buffer alone. 
6.1.8 Yeast two hybrid assay 
The yeast two-hybrid assay was done utilizing the Matchmaker GAL4 system (Clontech) 
according the manufacturers protocols. Appropriately transformed Saccharomyces cerevisiae 
strain AH109 was selected first on SD minimal medium plates lacking Leu and Trp. 
Approximately 11-18 individual clones were selected and then streaked onto SD medium lacking 
Leu and Trp, on plates without His, Leu, and Trp, or onto plates lacking Ade, His, Leu, and Trp. 
Clones representative of the growth pattern for the interaction being tested where then 
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resuspended, normalized by optical density and spotted identically onto dropout plates and yeast 
grown at 30°C for four days. 
6.2 CHAPTER 3 MATERIALS AND METHODS 
6.2.1 DNA constructs 
The β2-YFP plasmid was a kind gift from Alexander Sorkin (Sorkina et al., 2002). The tdRFP 
(tandem dimer Tomato)-β-arrestin1 was generated by first replacing EGFP with tdRFP (Shaner 
et al., 2004) between the NheI and BspE1 restriction sites in pEGFP-C1, followed by insertion of 
full-length Bos taurus β-arrestin 1 between XhoI and SalI sites. The tdRFP-β-arrestin 1 paired 
I386A and V387A (IV→AA) constitutively-active mutant, and the clathrin box 376LIEL→AAEA 
mutation or clathrin-box-deleted ∆LIELD were all generated using QuikChange Mutagenesis 
(Stratagene). The monomeric Cherry (mCherry)-PIPKIγ661 plasmid was kindly provided by 
Richard Anderson (Sun et al., 2007b) and was generated by inserting mCherry between HindIII 
and BamHI and PIPKIγ661 between BamHI and XbaI of pcDNA3 (Invitrogen). mCherry-
PIPKIγ(630-661) was generated by inserting a BamHI restriction site at residues 628-629 of 
PIPKIγ, cutting and religating the mCherry-PIPKIγ661 plasmid. The PIPKIγ(630-661) tandem 
and triplet plasmids were generated by inserting an additional restriction site in front of XbaI of 
mCherry-PIPKIγ(630-661), amplifying (630-661) with this new site at the 5’ end and an XbaI 
site at the 3’ end (with or without a new site prior to XbaI), and ligating this into mCherry-
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PIPKIγ(630-661). mCherry-PIPKIγ(630-661)x3 W642A was generated as above starting with 
W642A in the single repeat. 
6.2.2 Antibodies 
The anti-β-arrestin polyclonal antibody and anti-Talin monoclonal antibody were purchased 
from Sigma, the anti-tubulin mAb E7 from the Developmental Studies Hybridoma Bank. The 
AP-2 α-subunit mAb AP.6 has been described previously (Chin et al., 1989). HRP-conjugated 
donkey anti-mouse and anti-rabbit were purchased from Jackson Immunologicals. The Alexa 
Fluor 488 angiotensin II and Alexa Fluor 488 transferrin were obtained from Invitrogen. 
6.2.3 Cell culture 
HeLa SS6 cells (Elbashir et al., 2001) were cultured at 37°C humidified with 5% CO2 in DMEM 
supplemented with 10% fetal calf serum and 2 mM L-glutamine (Invitrogen). A line of HeLa 
SS6 cells stably expressing β2-YFP was selected in the same medium supplemented with 0.5 
mg/ml G-418. Analysis of these cells shows that <10% of cellular AP-2 contains the YFP-tagged 
β2 subunit. β-arrestin nullizygous mouse embryonic fibroblasts were kindly provided by Robert 
Lefkowitz (Kohout et al., 2001). Cells were maintained in DMEM supplemented with 10% fetal 
calf serum and 2 mM L-glutamine. HEK 293 cells stably expressing a FLAG-tagged type I 
angiotensin II receptor were kindly provided by Stéphane Laporte and cultured in EMEM.  
 182 
6.2.4 Immunofluorescence 
HeLa cells were prepared for immunofluorescence as previously described (Mishra et al., 2005). 
Alexa 488-labeled angiotensin II (100 nM) was added at 37°C for 5 or 20 min. For imaging of 
surface transferrin receptor-labeled fibroblasts, 25 µg/mL Tf488 was bound at 4°C for one hour 
in starvation media. Cells were washed once and imaged at 4°C in starvation media using a 
temperature-controlled stagemount (Harvard Apparatus). 
6.2.5 Microscopy 
Images were acquired on an Olympus Fluoview FV1000 as previously described (Keyel et al., 
2006). Total internal reflection fluorescence microscopy (TIR-FM) was performed as described 
previously (Keyel et al., 2004) with some modifications. Images were collected with a 
thermoelectrically cooled Cascade II 512 camera (Photometrics). Data sets were collected with 
Metamorph software at ~1 frame/5 seconds. For quantification of colocalization of tdRFP-β-
arrestin 1 with AP-2 in β2-YFP-expressing cells, an average of 55 spots/cell in 11-15 individual 
cells were analyzed. 
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6.3 CHAPTER 4 MATERIALS AND METHODS 
6.3.1 Plasmids and small interfering RNA (siRNA) 
The cloning of GFP-FCHO1 was described previously (Reider et al., 2009). To generate GFP-
FCHO2, full length human FCHO2 was PCR amplified from cDNA clone 9021067 (Open 
Biosystems, Huntsville, AL) and inserted into pEGFP-C1 using SalI restriction sites and Cold 
Fusion Cloning Technology (System Biosciences, Mountain View, CA). The tdRFP-conjugated 
FCHO2 was constructed by amplifying full length mouse FCHO2 from MGC cDNA clone 
6830607 (Open Biosystems, Huntsville, AL) with terminal SalI and NotI sites by PCR. At the 
same a NotI site was introduced into pEGFP-C1 by site-directed mutagenesis PCR then both 
vectors were digested with SalI/NotI and ligated. GFP was then replaced with tdRFP between 
NheI and BspE1. The epsin 1 ENTH domain-FCHO1 chimera (GFP-ENTH-µHD) was created 
by inserting a SpeI site by site-directed mutagenesis PCR at residues 274/275 of FCHO1 in the 
GFP-FCHO1 construct. Residues 1-163 of rat epsin 1 were amplified by PCR with terminal 
EcoRI/SpeI restriction sites and used to replace FCHO1 residues 1-275. The GFP-ENTH-
FCHO1 linker was generated by inserting a stop codon at FCHO1 residue 611 of the GFP-
ENTH-µHD. The GFP-ENTH plasmid was created by inserting a stop codon at residue 164 of 
GFP-epsin 1. GFP-eps15 was a kind gift of Pier Di Fiore (Fondazione Instituto FIRC di 
Oncologia Molecolare, Milan, Italy). To generate tdRFP-eps15, eps15 was amplified and cloned 
between the XhoI and BamHI restriction sites of tdRFP. 
The ON-TARGETplus SMARTpool siRNAs targeting human FCHO1 (L-014114-02-
0005) and FCHO2 (L-024508-02-0005) were purchased from Thermo Scientific (Waltham, 
 184 
MA). The Stealth siRNA targeting base pairs 434-458 of human FCHO2 (HSS151016, sequence 
CCAAGUGUGUAGAACAGGAGCGUUU) was purchased from Invitrogen.  
6.3.2 Antibodies 
The anti-FCHO2 polyclonal antibody was a kind gift of Harvey McMahon (Henne et al., 2010). 
The anti-clathrin heavy chain (CHC) monoclonal antibody (mAb) TD.1 (Nathke et al., 1992), the 
AP-1/2 β1/β2 subunit mAb 100/1 (Ahle et al., 1988), the AP-2α subunit mAb AP.6 (Chin et al., 
1989), rabbit R11-29 anti-AP-2 µ2 subunit serum was kindly provided by Juan Bonifacino 
(National Institutes of Health, Bethesda, MD (Aguilar et al., 1997)), anti-green fluorescent 
protein (GFP) polyclonal antibody B5 was generously provided by Phyllis Hanson (Washington 
University School of Medicine, St. Louis, MO; (Dalal et al., 2004)). The anti-CALM mAb was a 
kind gift of Jeong-Ah Kim. The anti-tubulin mAb E7 was from the Developmental Studies 
Hybridoma Bank (University of Iowa, Iowa City, IA). Affinity purified polyclonal antibodies to 
Dab2 (Mishra et al., 2002a) and epsin (Hawryluk et al., 2006) were generated in the lab by 
standard procedure. The anti-eps15 affinity purified polyclonal antibody was a kind gift of Ernst 
Ungewickell (Hanover Medical School, Hanover, Germany). Anti-AP-2α subunit mAb clone 8 
and anti-intersectin mAb were obtained from BD Biosciences Transduction Laboratories 
(Lexington, KY). A rabbit polyclonal antibody against bacterially expressed FCHO1 EFC (1-
275) was generated (Pickcell Laboratories, Lelystad, The Netherlands) and affinity purified. The 
anti-FCHO1 goat polyclonal (P-16), anti-eps15 rabbit polyclonal (C-20), and anti-Hrb goat 
polyclonal antibodies were purchased from Santa Cruz Biotech. (Santa Cruz, CA). The anti-
FCHO1 rabbit polyclonal, anti-eps15R rabbit polyclonal and C4 anti-actin mAb antibodies were 
purchased from Abcam (Cambridge, MA). The anti-LC3B (D11) monoclonal antibody was 
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purchased from Cell Signaling Technology (Danvers, MA). Horseradish Peroxidase-conjugated 
goat anti-rabbit and goat anti-mouse antibodies were purchased from GE Healthcare 
(Piscataway, NJ). Alexa Fluor 488-, and Alexa Fluor 568-conjugated goat anti-mouse and anti-
rabbit secondary antibodies and Transferrin-Alexa Fluor 568 were obtained from Invitrogen. All 
Western blots were performed as described in Chapter 2 materials and methods. 
6.3.3 Cell culture, Transfections and Tissue Preparation 
HeLa SS6 cells (Elbashir et al., 2001) were cultured at 37°C humidified with 5% CO2 in DMEM 
supplemented with 10% fetal calf serum, 25 mM HEPES pH 7.2 and 2 mM L-glutamine 
(Invitrogen). SH-SY5Y cells were a kind gift of Charleen Chu (University of Pittsburgh) and 
were cultured in the same medium. A line of HeLa SS6 cells stably expressing the AP-2 β2 
subunit conjugated to yellow fluorescent protein (YFP) was selected in the same medium 
supplemented with 0.5 mg/ml G-418 (Invitrogen). Analysis of these cells shows that <10% of 
cellular AP-2 contains the YFP-tagged β2 subunit. BS-C-1 cells stably expressing clathrin light 
chain (CLC) conjugated to EGFP were a kind gift of Tom Kirchhausen (Harvard University) and 
were maintained in the same medium supplemented with 0.4 mg/ml G-418. HT-1080 cells were 
a kind gift of Chuanyue Wu (University of Pittsburgh) and the MCF-7 cells were generously 
provided by Olivera Finn (University of Pittsburgh). Both of these cell lines were cultured in 
DMEM supplemented with 10% fetal calf serum, 25 mM HEPES pH 7.2 and 2 mM L-glutamine. 
For transient transfections, 1.3x105 cells were plated on coverslips in a 24-well dish or 
5x104 (HeLa) or 1.2 x104 BS-C-1 cells were plated directly on the coverglass of Mat-Tek dishes 
to yield approximately 60-70% confluency at 24 hs. The next day cells were transfected with 
400-500 ng DNA with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
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instructions. The cells were prepared for immunofluorescence or imaged live ~18 hs post-
transfection. For siRNA-mediated knockdown, 1x105 cells were plated in a 24-well dish on day 1 
to yield ~50% confluency the next day. On day 2, the cells were transfected with 100 nM siRNA 
with Oligofectamine (Invitrogen) according to the manufacturer’s instructions. The cells were 
split to coverslips in 24-well dishes or Mat-Tek dishes on day 3 to yield ~50% confluency the 
day following. On day 4, the cells were transfected in the same manner with siRNA with or 
without 100 ng rescue plasmid and the following day cells were imaged live or prepared for 
immunofluorescence at ~72 hs after the first transfection. Clathrin-coated vesicles were isolated 
from rat brain as described previously (Mishra et al., 2001). 
6.3.4 Immunofluorescence 
HeLa SS6 cells were prepared for immunofluorescence as described previously (Mishra et al., 
2005). For ligand internalization assays, cells were placed in DMEM supplemented with 25 mM 
HEPES-KOH, pH 7.2 and 0.5% bovine serum albumin (Starvation Media) for one h at 37°C to 
unload receptors. Cells were then incubated in the continuous presence of 25 µg/ml transferrin 
conjugated to Alexa Fluor 568 (Tf-568) (Invitrogen) for 10 mins or 10 µg/ml DiI labeled LDL 
(DiI-LDL) (Biomedical Technologies, Stoughton, MA) for 20 mins at 37°C. Uptake was stopped 
by incubating cells on coverslips in ice-cold 0.5 M NaCl and 0.2 N acetate (pH~3) to strip 
surface ligand for transferrin or ice-cold PBS for LDL. After two additional washes in ice-cold 
PBS, the cells were fixed in 2% paraformaldehyde and processed for immunofluorescence. 
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6.3.5 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
RNA was isolated from HeLa SS6 and SH-SY5Y cells by dissolving cells in culture in TRIzol 
(Invitrogen) followed by chloroform extraction. The aqueous layer was precipitated by 
isopropanol and resuspended in DEPC water. To generate cDNA, the SuperScript III kit 
(Invitrogen) was used with 4 µg DNase-treated RNA according to the manufacturer’s 
instructions. PCR of endocytic protein transcripts was performed with Taq polymerase 
(Genscript, Piscataway, NJ) and the following primers: FCHO1 sense 5’-CTG GCG CTG TGC 
CAC CTG GAA CT-3’, FCHO1 antisense 5’-GTA CTC TCC CTC CGC AGC CGC TC-3’, 
FCHO2 sense 5’-CCC CAG CAA TAT CTA GAC ACA GTC C-3’, FCHO2 antisense 5’-TAC 
AGA AAG AGG AGT TGT GGG CC-3’, SGIP1 sense 5’-GAA GTG GCA AGA CCC AGG 
CGT TCC-3’, SGIP1 antisense 5’-GGA GGT GTT CCA GTG GGA AAA GGC C-3’, Beta-
actin sense 5’-GAG AGG CAT CCT CAC CCT GAA GTA C-3’, Beta-actin antisense 5’-GCA 
CAG CCT GGA TAG CAA CGT ACA T-3’, Clathrin heavy chain sense 5’-GGA AGG AGA 
GTC TCA GCC AGT GAA A-3’, Clathrin heavy chain antisense 5’-TAT GTA ACT TCC CTC 
CAG CTT GGC C-3’, eps15 sense 5’-TTG TTG CAG CAA GCG ATT CAG CCA-3’, eps15 
antisense 5’-AGG GCA GGG TCT TGT TGG AGT TCC-3’, eps15R sense 5’-AGC CTC AAC 
AGC ACA GGG AGC CTG-3’, eps15R antisense 5’-AAG GTT CTG GGT GAG GCC CGA 
GTG-3’. The PCR cycle used was 94°C for 3 min, 94°C for 30 s, 53°C (FCHO2 and clathrin) or 
55°C (remainder) for 30 s, 72°C for one min, repeated for 30 cycles, final extension at 72°C for 
seven mins. 
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6.3.6 Microscopy 
Confocal fluorescence images were collected on an Olympus Fluoview 1000 microscope (Center 
Valley, PA) as described previously (Keyel et al., 2006), however red fluorophores Alexa Fluor 
568 and DiI were excited with a 558 nm laser line of a solid state diode laser. For fluorescence 
recovery after photobleaching experiments, cells were maintained on the microscope in DMEM 
supplemented with 10% fetal calf serum and 25 mM HEPES, pH 7.2 at 37°C on MatTek dishes 
(MatTek Corp., Ashland, MA). Cells were imaged continuously at 2s/frame with a 488 nm line 
argon laser and 5 µm diameter circular subregions were bleached simultaneously with a 405 nm 
diode laser at maximum intensity for 2 seconds. Alternatively, cells were incubated for ~20 
minutes in 0.45M sucrose containing media prior to imaging. 
For TIRF microscopy, cells were imaged on a Nikon Eclipse Ti inverted microscope 
(Melville, NY) with a 60x 1.49 NA oil immersion objective. GFP was excited with a 488 nm line 
sapphire solid state diode laser (Coherent Inc., Santa Clara, CA) while the DsRed variant tandem 
Tomato was excited with a 561 nm solid state diode laser (CrystaLaser, Reno, NV). For three 
color TIR-FM, transferrin-Alexa647 (Molecular Probes, Carlsbad, CA) was excited with a 638 
nm line solid state diode laser (Spectra Physics, Santa Clara, CA). All laser lines were selectively 
blocked within the laser bench and illumination (both intensity and blanking) was controlled by 
acousto-optical tunable filters. The excitation angle of incidence was controlled by a motorized 
TIRF illuminator and adjusted for each excitation wavelength between exposures. In all 
applications, a Z488/561/638rpc beamsplitter (Chroma Technology Corp., Bellows Falls, VT) 
was used. Images were collected using a CoolSNAP HQ2 CCD camera (Photometrics, Tucson, 
AZ). Data sets were acquired using Nikon Elements software. Typically images were collected at 
0.3-0.5 Hz.  
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6.3.7 Image Processing 
To quantify the behavior of FCHO1 relative to clathrin and spot lifetimes, random clathrin-
positive spots were chosen from the middle frame of data sets (typically around 5 mins) and 
manually scored for FCHO1 content and order of appearance. To quantify FRAP data, the 
integrated intensity of individual FCHO1/2 spots or AP-2 beta spots within the bleach region 
were measured over time and normalize to an adjacent region lacking spots in Metamorph 
software (Molecular Devices, Dowington, PA). Bleaching and recovery are reported relative to 
the average of three frames prior to bleaching. The recovery curves from 30 spots were fitted 
(Graphpad Prism Software) and the recovery and t1/2 values were averaged. 
Particle tracking to determine lifetimes of AP-2 in FCHO2 knockdown cells was 
performed in Imaris Software (Bitplane, St. Paul, MN). Data sets were smoothed with a Gaussian 
filter followed by the use of the Spots module. The spots were estimated at a diameter of 0.5 µm 
and tracked with a Brownian motion algorithm. A maximum of 0.25 µm lateral movement of 
spots between frames was permitted and gap filling was used for up to 4 consecutive frames. 
Only tracks greater than or equal to 2 frames with a mean lateral speed less than 0.1 µm/second 
were scored. A total of 12 cells were analyzed from each condition. To quantitate AP-2 structure 
properties, single confocal sections of the ventral cell surface were thresholded in Metamorph 
and regions were created around each thresholded object. Object size, fluorescence intensity and 
number were exported to Excel. To quantitate ligand internalization, confocal Z-stacks with 0.6 
µm step-size through the entire volume of the cell monolayer were used to create a maximum Z 
projection. Images were background corrected and the integrated fluorescence intensity from a 
14x14 µm region were recorded and averaged. 
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6.3.8 Electron Microscopy 
Adherent plasma membrane from cells treated with FCHO2 siRNA as described above were 
prepared for rapid-freeze, deep-etch electron microscopy as described previously (Heuser, 2000). 
Briefly, cells grown on oriented pieces of glass coverslip were disrupted by sonication, fixed in 
paraformaldehyde, and labeled with anti-FCHO2 rAb and then 15-nm gold-conjugated anti-
rabbit antibody before flash freezing in liquid helium (Keyel et al., 2006). 
6.3.9 Statistics 
In all figures, graphs represent average and error bars represent standard error. P values were 
determined by Student’s t-test or analysis of variance (ANOVA) and Tukey’s post-hoc test for 
multiple groups in SPSS (IBM, Chicago, IL). 
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